WorldWideScience

Sample records for countries harness biotechnology

  1. How can developing countries harness biotechnology to improve health?

    Directory of Open Access Journals (Sweden)

    Persad Deepa L

    2007-12-01

    Full Text Available Abstract Background The benefits of genomics and biotechnology are concentrated primarily in the industrialized world, while their potential to combat neglected diseases in the developing world has been largely untapped. Without building developing world biotechnology capacity to address local health needs, this disparity will only intensify. To assess the potential of genomics to address health needs in the developing world, the McLaughlin-Rotman Centre for Global Health, along with local partners, organized five courses on Genomics and Public Health Policy in the developing world. The overall objective of the courses was to collectively explore how to best harness genomics to improve health in each region. This article presents and analyzes the recommendations from all five courses. Discussion In this paper we analyze recommendations from 232 developing world experts from 58 countries who sought to answer how best to harness biotechnology to improve health in their regions. We divide their recommendations into four categories: science; finance; ethics, society and culture; and politics. Summary The Courses' recommendations can be summarized across the four categories listed above: Science - Collaborate through national, regional, and international networks - Survey and build capacity based on proven models through education, training, and needs assessments Finance - Develop regulatory and intellectual property frameworks for commercialization of biotechnology - Enhance funding and affordability of biotechnology - Improve the academic-industry interface and the role of small and medium enterprise Ethics, Society, Culture - Develop public engagement strategies to inform and educate the public about developments in genomics and biotechnology - Develop capacity to address ethical, social and cultural issues - Improve accessibility and equity Politics - Strengthen understanding, leadership and support at the political level for biotechnology

  2. Fostering biotechnology entrepreneurship in developing countries

    African Journals Online (AJOL)

    Fred

    countries cheaper and potentially easier to administer. Efficient sewage treatment ... developing countries, start-up funding for biotechnology companies is still very ... Business incubators are unique in stimulating spin-offs from universities and ...

  3. Biotechnology Patenting in the BRICS Countries: Strategies and Dynamics.

    Science.gov (United States)

    Streltsova, Ekaterina; Linton, Jonathan D

    2018-01-05

    The BRICS countries (Brazil, Russia, India, China, South Africa) account for 25% of global biotechnology patents. To understand the current and future landscape of the domain, it is important to better understand the capacity of these contributors. Here, we consider the thematic priorities, strategies, and key players of the BRICS countries in biotechnology patenting. Copyright © 2017 Elsevier Ltd. All rights reserved.

  4. Agricultural biotechnology and smallholder farmers in developing countries.

    Science.gov (United States)

    Anthony, Vivienne M; Ferroni, Marco

    2012-04-01

    Agricultural biotechnology holds much potential to contribute towards crop productivity gains and crop improvement for smallholder farmers in developing countries. Over 14 million smallholder farmers are already benefiting from biotech crops such as cotton and maize in China, India and other Asian, African and Central/South American countries. Molecular breeding can accelerate crop improvement timescales and enable greater use of diversity of gene sources. Little impact has been realized to date with fruits and vegetables because of development timescales for molecular breeding and development and regulatory costs and political considerations facing biotech crops in many countries. Constraints to the development and adoption of technology-based solutions to reduce yield gaps need to be overcome. Full integration with broader commercial considerations such as farmer access to seed distribution systems that facilitate dissemination of improved varieties and functioning markets for produce are critical for the benefits of agricultural biotechnology to be fully realized by smallholders. Public-private partnerships offer opportunities to catalyze new approaches and investment while accelerating integrated research and development and commercial supply chain-based solutions. Copyright © 2011. Published by Elsevier Ltd.

  5. Kumar, Prof. Har Darshan

    Indian Academy of Sciences (India)

    Fellow Profile. Elected: 1975 Section: Plant Sciences. Kumar, Prof. Har Darshan Ph.D. (London), FNA, FNASc. Date of birth: 25 February 1934. Specialization: Algology, Microbial Biotechnology, Genetics, Ecology and Environment Address: Mrigtrishna, B.32/32, H.K. 214, Saketnagar Colony, Naria, Varanasi 221 005, U.P.

  6. How can Small Countries in South Asia benefit from Biotechnology ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    This grant will help small developing countries in South Asia develop ... and Development) countries and emerging economies like India and China. The second concerns a plan to implement agro-biotechnology businesses based on tissue ... in India, including heat stress, water management, and climate-related migration.

  7. Agricultural biotechnologies in developing countries and their possible contribution to food security.

    Science.gov (United States)

    Ruane, John; Sonnino, Andrea

    2011-12-20

    Latest FAO figures indicate that an estimated 925 million people are undernourished in 2010, representing almost 16% of the population in developing countries. Looking to the future, there are also major challenges ahead from the rapidly changing socio-economic environment (increasing world population and urbanisation, and dietary changes) and climate change. Promoting agriculture in developing countries is the key to achieving food security, and it is essential to act in four ways: to increase investment in agriculture, broaden access to food, improve governance of global trade, and increase productivity while conserving natural resources. To enable the fourth action, the suite of technological options for farmers should be as broad as possible, including agricultural biotechnologies. Agricultural biotechnologies represent a broad range of technologies used in food and agriculture for the genetic improvement of plant varieties and animal populations, characterisation and conservation of genetic resources, diagnosis of plant or animal diseases and other purposes. Discussions about agricultural biotechnology have been dominated by the continuing controversy surrounding genetic modification and its resulting products, genetically modified organisms (GMOs). The polarised debate has led to non-GMO biotechnologies being overshadowed, often hindering their development and application. Extensive documentation from the FAO international technical conference on Agricultural Biotechnologies in Developing Countries (ABDC-10), that took place in Guadalajara, Mexico, on 1-4 March 2010, gave a very good overview of the many ways that different agricultural biotechnologies are being used to increase productivity and conserve natural resources in the crop, livestock, fishery, forestry and agro-industry sectors in developing countries. The conference brought together about 300 policy-makers, scientists and representatives of intergovernmental and international non

  8. Biotechnology: challenges and prospects

    Energy Technology Data Exchange (ETDEWEB)

    Sasson, A.

    1985-04-01

    Rapidly occurring technological breakthroughs in the wake of numerous discoveries in different fields, such as biochemistry, genetic engineering as well as cellular and molecular biology as described in this paper have a variety of industrial applications, and forcasts covering these and various other fields have been made. The emerging bio-industry, covering diverse industries, such as chemical, food, pharmaceutical, etc., as well as the domains of health, environmental protection and abatement of pollution present challenging prospects. Several biotechnology processes relating to bioenergy, fermentation, waste transformation, vaccines, etc. are of particular interest to the developing countries. The 'functioning systems' resulting from the breakthrouth in genetic engineering, entailing extraordinary refinement of analytical techniques and technological progress, pose the challenging task of harnessing them to the advantage of mankind. Providing effective legal protection, conducive to the development of biotechnologies-their innovative process and technological change-is a matter of serious concern, involving practical and economical considerations. Several other issues and questions, such as risk prevention and management of potential dangers and hazards in genetic recombination operation by way of safety regulations and necessary guidelines, questions relating to the clinical trials of the interferons-the wonder drug-as well as questions of professional ethics are raised by biotechnologies. Industry-funded research in biotechnology, where scientific and commercial imperatives are interlocked, has for instance, its repercussions on the traditional thrust of university system, specially the sanctity of autonomy for basic research.

  9. Bioenergy and the potential contribution of agricultural biotechnologies in developing countries

    Energy Technology Data Exchange (ETDEWEB)

    Ruane, John [FAO Working Group on Biotechnology, UN Food and Agriculture Organization (FAO), Viale delle Terme di Caracalla, 00153 Rome (Italy); Sonnino, Andrea [FAO Office of Knowledge Exchange, Research and Extension, UN Food and Agriculture Organization (FAO), Viale delle Terme di Caracalla, 00153 Rome (Italy); Agostini, Astrid [FAO Investment Centre, UN Food and Agriculture Organization (FAO), Viale delle Terme di Caracalla, 00153 Rome (Italy)

    2010-10-15

    We provide an overview of the current status of bioenergy development, focusing on first- and second-generation liquid biofuels, considering drivers of growth and risks that have raised concerns over recent years. We also describe the main areas where biotechnologies are being, or can be, applied for production of first- and second-generation biofuels as well as microalgal biodiesel and biogas. Greatest attention is paid to second-generation biofuels in the review because of the large expectations they have created and because of the significant role that biotechnology applications are likely to play in their development. We close with some specific considerations regarding applying biotechnologies for bioenergy development in developing countries. (author)

  10. Biotechnology to harness the benefits of dietary phenolics; focus on Lamiaceae.

    Science.gov (United States)

    Shetty, K

    1997-09-01

    Phytochemicals from herbs and fermented legumes are excellent dietary sources of phenolic metabolites. These phenolics have importance not only as food preservatives but increasingly have therapeutic and pharmaceutical applications. The long-term research objecitves of the food biotechnology program at the University of Massachusetts are to elucidate the molecular and physiological mechanisms associated with synthesis of important health-related, therapeutic phenolic metabolites in food-related plants and fermented plant foods. Current efforts focus on elucidation of the role of the proline-linked pentose phosphate pathway in regulating the synthesis of anti-inflammatory compound, rosmarinic acid (RA). Specific aims of the current research efforts are: (i) To develop novel tissue culture-based selection techniques to isolate high RA-producing, shoot-based clonal lines from genetically heterogeneous, cross-pollinating species in the family Lamiaceae; (ii) To target genetically uniform, regenerated shoot-based clonal lines for: (a) preliminary characterization of key enzymes associated with the pentose phosphate pathway and linked to RA synthesis; (b) development of genetic transformation techniques for subsequent engineering of metabolic pathways associated with RA synthesis. These research objectives have substantial implications for harnessing the genetic and biochemical potential of genetically heterogeneous, food-related medicinal plant species. The success of this research also provides novel methods and strategies to gain access to metabolic pathways of pharmaceutically important metabolites from ginger, curcuma, chili peppers, melon or other food-related species with novel phenolics.

  11. Biotechnology in developing countries : Proceedings of the symposium, Delft, The Netherlands, 13-14 October 1982

    NARCIS (Netherlands)

    Van Hemert, P.A.; Lelieveld, H.L.M.; La Rivière, J.W.M.

    1983-01-01

    Biotechnology in Developing Countries aims to be more than the cleverly chosen combination of two hot topics of today. It is obvious that Biotechnology, as the technology of using microorganisms and tissue cells, has certain intrinsic advantages over other technologies in the setting of a Developing

  12. Development of health biotechnology in developing countries: can private-sector players be the prime movers?

    Science.gov (United States)

    Abuduxike, Gulifeiya; Aljunid, Syed Mohamed

    2012-01-01

    Health biotechnology has rapidly become vital in helping healthcare systems meet the needs of the poor in developing countries. This key industry also generates revenue and creates employment opportunities in these countries. To successfully develop biotechnology industries in developing nations, it is critical to understand and improve the system of health innovation, as well as the role of each innovative sector and the linkages between the sectors. Countries' science and technology capacities can be strengthened only if there are non-linear linkages and strong interrelations among players throughout the innovation process; these relationships generate and transfer knowledge related to commercialization of the innovative health products. The private sector is one of the main actors in healthcare innovation, contributing significantly to the development of health biotechnology via knowledge, expertise, resources and relationships to translate basic research and development into new commercial products and innovative processes. The role of the private sector has been increasingly recognized and emphasized by governments, agencies and international organizations. Many partnerships between the public and private sector have been established to leverage the potential of the private sector to produce more affordable healthcare products. Several developing countries that have been actively involved in health biotechnology are becoming the main players in this industry. The aim of this paper is to discuss the role of the private sector in health biotechnology development and to study its impact on health and economic growth through case studies in South Korea, India and Brazil. The paper also discussed the approaches by which the private sector can improve the health and economic status of the poor. Copyright © 2012 Elsevier Inc. All rights reserved.

  13. Biotechnology 2007

    International Nuclear Information System (INIS)

    2007-12-01

    This book deals with Bio-vision 2016 on the meaning and important contents Next, it reveals vision of biotechnology, current condition of biotechnology in the main countries such as the U.S, Japan, Eu and China, promoting nation biotechnology with promotion policy, support policy for biotechnology such as agriculture and forestry and information and communication, competitiveness of biotechnology, research development by fields and related industries and regulation and system on biotechnology.

  14. Case studies on the use of biotechnologies and on biosafety provisions in four African countries.

    Science.gov (United States)

    Black, Robert; Fava, Fabio; Mattei, Niccolo; Robert, Vincent; Seal, Susan; Verdier, Valerie

    2011-12-20

    This review is based on a study commissioned by the European Commission on the evaluation of scientific, technical and institutional challenges, priorities and bottlenecks for biotechnologies and regional harmonisation of biosafety in Africa. Biotechnology was considered within four domains: agricultural biotechnologies ('Green'), industrial biotechnologies and biotechnologies for environmental remediation ('White'), biotechnologies in aquaculture ('Blue') and biotechnologies for healthcare ('Red'). An important consideration was the decline in partnerships between the EU and developing countries because of the original public antipathy to some green biotechnologies, particularly genetically modified organisms (GMOs) and food from GM crops in Europe. The study focus reported here was West Africa (Ghana, Senegal, Mali and Burkina Faso). The overall conclusion was that whereas high-quality research was proceeding in the countries visited, funding is not sustained and there is little evidence of practical application of biotechnology and benefit to farmers and the wider community. Research and development that was being carried out on genetically modified crop varieties was concentrating on improving food security and therefore unlikely to have significant impact on EU markets and consumers. However, there is much non-controversial green biotechnology such as molecular diagnostics for plant and animal disease and marker-assisted selection for breeding that has great potential application. Regarding white biotechnology, it is currently occupying only a very small industrial niche in West Africa, basically in the sole sector of the production of liquid biofuels (i.e., bio-ethanol) from indigenous and locally planted biomass (very often non-food crops). The presence of diffused small-scale fish production is the basis to develop and apply new (Blue) aquaculture technologies and, where the research conditions and the production sector can permit, to increase this type of

  15. Harnessing genomics to improve health in the Eastern Mediterranean Region – an executive course in genomics policy

    Directory of Open Access Journals (Sweden)

    Singer Peter A

    2005-01-01

    Full Text Available Abstract Background While innovations in medicine, science and technology have resulted in improved health and quality of life for many people, the benefits of modern medicine continue to elude millions of people in many parts of the world. To assess the potential of genomics to address health needs in EMR, the World Health Organization's Eastern Mediterranean Regional Office and the University of Toronto Joint Centre for Bioethics jointly organized a Genomics and Public Health Policy Executive Course, held September 20th–23rd, 2003, in Muscat, Oman. The 4-day course was sponsored by WHO-EMRO with additional support from the Canadian Program in Genomics and Global Health. The overall objective of the course was to collectively explore how to best harness genomics to improve health in the region. This article presents the course findings and recommendations for genomics policy in EMR. Methods The course brought together senior representatives from academia, biotechnology companies, regulatory bodies, media, voluntary, and legal organizations to engage in discussion. Topics covered included scientific advances in genomics, followed by innovations in business models, public sector perspectives, ethics, legal issues and national innovation systems. Results A set of recommendations, summarized below, was formulated for the Regional Office, the Member States and for individuals. • Advocacy for genomics and biotechnology for political leadership; • Networking between member states to share information, expertise, training, and regional cooperation in biotechnology; coordination of national surveys for assessment of health biotechnology innovation systems, science capacity, government policies, legislation and regulations, intellectual property policies, private sector activity; • Creation in each member country of an effective National Body on genomics, biotechnology and health to: - formulate national biotechnology strategies - raise

  16. Practicing environmental biotechnology

    OpenAIRE

    Bruce E.Rittmann

    2014-01-01

    Environmental biotechnology involves ″managing microbial communities to provide services to society″.Its success comes from partnering with prokaryotic microorganisms,whose wideranging metabolic capabilities can be harnessed to destroy pollutants and to generate renewable materials.Partnering with microorganisms requires that we understand them well,and important advances in molecular microbial ecology,analytical chemistry,and mathematical modeling are making it possible to look inside the b...

  17. Biotechnologizing Jatropha for local sustainable development

    NARCIS (Netherlands)

    Puente, D.

    2010-01-01

    This article explores whether and how the biotechnologization process that the fuel-plant Jatropha curcas is undergoing might strengthen local sustainable development. It focuses on the ongoing efforts of the multi-stakeholder network Gota Verde to harness Jatropha within local small-scale

  18. First report on the state of the world's animal genetic resources. Views on biotechnology as expressed in country reports

    International Nuclear Information System (INIS)

    Cardellino, R.; Hoffmann, I.; Tempelman, K.A.

    2005-01-01

    As part of the country-driven strategy for the management of farm animal genetic resources, FAO invited 188 counties to participate in the First Report on the State of the World's Animal Genetic Resources, with 145 consenting. Their reports are an important source of information on the use of biotechnology, particularly biotechnical products and processes. This paper analyses information from country reports so far submitted, and is therefore preliminary. There is clearly a big gap in biotechnology applications between developed and developing countries, with artificial insemination the most common technology used in developing countries, although not everywhere. More complex techniques, such as embryo transfer (ET) and molecular tools, are even less frequent in developing countries. Most developing countries wish to expand ET and establish gene banks and cryoconservation techniques. There are very few examples in developing countries of livestock breeding programmes capable of incorporating molecular biotechnologies in livestock genetic improvement programmes. (author)

  19. Patenting activity in biotechnology and pharmaceuticals: a comparative analysis of the Nordic Countries

    OpenAIRE

    Enrico Sorisio

    2009-01-01

    The main aim of this paper is to study innovative activity, as measured by patent indicators, in pharmaceutical and biotechnological sectors in the Nordic Countries. The biotech sector in general and pharmaceutical in particular is one of the areas selected for strategic investments in every Nordic country. In terms of patents granted by country of inventors Denmark plays a leading role followed by Sweden, while patenting activity in Finland and Norway is lower. A concentration of patents tow...

  20. Food production in developing countries - the role of plant biotechnology

    OpenAIRE

    D. I. Ferreira

    1995-01-01

    The world is facing major problems with regard to food production. Agricultural land suffers from various conditions which make it less efficient for crop production while the rapid population growth, especially in developing countries, raises concern for sustainable food production. The Green Revolution has failed to secure sustainable food production and it is hoped that biotechnology will facilitate the transition to more sustainable agriculture. Excellent progress has been made with b...

  1. Biotechnology 2009

    International Nuclear Information System (INIS)

    2009-12-01

    This book first reveals prospect on biotechnology with low-carbon green growth Next, it consists of four chapters, which deal with vision of biotechnology, trend of biotechnology in main countries like the U.S, Eu, Japan and China, current condition for biotechnology with support and promoting policy such as health and medical treatment and maritime and fisheries, major product on investment, human power, paper and pattern, research development such as genomic, system biology, bio new medicine, agriculture, stock breeding and food, biological resources and legal system related biotechnology.

  2. Decomposing the effects of time on the social acceptability of biotechnology using age-period-cohort-country models.

    Science.gov (United States)

    Rousselière, Damien; Rousselière, Samira

    2017-08-01

    The study of European attitudes toward biotechnologies underlines a situation that is relatively contrasting in Europe. However, as different effects of time can influence the social attitudes (a life-cycle effect, a generational effect, and an exogenous temporal effect potentially affecting the entire population), an appropriate methodology should be used. To this end, age-period-cohort-country models have thus been estimated based on Eurobarometer data from 1991 onward. Applied to different data subsets, these models give similar results underlining the importance of the life-cycle effects as well as the heterogeneity of the link between political affiliation and biotechnologies attitudes across the European countries.

  3. Development of biotechnology in India.

    Science.gov (United States)

    Ghose, T K; Bisaria, V S

    2000-01-01

    India has embarked upon a very ambitious program in biotechnology with a view to harnessing its available human and unlimited biodiversity resources. It has mainly been a government sponsored effort with very little private industry participation in investment. The Department of Biotechnology (DBT) established under the Ministry of Science and Technology in 1986 was the major instrument of action to bring together most talents, material resources, and budgetary provisions. It began sponsoring research in molecular biology, agricultural and medical sciences, plant and animal tissue culture, biofertilizers and biopesticides, environment, human genetics, microbial technology, and bioprocess engineering, etc. The establishment of a number of world class bioscience research institutes and provision of large research grants to some existing universities helped in developing specialized centres of biotechnology. Besides DBT, the Department of Science & Technology (DST), also under the Ministry of S&T, sponsors research at universities working in the basic areas of life sciences. Ministry of Education's most pioneering effort was instrumental in the creation of Biochemical Engineering Research Centre at IIT Delhi with substantial assistance from the Swiss Federal Institute of Technology, Zurich, Switzerland to make available state-of-the-art infrastructure for education, training, and research in biochemical engineering and biotechnology in 1974. This initiative catalysed biotechnology training and research at many institutions a few years later. With a brief introduction, the major thrust areas of biotechnology development in India have been reviewed in this India Paper which include education and training, agricultural biotechnology, biofertilizers and biopesticides, tissue culture for tree and woody species, medicinal and aromatic plants, biodiversity conservation and environment, vaccine development, animal, aquaculture, seri and food biotechnology, microbial

  4. Practicing environmental biotechnology

    Directory of Open Access Journals (Sweden)

    Bruce E.Rittmann

    2014-02-01

    Full Text Available Environmental biotechnology involves ″managing microbial communities to provide services to society″.Its success comes from partnering with prokaryotic microorganisms,whose wideranging metabolic capabilities can be harnessed to destroy pollutants and to generate renewable materials.Partnering with microorganisms requires that we understand them well,and important advances in molecular microbial ecology,analytical chemistry,and mathematical modeling are making it possible to look inside the black box of microbial communities.Also crucial is translating the understanding to biotechnological processes that ″work for the microorganisms so that they work for us″.Successful translation demands novel reactor designs,application of advanced materials,and partnering with practitioners and users.The Swette Center for Environmental Biotechnology,founded in at Arizona State University in 2005,brings together the science and engineering tools in an interdisciplinary environment.The Center emphasizes teamwork and collaborations with research and practice partners around the world.Three new technologies illustrate how the Center applies these principles to ″work for the microorganisms″:the H2-based membrane biofilm reactor (MBfR for reducing many oxidized contaminants in water,the microbial electrochemical cells (MXCs for converting organic wastes into renewable products,and Intimately Coupled PhotoBioCatalysis (ICPBC to detoxify very difficult to biodegrade organic pollutants.

  5. An Overview on Indian Patents on Biotechnology.

    Science.gov (United States)

    Mallick, Anusaya; Chandra Santra, Subhas; Samal, Alok Chandra

    2015-01-01

    The application of biotechnology is a potential tool for mitigating the present and future fooding and clothing demands in developing countries like India. The commercialization of biotechnological products might benefiting the poor`s in developing countries are unlikely to be developed. Biotechnology has the potential to provide a wide range of products and the existing production skills in the industrial, pharmaceuticals and the agricultural sector. Ownership of the intellectual property rights is the key factors in determining the success of any technological invention, which was introduced in the market. It provides the means for technological progress to continue of the industry of the country. The new plans, animal varieties, new methods of treatments, new crops producing food articles as such are the inventions of biotechnology. Biotechnology is the result of the application of human intelligence and knowledge to the biological processes. Most of the tools of biotechnology have been developed, by companies, governments, research in- stitutes and universities in developed nations. These human intellectual efforts deserve protection. India is a developing country with advance biotechnology based segments of pharmaceutical and agricultural industries. The Trade Related Intellectual Property Rights (TRIPS) is not likely to have a significant impact on incentives for innovation creation in the biotechnology sectors. In the recent years, the world has seen the biotechnology sector as one of greatest investment area through the Patent Law and will giving huge profit in future. The Research and Development in the field of biotechnology should be encouraged for explor- ing new tools and improve the biological systems for interest of the common people. Priority should be given to generation, evaluation, protection and effective commercial utilization of tangible products of intellectual property in agriculture and pharmaceuticals. To support the future growth and

  6. STRENGTHENING BIOTECHNOLOGY RESEARCH IN INDONESIA

    Directory of Open Access Journals (Sweden)

    S. Sastrapradja

    2012-09-01

    Full Text Available The wave of biotechnology promises has struck not only the developed countries but the developing countries as well. The scientific community in Indonesia is aware of the opportunities and is eager to take an active part in this particular endeavour. Meanwhile resources are required to welcoming the biotech­nology era. The need of trained manpower, appropriate infrastructure and equipment, operational and maintenance costs requires serious consideration if a unit or a laboratory is expected to be functional in biotechnology. There is a good opportunity of applying biotechnology in the field of agriculture and industry considering the availability of biological resources in Indonesia. This paper outlines what have been done so far, the difficulties encountered and the efforts made to strengthening biotechnology research in Indonesia.

  7. A bibliometric assessment of ASEAN collaboration in plant biotechnology

    KAUST Repository

    Payumo, Jane

    2015-04-03

    This study draws on publication and citation data related to plant biotechnology from a 10-year (2004–2013) period to assess the research performance, impact, and collaboration of member states of the Association of Southeast Asian Nations (ASEAN). Plant biotechnology is one of the main areas of cooperation between ASEAN member states and among the research areas promoted to achieve regional food security and sustainable development. In general, findings indicate increased scientific output, influence, and overall collaboration of ASEAN countries in plant biotechnology over time. Research performance and collaboration (domestic, regional, and international) of the region in plant biotechnology are linked to the status of the economic development of each member country. Thailand produced the most publications of the ASEAN member states while Singapore had the highest influence as indicated by its citation activity in plant biotechnology among the ASEAN countries. Domestic and international collaborations on plant biotechnology are numerous. Regional collaboration or partnership among ASEAN countries was, however, was found to be very limited, which is a concern for the region’s goal of economic integration and science and technology cooperation. More studies using bibliometric data analysis need to be conducted to understand plant biotechnology cooperation and knowledge flows between ASEAN countries. © 2015 Akadémiai Kiadó, Budapest, Hungary

  8. Agricultural biotechnology research and development in Ethiopia ...

    African Journals Online (AJOL)

    Ethiopia is an agrarian country that can have enormous benefit from the applications of biotechnology for increasing its agricultural productivity. The country is at initial stages of research and development in agricultural biotechnology with scattered efforts underway in various public institutions. Research efforts and ...

  9. BIOTECHNOLOGY CAN IMPROVE FOOD SECURITY IN AFRICA ...

    African Journals Online (AJOL)

    BIOTECHNOLOGY CAN IMPROVE FOOD SECURITY IN AFRICA. ... and capacity to innovate and patent new materials as well as enforce biosafety requirements. In order for countries to access biotechnology products or technologies, it will ...

  10. Risk evaluation in biotechnology of environment

    International Nuclear Information System (INIS)

    Mazaheri Asadi, M.

    2003-01-01

    It is the Era of technology and many countries are adjusting their economy with it. The research on biotechnology is done with a logarithmic rate at different technologies such as pharmacy, agriculture, environment, food, oil, and etc. The relevant research would result in the production of new materials which are released into the environment. In many developed countries biotechnology is regarded as a firm base for economic development and without doubt plays a determined role in humane wealth and well-being, but this technology should be sustainable and controllable. The producer and consumer of biotechnology must think deeply about this matter and take into account the health and sustain ability of earth and the environment. Evaluation of ecological impacts of micro- organisms and manipulated genetically organism should be considered in all countries of the world and such an activities should be regulated and controlled as it was don in Canada under the supervision of Dept

  11. Bioceres: AG Biotechnology from Argentina

    Directory of Open Access Journals (Sweden)

    Roberto Feeney

    2016-04-01

    Full Text Available In this case we present a business decision-making situation in which the CEO of an Argentine Ag Biotech company, Bioceres, has to decide the best way to commercialize a new drought-tolerant transgenic technology. The company was founded by twenty three farmers, who shared a common dream that Argentina could become a benchmark in the development of Ag biotechnology. The case has strategic and financial implications, as well as decision-making situation involving a joint venture with an American biotechnology company. It also introduces to discussion the business models of Ag biotechnology companies in developing countries.

  12. Medical Biotechnology: Problems and Prospects in Bangladesh

    Directory of Open Access Journals (Sweden)

    Shaikh Mizan

    2013-01-01

    Full Text Available Biotechnology is the knowledge and techniques of developing and using biological systems for deriving special products and services. The age-old technology took a new turn with the advent of recombinant DNA techniques, and boosted by the development of other molecular biological techniques, cell culture techniques and bioinformatics. Medical biotechnology is the major thrust area of biotechnology. It has brought revolutions in medicine – quick methods for diagnosing diseases, generation of new drugs and vaccines, completely novel approach of treatment are only a few to mention. The industrial and financial bulk of the industry mushroomed very rapidly in the last three decades, led by the USA and western advanced nations. Asian countries like China, India, South Korea, Taiwan and Singapore joined late, but advancing forward in a big way. In all the Asian countries governments supported the initiatives of the expert and entrepreneur community, and invested heavily in its development. Bangladesh has got great potential in developing biotechnology and reaping its fruits. However, lack of commitment and patriotism, and too much corruption and irresponsibility in political and bureaucratic establishment are the major hindrance to the development of biotechnology in Bangladesh.

  13. Feeding the world with induced mutations and biotechnology

    International Nuclear Information System (INIS)

    Mohan Jain, S.

    2002-01-01

    The paper discussed the following subjects: biotechnology - somaclonal variation, somatic embryogenesis, somatic cell hybridization; induced mutations - in banana, ornamental plants; in vitro mutagenesis; T-DNA insertional mutagenesis. Suggestions for improving biotechnology in the developing countries also presented in the paper

  14. The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico

    Science.gov (United States)

    2018-01-01

    This paper analyzes the patterns of health biotechnology publications in six Latin American countries from 2001 to 2015. The countries studied were Argentina, Brazil, Chile, Colombia, Cuba and Mexico. Before our study, there were no data available on HBT development in half of the Latin-American countries we studied, i.e., Argentina, Colombia and Chile. To include these countries in a scientometric analysis of HBT provides fuller coverage of HBT development in Latin America. The scientometric study used the Web of Science database to identify health biotechnology publications. The total amount of health biotechnology production in the world during the period studied was about 400,000 papers. A total of 1.2% of these papers, were authored by the six Latin American countries in this study. The results show a significant growth in health biotechnology publications in Latin America despite some of the countries having social and political instability, fluctuations in their gross domestic expenditure in research and development or a trade embargo that limits opportunities for scientific development. The growth in the field of some of the Latin American countries studied was larger than the growth of most industrialized nations. Still, the visibility of the Latin American research (measured in the number of citations) did not reach the world average, with the exception of Colombia. The main producers of health biotechnology papers in Latin America were universities, except in Cuba were governmental institutions were the most frequent producers. The countries studied were active in international research collaboration with Colombia being the most active (64% of papers co-authored internationally), whereas Brazil was the least active (35% of papers). Still, the domestic collaboration was even more prevalent, with Chile being the most active in such collaboration (85% of papers co-authored domestically) and Argentina the least active (49% of papers). We conclude that the

  15. The rise of health biotechnology research in Latin America: A scientometric analysis of health biotechnology production and impact in Argentina, Brazil, Chile, Colombia, Cuba and Mexico.

    Science.gov (United States)

    León-de la O, Dante Israel; Thorsteinsdóttir, Halla; Calderón-Salinas, José Víctor

    2018-01-01

    This paper analyzes the patterns of health biotechnology publications in six Latin American countries from 2001 to 2015. The countries studied were Argentina, Brazil, Chile, Colombia, Cuba and Mexico. Before our study, there were no data available on HBT development in half of the Latin-American countries we studied, i.e., Argentina, Colombia and Chile. To include these countries in a scientometric analysis of HBT provides fuller coverage of HBT development in Latin America. The scientometric study used the Web of Science database to identify health biotechnology publications. The total amount of health biotechnology production in the world during the period studied was about 400,000 papers. A total of 1.2% of these papers, were authored by the six Latin American countries in this study. The results show a significant growth in health biotechnology publications in Latin America despite some of the countries having social and political instability, fluctuations in their gross domestic expenditure in research and development or a trade embargo that limits opportunities for scientific development. The growth in the field of some of the Latin American countries studied was larger than the growth of most industrialized nations. Still, the visibility of the Latin American research (measured in the number of citations) did not reach the world average, with the exception of Colombia. The main producers of health biotechnology papers in Latin America were universities, except in Cuba were governmental institutions were the most frequent producers. The countries studied were active in international research collaboration with Colombia being the most active (64% of papers co-authored internationally), whereas Brazil was the least active (35% of papers). Still, the domestic collaboration was even more prevalent, with Chile being the most active in such collaboration (85% of papers co-authored domestically) and Argentina the least active (49% of papers). We conclude that the

  16. A bibliometric assessment of ASEAN collaboration in plant biotechnology

    KAUST Repository

    Payumo, Jane; Sutton, Taurean C.

    2015-01-01

    , influence, and overall collaboration of ASEAN countries in plant biotechnology over time. Research performance and collaboration (domestic, regional, and international) of the region in plant biotechnology are linked to the status of the economic development

  17. Industrial use of Biotechnology in Agriculture

    International Nuclear Information System (INIS)

    But, S.J.

    2006-01-01

    In the past the biological research was restricted within the boundary of laboratories and the subsequent results were often employed merely to strengthen the research knowledge and information. In life sciences, the traditional methods took years in proving the biological facts. At the leg of last century, the practical application of biotechnology provided a powerful tool to mankind that has led to a revolutionary change in modern agriculture. In the present era, the economy of agro-based countries all over the world is dependent on the adaptation of the pattern of crop-production and their improvement through modern biotechnological means. Biotechnology is in fact the name of a combination of techniques involved to make the full use of living organisms, either in total or in part, for the benefit of plants, animals or human beings. Progressive and dynamic investors, associated with researches/scientists, should be encouraged to step forward for the mobilization of emerging trend of biotechnological industry in agriculture. Researcher/Scientists of biological programmes in Pakistan should be encouraged at Government level to come forward in contributing their tremendous role to boost Agr- industry in the country. (author)

  18. A novel approach for harnessing biofilm communities in moving bed biofilm reactors for industrial wastewater treatment

    OpenAIRE

    Joe A. Lemire; Marc A. Demeter; Iain George; Howard Ceri; Raymond J. Turner

    2015-01-01

    Moving bed biofilm reactors (MBBRs) are an effective biotechnology for treating industrial wastewater. Biomass retention on moving bed biofilm reactor (MBBR) carriers (biofilm support materials), allows for the ease-of-operation and high treatment capacity of MBBR systems. Optimization of MBBR systems has largely focused on aspects of carrier design, while little attention has been paid to enhancing strategies for harnessing microbial biomass. Previously, our research group demonstrated that ...

  19. Agave biotechnology: an overview.

    Science.gov (United States)

    Nava-Cruz, Naivy Y; Medina-Morales, Miguel A; Martinez, José L; Rodriguez, R; Aguilar, Cristóbal N

    2015-01-01

    Agaves are plants of importance both in Mexican culture and economy and in other Latin-American countries. Mexico is reported to be the place of Agave origin, where today, scientists are looking for different industrial applications without compromising its sustainability and preserving the environment. To make it possible, a deep knowledge of all aspects involved in production process, agro-ecological management and plant biochemistry and physiology is required. Agave biotechnology research has been focusing on bio-fuels, beverages, foods, fibers, saponins among others. In this review, we present the advances and challenges of Agave biotechnology.

  20. The emerging CHO systems biology era: harnessing the ‘omics revolution for biotechnology

    DEFF Research Database (Denmark)

    Kildegaard, Helene Faustrup; Baycin-Hizal, Deniz; Lewis, Nathan

    2013-01-01

    into mathematical models that describe CHO phenotypes will provide crucial biotechnology insights. As ‘omics technologies and computational systems biology mature, genome-scale approaches will lead to major innovations in cell line development and metabolic engineering, thereby improving protein production......Chinese hamster ovary (CHO) cells are the primary factories for biopharmaceuticals because of their capacity to correctly fold and post-translationally modify recombinant proteins compatible with humans. New opportunities are arising to enhance these cell factories, especially since the CHO-K1 cell...

  1. [Trends of microalgal biotechnology: a view from bibliometrics].

    Science.gov (United States)

    Yang, Xiaoqiu; Wu, Yinsong; Yan, Jinding; Song, Haigang; Fan, Jianhua; Li, Yuanguang

    2015-10-01

    Microalgae is a single-cell organism with the characteristics of high light energy utilization rate, fast growth rate, high-value bioactive components and high energy material content. Therefore, microalgae has broad application prospects in food, feed, bioenergy, carbon sequestration, wastewater treatment and other fields. In this article, the microalgae biotechnology development in recent years were fully consulted, through analysis from the literature and patent. The progress of microalgal biotechnology at home and abroad is compared and discussed. Furthermore, the project layout, important achievements and development bottlenecks of microalgae biotechnology in our country were also summarized. At last, future development directions of microalgae biotechnology were discussed.

  2. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation

    KAUST Repository

    Mahas, Ahmed

    2017-11-29

    Genome editing has enabled broad advances and novel approaches in studies of gene function and structure; now, emerging methods aim to precisely engineer post-transcriptional processes. Developing precise, efficient molecular tools to alter the transcriptome holds great promise for biotechnology and synthetic biology applications. Different approaches have been employed for targeted degradation of RNA species in eukaryotes, but they lack programmability and versatility, thereby limiting their utility for diverse applications. The CRISPR/Cas9 system has been harnessed for genome editing in many eukaryotic species and, using a catalytically inactive Cas9 variant, the CRISPR/dCas9 system has been repurposed for transcriptional regulation. Recent studies have used other CRISPR/Cas systems for targeted RNA degradation and RNA-based manipulations. For example, Cas13a, a Type VI-A endonuclease, has been identified as an RNA-guided RNA ribonuclease and used for manipulation of RNA. Here, we discuss different modalities for targeted RNA interference with an emphasis on the potential applications of CRISPR/Cas systems as programmable transcriptional regulators for broad uses, including functional biology, biotechnology, and synthetic biology applications.

  3. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation

    KAUST Repository

    Mahas, Ahmed; Neal Stewart, C.; Mahfouz, Magdy M.

    2017-01-01

    Genome editing has enabled broad advances and novel approaches in studies of gene function and structure; now, emerging methods aim to precisely engineer post-transcriptional processes. Developing precise, efficient molecular tools to alter the transcriptome holds great promise for biotechnology and synthetic biology applications. Different approaches have been employed for targeted degradation of RNA species in eukaryotes, but they lack programmability and versatility, thereby limiting their utility for diverse applications. The CRISPR/Cas9 system has been harnessed for genome editing in many eukaryotic species and, using a catalytically inactive Cas9 variant, the CRISPR/dCas9 system has been repurposed for transcriptional regulation. Recent studies have used other CRISPR/Cas systems for targeted RNA degradation and RNA-based manipulations. For example, Cas13a, a Type VI-A endonuclease, has been identified as an RNA-guided RNA ribonuclease and used for manipulation of RNA. Here, we discuss different modalities for targeted RNA interference with an emphasis on the potential applications of CRISPR/Cas systems as programmable transcriptional regulators for broad uses, including functional biology, biotechnology, and synthetic biology applications.

  4. The biotechnology and bioeconomy landscape in Malaysia.

    Science.gov (United States)

    Arujanan, Mahaletchumy; Singaram, Muthu

    2018-01-25

    Since 1990s Malaysia aspired to make biotechnology and bioeconomy as her engines of economic growth to utlise the abundance of natural resources and biodiversity. The public sector plays an integral role in developing the sector and various incentives are in place for the private sector to be actively involved and to forge collaboration with the public sector. The country launched its National Biotechnology Policy in 2005 and later launched its National Bioeconomy Programme in 2010 to become the first country in South East Asia and second in Asia after China to have such an initiative. Malaysia is also very proactive in its biosafety law and regulations and has most of the related legal instrument in place. A lot of success has been recorded since the inception of the National Biotechnology Policy in terms of job creation, contribution to GDP through biobusinesses and investment from foreign companies, but the sector is not spared from challenges too. Due to the nature of the discipline that is multidisciplinary and that requires huge amount of investment, expertise and political will, there are a lot of barriers before the country emerges as a bioeconomy player. This paper discusses the public policies, initiatives and funding mechanisms in place in Malaysia that drive its research, development and commercialisation in the area of biotechnology and bioeconomy. The authors also discuss the challenges faced in Malaysia in implementing the policies. Copyright © 2017 Elsevier B.V. All rights reserved.

  5. Biotechnology in China II. Chemicals, energy and environment

    Energy Technology Data Exchange (ETDEWEB)

    Tsao, G.T. [Purdue Univ., West Lafayette, IN (United States). Lab. Renewable Resources Engineering; Ouyang, Pingkai [Nanjing Univ. of Technology (China). College of Life Science and Pharmaceutical Engineering; Chen, Jian (eds.) [Jiangnan Univ., Wuxi (China). School of Biotechnology

    2010-07-01

    The biochemical engineering and biotechnology is now becoming the most important industry all over the world. China, as a country that has more than 1.3 billion people, has become one of the fastest growing countries in the world during the last several decades. Both the Chinese government and companies pay more and more attention on the research and the application of biotechnology. In the 11th five-year plan (2006-2010), Chinese government unprecedented enhanced the support on the biotechnology in both policy and finance. Currently, the biotechnology gains the most R and D funding in China. With the great support and the increasingly frequent exchanges from abroad, the biotechnology in China becomes more and more important in the world. In recognition of the enormous advances in biotechnology in China, we are pleased to present the second volume of Advances in Biochemical Engineering/ Biotechnology: Biotechnology in China II, edited by P. K. Ouyang, J. Chen and G. T. Tsao, relatively soon after the introduction of the first volume of this multivolume comprehensive books. Since the previous volume was extremely well accepted by the scientific community, we have maintained the overall goal of creating a number of chapters, each devoted to a certain topic by several Chinese research groups working in the field, which provide scientists in academia and public institutions with a well-balanced and comprehensive overview of this growing field in China. We have fully revised the volume and expanded it from bioreaction, bioseparation and bioremediation to more extensive issues in order to cover all recent developments in China into account as much as possible. The new volume of Advances in Biochemical Engineering/Biotechnology: Biotechnology in China II is a comprehensive description of the state-of-the-art in China, and a guide to the understanding the work of Chinese biochemical engineering and biotechnology researchers. It is specifically directed to microbiologists

  6. The plant biotechnology flight: Is Africa on board? | Obembe | African ...

    African Journals Online (AJOL)

    The development of plant biotechnologies has been very rapid in recent times, especially in the developed countries. The technologies have created a new branch of biotechnology known as molecular farming, where plants are engineered to produce pharmaceutical and technical proteins in large quantities. An evaluation ...

  7. National Strategies to Harness Information Technology Seeking Transformation in Singapore, Finland, the Philippines, and South Africa

    CERN Document Server

    Knight, Peter

    2012-01-01

    The ability to harness Information Communication Technologies (ICTs) is increasingly at the heart of competitiveness and sustainable growth. As countries engage in an increasingly competitive global economy, they are trying to weave ICT into their development strategies, in the same way enterprises have learned to use ICT to transform their business models and strategies. This integration offers a new path to development that is responsive to the challenges of our times.  In National Strategies to Harness Information Technology, Nagy Hanna and Peter Knight provide a framework for assessing the opportunities, challenges, and prospects for “e-transformation” and for analyzing the options and innovations adopted to manage the e-transformation process.  They ask hard questions: what does it take to harness ICT to transform an economy?  Why some countries accelerate their development journey with ICT while others fail?  How did successful countries balance the need for strategic leadership with bottom up ...

  8. The Current Developments of Agricultural Biotechnologies Market

    Directory of Open Access Journals (Sweden)

    Anna M. Shkolyarenko

    2016-01-01

    Full Text Available Population growth in the context of limited land resources makes the global scientific society research new ways to increase the agricultural yields. Over the past 20 years, biotechnology and GM crops have become widely spread and now are cultivated in 28 countries. The total area of crops has tripled, and it suggests the further vertical and horizontal integration in short term. In 2015, the US Department of Agriculture authorized the commercial use of GM farm animals. The development of agricultural biotechnology market is constrained by opponents of GM crops in more than 160 countries, which include Russia and the European Union, where the production of GM crops is banned due to economic, ethical, ideological and biological reasons. Currently, the EU is seeking to reduce the imports of GM crops and products; Russia's GM imports and exports are prohibited, and the deadline of designing a consolidated position on agricultural biotechnology has been moved to 2017. The author seeks to analyze the volume of production and international trade of agricultural products based on biotechnologies and to describe the main trends in the global market, which could be integrated into the food value chain in Russia. In the context of the worsening economic indicators, the article proposes the possibility of extending the use of GM crops in Russia non-food sector.

  9. Agenda 21: biotechnology at the United Nations Conference on Environment and Development.

    Science.gov (United States)

    Taylhardat, A R; Zilinskas, R A

    1992-04-01

    Preparation has yet to be completed for the 1992 Earth Summit, UN Conference on Environment and Development (UNCED), in Rio de Janeiro, Brazil. Nonetheless, it has been planned as a forum in which recommendations will be made to governments and international organizations on how to alleviate environmental damage caused by human activities and how to prevent future damage without retarding development in the Third World. It will declare basic principles for national and individual conduct regarding environmental preservation and sustainable development; adopt international conventions to protect biodiversity and manage climatic change; lay out Agenda 21 activities as specified by UNCED; provide an agenda to help Third World governments manage environmental matters; and provide an agenda for improving the transfer of technology to developing countries. Where biotechnology is concerned, scientists and policy makers in developing countries have shown their interest. Limited resources and capabilities, however, constrain their abilities to engage in serious research and development. International organizations such as the UN Industrial Development Organization (UNIDO) may help UNCED and developing countries with biotechnology. Since 1986, UNIDO has held the International Centre for Genetic Engineering and Biotechnology (ICGEB) as a special project. The ICGEB conducts research and development (R&D) on high priority topics in developing countries; trains scientific and technical personnel from member countries in advanced biotechnology techniques; helps member countries implement and operate ICGEB-affiliated R&D and training centers; and manages an information exchange for internationally affiliated centers. To maximize the potential of biotechnology to help Third World nations clear their environments of pollutants while safely exploiting natural resources, organizations should promote full use of available training resources; promote biosafety and the dissemination of

  10. Har erhvervsuddannelserne en fremtid?

    DEFF Research Database (Denmark)

    Jørgensen, Christian Helms

    2012-01-01

    Har erhvervsuddannelserne en fremtid? Eller mere præcist: Har de en fremtid med den grundform som nu har fungeret i over 50 år? Det vil sige som et separat system baseret på vekseluddannelser, hvor hovedparten af uddannelserne foregår i praktik, og som i vid udstrækning styres af arbejdsmarkedets...

  11. Medical Biotechnology Trends and Achievements in Iran

    Science.gov (United States)

    Mahboudi, Fereidoun; Hamedifar, Haleh; Aghajani, Hamideh

    2012-01-01

    A healthcare system has been the most important priority for all governments worldwide. Biotechnology products have affected the promotion of health care over the last thirty years. During the last several decades, Iran has achieved significant success in extending healthcare to the rural areas and in reducing the rates of infant mortality and increasing population growth. Biomedical technology as a converging technology is considered a helpful tool to fulfill the Iranian healthcare missions. The number of biotechnology products has reached 148 in 2012. The total sales have increased to 98 billion USD without considering vaccines and plasma derived proteins in 2012. Iran is one of the leading countries in the Middle East and North Africa in the area of Medical biotechnology. The number of biotechnology medicines launched in Iran is 13 products until 2012. More than 15 products are in pipelines now. Manufacturers are expecting to receive the market release for more than 8 products by the end of 2012. Considering this information, Iran will lead the biotechnology products especially in area of biosimilars in Asia after India in next three years. The present review will discuss leading policy, decision makers’ role, human resource developing system and industry development in medical biotechnology. PMID:23407888

  12. Biotechnologies for the management of genetic resources for food and agriculture.

    Science.gov (United States)

    Lidder, Preetmoninder; Sonnino, Andrea

    2012-01-01

    In recent years, the land area under agriculture has declined as also has the rate of growth in agricultural productivity while the demand for food continues to escalate. The world population now stands at 7 billion and is expected to reach 9 billion in 2045. A broad range of agricultural genetic diversity needs to be available and utilized in order to feed this growing population. Climate change is an added threat to biodiversity that will significantly impact genetic resources for food and agriculture (GRFA) and food production. There is no simple, all-encompassing solution to the challenges of increasing productivity while conserving genetic diversity. Sustainable management of GRFA requires a multipronged approach, and as outlined in the paper, biotechnologies can provide powerful tools for the management of GRFA. These tools vary in complexity from those that are relatively simple to those that are more sophisticated. Further, advances in biotechnologies are occurring at a rapid pace and provide novel opportunities for more effective and efficient management of GRFA. Biotechnology applications must be integrated with ongoing conventional breeding and development programs in order to succeed. Additionally, the generation, adaptation, and adoption of biotechnologies require a consistent level of financial and human resources and appropriate policies need to be in place. These issues were also recognized by Member States at the FAO international technical conference on Agricultural Biotechnologies for Developing Countries (ABDC-10), which took place in March 2010 in Mexico. At the end of the conference, the Member States reached a number of key conclusions, agreeing, inter alia, that developing countries should significantly increase sustained investments in capacity building and the development and use of biotechnologies to maintain the natural resource base; that effective and enabling national biotechnology policies and science-based regulatory frameworks can

  13. Biotechnology and Nuclear Agriculture Research Institute (BNARI) at a glance

    International Nuclear Information System (INIS)

    2007-01-01

    Biotechnology and Nuclear Agriculture Research Institute (BNARI) was established in 1993 as one of the research, development and technology transfer institutes of the Ghana Atomic Energy Commission (GAEC). This was to help the GAEC to expand its research and development in the area of biotechnology and nuclear agriculture, which have been found to have a major impact on the agricultural development in countries involved in peaceful application of nuclear energy. The main objective of the Institute is to explore and exploit the application of isotopes, ionizing radiation and biotechnologies for increased agricultural and economic development of Ghana and to help the Country attain self-sufficiency in food and agriculture in order to alleviate malnutrition, hunger and poverty. This brochure describes the organizational structure; research facilities and programmes; services of the various departments of the Institute as well as achievements

  14. Editorial: Biotechnology Journal brings more than biotechnology.

    Science.gov (United States)

    Jungbauer, Alois; Lee, Sang Yup

    2015-09-01

    Biotechnology Journal always brings the state-of-the-art biotechnologies to our readers. Different from other topical issues, this issue of Biotechnology Journal is complied with a series of exiting reviews and research articles from spontaneous submissions, again, addressing society's actual problems and needs. The progress is a real testimony how biotechnology contributes to achievements in healthcare, better utilization of resources, and a bio-based economy. Copyright © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  15. Biotechnology essay competition: biotechnology and sustainable food practices.

    Science.gov (United States)

    Peng, Judy; Schoeb, Helena; Lee, Gina

    2013-06-01

    Biotechnology Journal announces our second biotechnology essay competition with the theme "biotechnology and sustainable food practices", open to all undergraduate students. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  16. Biotechnology

    International Nuclear Information System (INIS)

    Lewanika, Mbikusita Mwananyanda

    2005-01-01

    The article sets out to explain in simple terms the main concepts of Biotechnology beginning with traditional biotechnology to modern biotechnology. It outlines fundamentals of Recombinant Deoxyribonucleic Acid (DNA), Genetically Modified Organisms (GMOs) and Genetic Engineering. The article offers a discussion of the benefits, disadvantages and the general public and policy concerns regarding genetically modified organisms

  17. Knowledge Management and Analysis of Scientific Biotechnology Trends in Venezuela

    Directory of Open Access Journals (Sweden)

    Maria Fatima Ebole Santana

    2012-03-01

    Full Text Available This paper presents a study on knowledge management and analysis of scientific Biotechnology trends in Venezuela, providing an overview of the science profile as well as regional development and its relation to issues of topics covered by Biotechnology based on the analysis of scientific publications for the period of 1995 to 2010. The survey was accomplished in database ISI/Web of Science using 60 terms selected by experts in Biotechnology and 803 register has been organized. Scientific indicators were produced using data/ text mining tools. It was possible to find a greater number of scientific publications in areas such as Ecology and Health, showing a greater frequency in these terms: DNA, PCR and Biodiversity. Results pointed out The United States of America as the main foreign partner-country of scientific publications followed by Spain and France. It was possible to verify cooperation network with others Latin American countries: Brazil, Colombia and Chile.

  18. Biotechnology Education in India: An Overview

    Science.gov (United States)

    Joshi, Kirti; Mehra, Kavita; Govil, Suman; Singh, Nitu

    2013-01-01

    Among the developing countries, India is one of those that recognises the importance of biotechnology. The trajectory of different policies being formulated over time is proof that the government is progressing towards achieving self-sufficiency. However, to cater to the ever-growing biotech industry, skilled manpower is required. This article…

  19. Cassava: constraints to production and the transfer of biotechnology to African laboratories.

    Science.gov (United States)

    Bull, Simon E; Ndunguru, Joseph; Gruissem, Wilhelm; Beeching, John R; Vanderschuren, Hervé

    2011-05-01

    Knowledge and technology transfer to African institutes is an important objective to help achieve the United Nations Millennium Development Goals. Plant biotechnology in particular enables innovative advances in agriculture and industry, offering new prospects to promote the integration and dissemination of improved crops and their derivatives from developing countries into local markets and the global economy. There is also the need to broaden our knowledge and understanding of cassava as a staple food crop. Cassava (Manihot esculenta Crantz) is a vital source of calories for approximately 500 million people living in developing countries. Unfortunately, it is subject to numerous biotic and abiotic stresses that impact on production, consumption, marketability and also local and country economics. To date, improvements to cassava have been led via conventional plant breeding programmes, but with advances in molecular-assisted breeding and plant biotechnology new tools are being developed to hasten the generation of improved farmer-preferred cultivars. In this review, we report on the current constraints to cassava production and knowledge acquisition in Africa, including a case study discussing the opportunities and challenges of a technology transfer programme established between the Mikocheni Agricultural Research Institute in Tanzania and Europe-based researchers. The establishment of cassava biotechnology platform(s) should promote research capabilities in African institutions and allow scientists autonomy to adapt cassava to suit local agro-ecosystems, ultimately serving to develop a sustainable biotechnology infrastructure in African countries.

  20. Concepts in Biotechnology An Affordable Overview of Biotechnology ...

    Indian Academy of Sciences (India)

    Home; Journals; Resonance – Journal of Science Education; Volume 2; Issue 9. Concepts in Biotechnology An Affordable Overview of Biotechnology Through Self Study ... Author Affiliations. Narayan S Punekar1. Molecular Enzymology Group, Biotechnology Centre, Indian Institute of Technology, Mumbai 400 076, India.

  1. Turkish university students' knowledge of biotechnology and attitudes toward biotechnological applications.

    Science.gov (United States)

    Öztürk-Akar, Ebru

    2017-03-04

    This study questions the presumed relation between formal schooling and scientific literacy about biotechnologies. Comparing science and nonscience majors' knowledge of and attitudes toward biotechnological applications, conclusions are drawn if their formal learnings improve pupils' understandings of and attitudes toward biotechnology applications. Sample of the study consists of 403 undergraduate and graduate students, 198 nonscience, and 205 science majors. The Biotechnology Knowledge Questionnaire and the Biotechnology Attitude Questionnaire were administered. Descriptive statistics (mean and percentages), t test, and correlations were used to examine the participants' knowledge of biotechnology and attitudes toward biotechnological applications and differences as regards their majors. Although the science majors had higher knowledge and attitude scores than the nonscience majors, it is not possible to say that they have sufficient knowledge of biotechnologies. Besides, the participants' attitudes toward biotechnological applications were not considerably related to their knowledge of biotechnology. © 2016 by The International Union of Biochemistry and Molecular Biology, 45(2):115-125, 2017. © 2016 The International Union of Biochemistry and Molecular Biology.

  2. [The role of biotechnology in pharmaceutical drug design].

    Science.gov (United States)

    Gaisser, Sibylle; Nusser, Michael

    2010-01-01

    Biotechnological methods have become an important tool in pharmaceutical drug research and development. Today approximately 15 % of drug revenues are derived from biopharmaceuticals. The most relevant indications are oncology, metabolic disorders and disorders of the musculoskeletal system. For the future it can be expected that the relevance of biopharmaceuticals will further increase. Currently, the share of substances in preclinical testing that rely on biotechnology is more than 25 % of all substances in preclinical testing. Products for the treatment of cancer, metabolic disorders and infectious diseases are most important. New therapeutic approaches such as RNA interference only play a minor role in current commercial drug research and development with 1.5 % of all biological preclinical substances. Investments in sustainable high technology such as biotechnology are of vital importance for a highly developed country like Germany because of its lack of raw materials. Biotechnology helps the pharmaceutical industry to develop new products, new processes, methods and services and to improve existing ones. Thus, international competitiveness can be strengthened, new jobs can be created and existing jobs preserved.

  3. Biotechnology worldwide and the 'European Biotechnology Thematic Network' Association (EBTNA).

    Science.gov (United States)

    Bruschi, F; Dundar, M; Gahan, P B; Gartland, K; Szente, M; Viola-Magni, M P; Akbarova, Y

    2011-09-01

    The European Biotechnology Congress 2011 held under the auspices of the European Biotechnology Thematic Network Association (EBTNA) in conjunction with the Turkish Medical Genetics Association brings together a broad spectrum of biotechnologists from around the world. The subsequent abstracts indicate the manner in which biotechnology has permeated all aspects of research from the basic sciences through to small and medium enterprises and major industries. The brief statements before the presentation of the abstracts aim to introduce not only Biotechnology in general and its importance around the world, but also the European Biotechnology Thematic Network Association and its aims especially within the framework of education and ethics in biotechnology. Copyright © 2011 Elsevier Ltd. All rights reserved.

  4. PUTTING PLANT BIOTECHNOLOGY TO WORK FOR FOOD ...

    African Journals Online (AJOL)

    Plant biotechnology is safely bringing valuable new benefits to farmers around the world, including those in developing countries where the needs for food, nutrition and overall development may be greatest. >From the current base of experience, it is reasonable to expect even greater benefits in the future, provided that ...

  5. Incidence of the biotechnology in the academic development of the chemical engineering in Colombia

    International Nuclear Information System (INIS)

    Castellanos, Oscar Fernando; Rueda Maria Angelica; Ramirez, Julio Cesar

    1998-01-01

    In Colombia, the biotechnology, during the last years, it has been developed in a quick way, particularly in their fundamental and theoretical aspect. In the national market consumption there are products obtained with the help of the advances of the industrial biotechnology, which, for their implementation, it has had to appeal to import technologies and of transfer. This way, among the theoretical investigations in biotechnology and the applicability of their results in production processes in our country a direct relationship has not existed generally. At the moment, the necessities of scientific and technological progress demand the harmonic interaction of the different aspects of the biotechnology. For it, it is indispensable the formation of professionals, able to apply engineering concepts in the processes developed in biotechnical laboratories, like they have already made it other countries, with more scientific and economic advance. In the Colombian universities it is hour of reinforcing the line considerably in biochemical engineering of chemical engineering programs in the different pre and graduate levels; this profundity will allow significantly shortening distances between the different areas of the biotechnology and its industrial application

  6. Disclosing Biology Teachers' Beliefs about Biotechnology and Biotechnology Education

    Science.gov (United States)

    Fonseca, Maria Joao; Costa, Patricio; Lencastre, Leonor; Tavares, Fernando

    2012-01-01

    Teachers have been shown to frequently avoid addressing biotechnology topics. Aiming to understand the extent to which teachers' scarce engagement in biotechnology teaching is influenced by their beliefs and/or by extrinsic constraints, such as practical limitations, this study evaluates biology teachers' beliefs about biotechnology and…

  7. "Othering" agricultural biotechnology: Slovenian media representation of agricultural biotechnology.

    Science.gov (United States)

    Zajc, Jožica; Erjavec, Karmen

    2014-08-01

    While studies on media representations of agricultural biotechnology mostly analyse media texts, this work is intended to fill a research gap with an analysis of journalistic interpretations of media representations. The purpose of this project was to determine how news media represent agricultural biotechnology and how journalists interpret their own representations. A content and critical discourse analysis of news texts published in the Slovenian media over two years and in-depth interviews with their authors were conducted. News texts results suggest that most of the news posts were "othering" biotechnology and biotechnologists: biotechnology as a science and individual scientists are represented as "they," who are socially irresponsible, ignorant, arrogant, and "our" enemies who produce unnatural processes and work for biotechnology companies, whose greed is destroying people, animals, and the environment. Most journalists consider these representations to be objective because they have published the biotechnologists' opinions, despite their own negative attitudes towards biotechnology.

  8. in OECD countries concerning biological drugs

    African Journals Online (AJOL)

    Jane

    2011-08-22

    Aug 22, 2011 ... the pharmaceutical sector about biological drugs come under the umbrella of innovation system of each country. ... The cost of biotechnology R and D within public research centres and ... Existence of a suitable system to protect intellectual property ... biotechnology that provide the capital for industry and.

  9. Universities plan revolution in research; Four institutes will harness top brains

    CERN Multimedia

    Buie, E

    2003-01-01

    "Scotland is on the brink of revolutionising its approach to university research by creating four institutions that would harness the country's top brains to work together in specific areas. The move to create pan-academic institutes in physics, life-sciences, economics and creative arts has won the backing of the principals of every higher education institution in Scotland..." (1 page).

  10. Construction Biotechnology: a new area of biotechnological research and applications.

    Science.gov (United States)

    Stabnikov, Viktor; Ivanov, Volodymyr; Chu, Jian

    2015-09-01

    A new scientific and engineering discipline, Construction Biotechnology, is developing exponentially during the last decade. The major directions of this discipline are selection of microorganisms and development of the microbially-mediated construction processes and biotechnologies for the production of construction biomaterials. The products of construction biotechnologies are low cost, sustainable, and environmentally friendly microbial biocements and biogrouts for the construction ground improvement. The microbial polysaccharides are used as admixtures for cement. Microbially produced biodegradable bioplastics can be used for the temporarily constructions. The bioagents that are used in construction biotechnologies are either pure or enrichment cultures of microorganisms or activated indigenous microorganisms of soil. The applications of microorganisms in the construction processes are bioaggregation, biocementation, bioclogging, and biodesaturation of soil. The biotechnologically produced construction materials and the microbially-mediated construction technologies have a lot of advantages in comparison with the conventional construction materials and processes. Proper practical implementations of construction biotechnologies could give significant economic and environmental benefits.

  11. Warming Up to Trade? Harnessing International Trade to Support Climate Change Objectives

    OpenAIRE

    World Bank

    2007-01-01

    This study on harnessing international trade to support climate change objectives assesses the following: 1) What are the main policy prescriptions for reducing greenhouse gases that are employed by OECD countries and how do they impact the competitiveness of their energy-intensive industries? 2) On account of the impact on competitiveness, is there is leakage of energy intensive industrie...

  12. Biotechnology: reality or dream

    Directory of Open Access Journals (Sweden)

    Konstantinov Kosana

    2002-01-01

    foreign gene with a genome of an integrated organism. Also application of biotechnology provides transfer of one or several favorable genes from any evolutionary category into other category of an organism and in such a way it is possible to develop genetically modified organisms (GMO having expressed desired, target traits. A survey of the application of biotechnology in the world and our country is presented in this paper.

  13. Students' knowledge of, and attitudes towards biotechnology revisited, 1995-2014: Changes in agriculture biotechnology but not in medical biotechnology.

    Science.gov (United States)

    Chen, Shao-Yen; Chu, Yih-Ru; Lin, Chen-Yung; Chiang, Tzen-Yuh

    2016-09-10

    Modern biotechnology is one of the most important scientific and technological revolutions in the 21st century, with an increasing and measurable impact on society. Development of biotechnology curriculum has become important to high school bioscience classrooms. This study has monitored high school students in Taiwan on their knowledge of and attitudes towards biotechnology for nearly two decades. Not surprisingly, knowledge of biotechnology of current students has increased significantly (p students have learned some definitions and examples of biotechnology. There was a positive correlation between biotechnology knowledge and attitudes toward biotechnology for current students who study Advanced Biology (AB). However, for current students who did not study AB, there was a negative correlation.The attitude results showed that students today expressed less favorable opinions toward agricultural biotechnology (p students today and 18 years ago in opinions towards medical biotechnology. In addition, current students showed a greater concern involving environmental risks than former students. Interestingly, the high school curriculum did affect students' attitudes toward genetically engineered (GE) plants but not GE animals. Our current study also found that the students' attitude towards GE animals was influenced more by their limited knowledge than by their moral belief. On the basis of findings from this study, we suggest that more materials of emerging animal biotechnology should be included in high school curriculum and recommend that high school teachers and university faculty establish a collaborative framework in the near future. © 2016 by The International Union of Biochemistry and Molecular Biology, 44(5):475-491, 2016. © 2016 The International Union of Biochemistry and Molecular Biology.

  14. The need for biosafety regulation in developing countries: Benefits ...

    African Journals Online (AJOL)

    Jane

    2011-09-30

    Sep 30, 2011 ... Key words: Biotechnology, biosafety, developing countries, benefits, risks and controversies. ... biotechnology concerns relate more to human health and ..... animals in laboratory, when they are tested outdoors, and when they ...

  15. Identification of External Critical Success Factors in Microbial Biotechnology Firms

    Directory of Open Access Journals (Sweden)

    Alireza AZIMI

    2013-03-01

    Full Text Available Microbial biotechnology is expected to change production methods, the products themselves and the structure of the industries in the new economies. Hopefully, countries in the Middle-East, Latin America, Asia and Africa have already recognized the importance of microbial biotechnology's promise. In this sense, the importance of externalities which might affect the success or failure of these companies becomes an issue of paramount importance. In the present study, we will try to identify the main external factors which could lead in the success of microbial biotechnology firms in Iran. To do so, the research follows a qualitative research design to answer this main question. Based on our findings, critical success factors are categorized in the following categories: General Environment (GE, Political Position (PP, Economic Position (EP, and Market Position (MP.

  16. Contributions of biotechnology to the control and prevention of ...

    African Journals Online (AJOL)

    Zoonotic diseases such as brucellosis have a major impact on the health and economic prosperity of the developing world. Recent advances in our understanding of brucellosis and new developments in diagnostics and vaccine technology provide unique opportunities for biotechnology companies in developing countries ...

  17. A novel approach for harnessing biofilm communities in moving bed biofilm reactors for industrial wastewater treatment

    Directory of Open Access Journals (Sweden)

    Joe A. Lemire

    2015-10-01

    Full Text Available Moving bed biofilm reactors (MBBRs are an effective biotechnology for treating industrial wastewater. Biomass retention on moving bed biofilm reactor (MBBR carriers (biofilm support materials, allows for the ease-of-operation and high treatment capacity of MBBR systems. Optimization of MBBR systems has largely focused on aspects of carrier design, while little attention has been paid to enhancing strategies for harnessing microbial biomass. Previously, our research group demonstrated that mixed-species biofilms can be harvested from an industrial wastewater inoculum [oil sands process water (OSPW] using the Calgary Biofilm Device (CBD. Moreover, the resultant biofilm communities had the capacity to degrade organic toxins (naphthenic acids—NAs that are found in OSPW. Therefore, we hypothesized that harnessing microbial communities from industrial wastewater, as biofilms, on MBBR carriers may be an effective method to bioremediate industrial wastewater.Here, we detail our methodology adapting the workflow employed for using the CBD, to generate inoculant carriers to seed an MBBR.In this study, OSPW-derived biofilm communities were successfully grown, and their efficacy evaluated, on commercially available MBBR carriers affixed within a modified CBD system. The resultant biofilms demonstrated the capacity to transfer biomass to recipient carriers within a scaled MBBR. Moreover, MBBR systems inoculated in this manner were fully active 2 days post-inoculation, and readily degraded a select population of NAs. Together, these findings suggest that harnessing microbial communities on carriers affixed within a modified CBD system may represent a facile and rapid method for obtaining functional inoculants for use in wastewater MBBR treatment systems.

  18. Comparing Perceptions of Biotechnology in Fresh versus Processed Foods: A Cross-Cultural Study

    OpenAIRE

    Kim, Hyeyoung; House, Lisa

    2013-01-01

    This study focused on investigating how respondents’ perceptions of biotechnology used in food production differs depending on the level of product transformation (i.e. fresh versus processed food). Using cluster analysis, respondents were clustered into two groups, genetically engineered (GE) tolerant and GE sensitive, based on changes in their perceptions about fresh apples and apple juice produced with and without biotechnology. Comparisons of respondents from six countries were performed ...

  19. Perceptions and attitudes of geography teachers to biotechnology: A ...

    African Journals Online (AJOL)

    This study reports the perceptions and attitudes of geography teachers towards biotechnology and genetically-modified (GM) foods in Turkey. A survey was conducted with secondary school geography teachers attending teacher workshops in various parts of the country in 2008 and was responded to by 78 teachers from ...

  20. Development and application of modern agricultural biotechnology in Botswana: the potentials, opportunities and challenges.

    Science.gov (United States)

    Batlang, Utlwang; Tsurupe, Gorata; Segwagwe, Amogelang; Obopile, Motshwari

    2014-07-03

    In Botswana, approximately 40% of the population live in rural areas and derive most of their livelihood from agriculture by keeping livestock and practising arable farming. Due to the nature of their farming practises livestock and crops are exposed to diseases and environmental stresses. These challenges offer opportunities for application of biotechnology to develop adaptable materials to the country's environment. On the other hand, the perceived risk of genetically modified organisms (GMOs) has dimmed the promise of the technology for its application in agriculture. This calls for a holistic approach to the application of biotechnology to address issues of biosafety of GMOs. We have therefore assessed the potentials, challenges and opportunities to apply biotechnology with specific emphasis on agriculture, taking cognisance of requirement for its research, development and application in research and teaching institutions. In order to achieve this, resource availability, infrastructure, human and laboratory requirements were analyzed. The analysis revealed that the country has the capacity to carry out research in biotechnology in the development and production of genetically modified crops for food and fodder crops. These will include gene discovery, genetic transformation and development of systems to comply with the world regulatory framework on biosafety. In view of the challenges facing the country in agriculture, first generation biotech crops could be released for production. Novel GM products for development may include disease diagnosis kits, animal disease vaccines, and nutrient use efficiency, drought, and pest and disease resistant food and fodder crops.

  1. Enterprise Factors Contributing to The Success of Malaysian Biotechnology SMEs: A Grounded Theory Approach

    Directory of Open Access Journals (Sweden)

    Saridan Abu Bakar

    2013-07-01

    Full Text Available While numerous empirical studies have been conducted in Western countries on biotechnology enterprises, little empirical research has been done in Malaysia especially in respect to the factors that contribute to the success of biotechnology small and medium enterprises (SMEs. In view of this, a study was undertaken recently in Malaysia to address this gap in the existing body of biotechnology knowledge. Using a grounded theory approach, this qualitative study managed to develop a conceptual framework that sheds useful information on the enterprise factors that significantly impact the success of Malaysian biotechnology SMEs. Specifically, this study found that organizational structure, innovation activities, linkages with academic research institutions, linkages with other private enterprises, personal linkages with academic researchers, access to financial capital, the procuring of government assistances, vertical integration, enterprise image, GMP compliance and halal certification, strongly influence enterprise success.Keywords: biotechnology, SMEs, Malaysia, success, qualitative study, grounded theory

  2. Can biotechnology help meet the nutrition challenge in sub-Saharan Africa?

    Science.gov (United States)

    Tagwireyi, Julia

    2002-12-01

    The successful efforts in the 1980s to redress nutrition problems in sub-Saharan Africa are being eroded. Countries in eastern and southern Africa are now facing serious food shortages because of recurrent droughts, floods, civil wars, and the concomitant growing poverty. The potential for biotechnology to alleviate hunger holds promise if the new technology can be adapted to the prevailing sociocultural context in Africa. Agronomists and biotechnologists need to work together to ensure that the biotechnology agenda for Africa is responsive to the food and nutrition needs of its people.

  3. Advanced biotechnology: metabolically engineered cells for the bio-based production of chemicals and fuels, materials, and health-care products.

    Science.gov (United States)

    Becker, Judith; Wittmann, Christoph

    2015-03-09

    Corynebacterium glutamicum, Escherichia coli, and Saccharomyces cerevisiae in particular, have become established as important industrial workhorses in biotechnology. Recent years have seen tremendous progress in their advance into tailor-made producers, driven by the upcoming demand for sustainable processes and renewable raw materials. Here, the diversity and complexity of nature is simultaneously a challenge and a benefit. Harnessing biodiversity in the right manner through synergistic progress in systems metabolic engineering and chemical synthesis promises a future innovative bio-economy. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  4. A cross-sectional study of biotechnology awareness and teaching in European high schools.

    Science.gov (United States)

    Vanderschuren, Hervé; Heinzmann, Dominik; Faso, Carmen; Stupak, Martin; Arga, Kazim Yalçin; Hoerzer, Helen; Laizet, Yech'an; Leduchowska, Paulina; Silva, Nádia; Simková, Klára

    2010-12-31

    Undoubtedly, biotechnology has a tremendous impact on our daily lives. As a result of this and in parallel to the advancement of knowledge in this field of applied research, consumer awareness of the potential benefits and risks of this technology has steadily increased, leading to a thorough investigation of the public perception of biotechnology in the past years. Indeed, it has become clear that it is in the general interest of science and especially of applied research to inform the public of its advances. A promising next step is to strengthen biotechnology communication in scholastic institutions. In this paper, we investigate the perception of biotechnology in a specific target group, namely high-school students in the 16-20-year-old age range. We conducted a questionnaire-based survey on a total of 1410 students in six European countries to investigate students' perception, concern, scientific knowledge, and awareness. Our data revealed some unexpected patterns of acceptance and concern about biotechnology. Knowledge analysis indicated that pupils lack specific knowledge about biotechnological applications and their interest in biotechnology appeared to be linked to knowledge. Analysis of specific questions about teaching practices at schools suggests that a better targeted choice in media as vehicles for information together with selected speakers could be instrumental in increasing students' interest in science and more specifically in biotechnology. Copyright © 2010 Elsevier B.V. All rights reserved.

  5. Development of agriculture biotechnology in Pakistan.

    Science.gov (United States)

    Zafar, Yusuf

    2007-01-01

    Agriculture plays an important role in the national economy of Pakistan, where most of the rapidly increasing population resides in rural areas and depends on agriculture for subsistence. Biotechnology has considerable potential for promoting the efficiency of crop improvement, food production, and poverty reduction. Use of modern biotechnology started in Pakistan since 1985. Currently, there are 29 biotech centers/institutes in the country. However, few centers have appropriate physical facilities and trained manpower to develop genetically modified (GM) crops. Most of the activities have been on rice and cotton, which are among the top 5 crops of Pakistan. Biotic (virus/bacterial/insect) and abiotic (salt) resistant and quality (male sterility) genes have already been incorporated in some crop plants. Despite acquiring capacity to produce transgenic plants, no GM crops, either produced locally or imported, have been released in the country. Pakistan is signatory to the World Trade Organization, Convention on Biological Diversity, and Cartagena protocols. Several legislations under the Agreement on Trade-Related Aspects of Intellectual Property Rights have been promulgated in the country. National Biosafety Guidelines have been promulgated in April 2005. The Plant Breeders Rights Act, Amendment in Seed Act-1976, and Geographical Indication for Goods are still passing through discussion, evaluation, and analysis phases. Meanwhile, an illegal GM crop (cotton) has already sneaked into farmer's field. Concerted and coordinated efforts are needed among various ministries for implementation of regulation and capacity building for import/export and local handling of GM crops. Pakistan could easily benefit from the experience of Asian countries, especially China and India, where conditions are similar and the agriculture sector is almost like that of Pakistan. Thus, the exchange of information and experiences is important among these nations.

  6. Interface of nuclear and biotechnologies

    International Nuclear Information System (INIS)

    Castro Diaz-Balart, F.

    2005-01-01

    Addressing nuclear and biotechnologies in the International Year of Physics should begin by highlighting the important role that this science has played in the development of both branches of science and technologies. The first as a direct consequence of the Theory of Relativity, the further was considerably influenced by Schroedinger's remarks that there must be a code of some kind that allowed molecules in cells to carry information, making a connection between genes and proteins. Both, like any highly technical endeavor, have also in common that the use of technologies demands a vast accumulation of knowledge, i.e. volumes of scientific research, engineering analysis, strict regulatory controls and a huge amount of information combined with a complex assortment of people with the required educational background, expertise and skills to master it. This presentation briefly explores the ways in which nuclear technology has been used in the last decades of the 20th century in the field of biomedicine applications, which includes the use of radiation to obtain accurate images as well as in diagnosis and therapy. The paper looks at the present prospects of some nuclear methods and instrumentation in the so-called Red biotechnology and its genetically engineered therapeutic agents and diagnostic tests as well as some related perspectives in the field of bioinformatics. As an example of biotechnology being successfully applied to health problems in developing countries the presentation gives an outlook of relevant Cuban achievements in this field. (author)

  7. Evaluation of Brazilian biotechnology patent activity from 1975 to 2010.

    Science.gov (United States)

    Dias, F; Delfim, F; Drummond, I; Carmo, A O; Barroca, T M; Horta, C C; Kalapothakis, E

    2012-08-01

    The analysis of patent activity is one methodology used for technological monitoring. In this paper, the activity of biotechnology-related patents in Brazil were analyzed through 30 International Patent Classification (IPC) codes published by the Organization for Economic Cooperation and Development (OECD). We developed a program to analyse the dynamics of the major patent applicants, countries and IPC codes extracted from the Brazilian Patent Office (INPI) database. We also identified Brazilian patent applicants who tried to expand protection abroad via the Patent Cooperation Treaty (PCT). We had access to all patents published online at the INPI from 1975 to July 2010, including 9,791 biotechnology patent applications in Brazil, and 163 PCTs published online at World Intellectual Property Organization (WIPO) from 1997 to December 2010. To our knowledge, there are no other online reports of biotechnology patents previous to the years analyzed here. Most of the biotechnology patents filed in the INPI (10.9%) concerned measuring or testing processes involving nucleic acids. The second and third places belonged to patents involving agro-technologies (recombinant DNA technology for plant cells and new flowering plants, i.e. angiosperms, or processes for obtaining them, and reproduction of flowering plants by tissue culture techniques). The majority of patents (87.2%) were filed by nonresidents, with USA being responsible for 51.7% of all biotechnology patents deposited in Brazil. Analyzing the resident applicants per region, we found a hub in the southeast region of Brazil. Among the resident applicants for biotechnology patents filed in the INPI, 43.5% were from São Paulo, 18.3% were from Rio de Janeiro, and 9.7% were from Minas Gerais. Pfizer, Novartis, and Sanofi were the largest applicants in Brazil, with 339, 288, and 245 biotechnology patents filed, respectively. For residents, the largest applicant was the governmental institution FIOCRUZ (Oswaldo Cruz

  8. Biotechnology and the bioeconomy-Towards inclusive and sustainable industrial development.

    Science.gov (United States)

    Lokko, Yvonne; Heijde, Marc; Schebesta, Karl; Scholtès, Philippe; Van Montagu, Marc; Giacca, Mauro

    2018-01-25

    To transform developing and least developing countries into industrialised ones, biotechnology could be deployed along the value chain, to provide support to the development of the bio-based industries in such a way to ensure sustainability of the sector and to reduce negative environmental impacts that might otherwise occur. In agribusiness development, for instance, interventions could start from inputs and agricultural mechanization, modern processing technologies, packaging of perishable products, the promotion of food safety in the processing and regulatory environment; and interventions to improve competitiveness and productivity. Worth over USD 300 billion in revenue, the role of the biotechnology goes beyond industrial growth, since it provides opportunities for progress towards many of the UN sustainable development goals (SDGs). This paper reviews the status of industrial biotechnology as it relates to inclusive and sustainable industrial development. Copyright © 2017 Elsevier B.V. All rights reserved.

  9. A Brave New World: Students Debate Ethics of Biotechnology.

    Science.gov (United States)

    Barksdale, Francia

    1996-01-01

    This article describes an interdisciplinary classroom project in which ninth graders simulate a "World Council on Genetic Technology." Students in small groups take on the persona and interests of individuals from specific countries in the group effort to develop a covenant for regulating the use of biotechnology. The benefits of having gifted…

  10. Cascades in Compartments: En Route to Machine-Assisted Biotechnology.

    Science.gov (United States)

    Rabe, Kersten S; Müller, Joachim; Skoupi, Marc; Niemeyer, Christof M

    2017-10-23

    Biological compartmentalization is a fundamental principle of life that allows cells to metabolize, propagate, or communicate with their environment. Much research is devoted to understanding this basic principle and to harness biomimetic compartments and catalytic cascades as tools for technological processes. This Review summarizes the current state-of-the-art of these developments, with a special emphasis on length scales, mass transport phenomena, and molecular scaffolding approaches, ranging from small cross-linkers over proteins and nucleic acids to colloids and patterned surfaces. We conclude that the future exploration and exploitation of these complex systems will largely benefit from technical solutions for the integrated, machine-assisted development and maintenance of a next generation of biotechnological processes. These goals should be achievable by implementing microfluidics, robotics, and added manufacturing techniques supplemented by theoretical simulations as well as computer-aided process modeling based on big data obtained from multiscale experimental analyses. © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

  11. Third-generation biofuels: current and future research on microalgal lipid biotechnology

    Directory of Open Access Journals (Sweden)

    Li-Beisson Yonghua

    2013-11-01

    Full Text Available One pressing issue faced by modern societies is to develop renewable energy for transportation. Microalgal biomass offers an attractive solution due to its high (annual surface biomass productivity, efficient conversion of solar energy into chemical energy and the ability to grow on non-agricultural land. Despite these considerable advantages, microalgal biofuels are not yet commercially sustainable. Major challenges lie in improving both cultivation technologies and microalgal strains. A microalgal crop species is yet to emerge. In this review, we focus on researches aiming at understanding and harnessing lipid metabolism in microalgae in view of producing lipid-based biofuels such as biodiesel. Current biotechnological challenges and key progresses made in the development of algal models, genetic tools and lipid metabolic engineering strategies are reviewed. Possible future research directions to increase oil yields in microalgae are also highlighted.

  12. Harnessing cell-to-cell variations to probe bacterial structure and biophysics

    Science.gov (United States)

    Cass, Julie A.

    Advances in microscopy and biotechnology have given us novel insights into cellular biology and physics. While bacteria were long considered to be relatively unstructured, the development of fluorescence microscopy techniques, and spatially and temporally resolved high-throughput quantitative studies, have uncovered that the bacterial cell is highly organized, and its structure rigorously maintained. In this thesis I will describe our gateTool software, designed to harness cell-to-cell variations to probe bacterial structure, and discuss two exciting aspects of structure that we have employed gateTool to investigate: (i) chromosome organization and the cellular mechanisms for controlling DNA dynamics, and (ii) the study of cell wall synthesis, and how the genes in the synthesis pathway impact cellular shape. In the first project, we develop a spatial and temporal mapping of cell-cycle-dependent chromosomal organization, and use this quantitative map to discover that chromosomal loci segregate from midcell with universal dynamics. In the second project, I describe preliminary time- lapse and snapshot imaging analysis suggesting phentoypical coherence across peptidoglycan synthesis pathways.

  13. Enterprise Factors Contributing to The Success of Malaysian Biotechnology SMEs: A Grounded Theory Approach

    Directory of Open Access Journals (Sweden)

    Saridan Abu Bakar

    2007-10-01

    Full Text Available While numerous empirical studies have been conducted in Western countries on biotechnology enterprises, little empirical research has been done in Malaysia especially in respect to the factors that contribute to the success of biotechnology small and medium enterprises (SMEs. In view of this, a study was undertaken recently in Malaysia to address this gap in the existing body of biotechnology knowledge. Using a grounded theory approach, this qualitative study managed to develop a conceptual framework that sheds useful information on the enterprise factors that significantly impact the success of Malaysian biotechnology SMEs. Specifically, this study found that organizational structure, innovation activities, linkages with academic research institutions, linkages with other private enterprises, personal linkages with academic researchers, access to financial capital, the procuring of government assistances, vertical integration, enterprise image, GMP compliance and halal certification, strongly influence enterprise success.

  14. Biotechnology and the Third World: Panacea or Recipe for Social Disaster? Academy for Educational Development 25th Anniversary Series.

    Science.gov (United States)

    Morehouse, Ward

    Asserting that developmental growth is easier to attain in developing countries than social change, this paper assesses the prospective impact of biotechnology on the developing nations. Biotechnology is defined as the integrated use of biochemistry, microbiology, and chemical engineering to achieve the industrial processes of fermentation, enzyme…

  15. Cacao biotechnology: current status and future prospects.

    Science.gov (United States)

    Wickramasuriya, Anushka M; Dunwell, Jim M

    2018-01-01

    Theobroma cacao-The Food of the Gods, provides the raw material for the multibillion dollar chocolate industry and is also the main source of income for about 6 million smallholders around the world. Additionally, cocoa beans have a number of other nonfood uses in the pharmaceutical and cosmetic industries. Specifically, the potential health benefits of cocoa have received increasing attention as it is rich in polyphenols, particularly flavonoids. At present, the demand for cocoa and cocoa-based products in Asia is growing particularly rapidly and chocolate manufacturers are increasing investment in this region. However, in many Asian countries, cocoa production is hampered due to many reasons including technological, political and socio-economic issues. This review provides an overview of the present status of global cocoa production and recent advances in biotechnological applications for cacao improvement, with special emphasis on genetics/genomics, in vitro embryogenesis and genetic transformation. In addition, in order to obtain an insight into the latest innovations in the commercial sector, a survey was conducted on granted patents relating to T. cacao biotechnology. © 2017 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd.

  16. Biotechnology: Challenge for the food industry

    Directory of Open Access Journals (Sweden)

    Popov Stevan

    2007-01-01

    Full Text Available According to the broadest definition, biotechnology is the use of living matter (plants, animals and microorganisms in industry, environment protection, medicine and agriculture. Biotechnology takes a key position in the field of food processing during thousands of years. Last about fifty years brought dynamical development of knowledges in the natural sciences especially in domain of genetics and manipulation of genes. Biotechnology for which active role in the on-coming times could be foreseen, not only with respect of R&D, but also in general technological development represents scope of priority in the USA and in European Union (EU as well. It is accepted that the results achieved in biotechnology oversize scientific domain and find their entrance into economics, legislation, quality of life and even of politics. Corresponding with the definition of biotechnology as "the integration of natural sciences and engineering in the application of microorganisms, cells, their components and molecular analogues in production (General assembly of the European federation for Biotechnology, 1989 European Commission (1999 adopted the biotechnological taxonomy, i.e. fields and sub-fields of biotechnology. R&D activities in this domain are oriented to eight fields and branched through them. Fields of biotechnology (EC, 1999 are: 1 Plant biotechnology (agricultural cultivars, trees, bushes etc; 2 Animal biotechnology; 3 Biotechnology in environment protection; 4 Industrial biotechnology (food, feed, paper, textile, pharmaceutical and chemical productions; 5 Industrial biotechnology (production of cells and research of cells - producers of food and of other commodities; 6 Development of humane and veterinarian diagnostics (therapeutical systems 7 Development of the basic biotechnology, and 8 Nontechnical domains of biotechnology. In concordance with some judgments, in the World exist about 4000 biotechnological companies. World market of biotechnological

  17. Healthcare biotechnology in India.

    Science.gov (United States)

    Srivastava, L M

    2005-01-01

    Biotechnology in India has made great progress in the development of infrastructure, manpower, research and development and manufacturing of biological reagents, biodiagnostics, biotherapeutics, therapeutic and, prophylactic vaccines and biodevices. Many of these indigenous biological reagents, biodiagnostics, therapeutic and prophylactic vaccines and biodevices have been commercialized. Commercially when biotechnology revenue has reached $25 billions in the U.S. alone in 2000 excluding the revenues of biotech companies that were acquired by pharmaceutical companies, India has yet to register a measurable success. The conservative nature and craze of the Indian Industry for marketing imported biotechnology products, lack of Government support, almost non-existing national healthcare system and lack of trained managers for marketing biological and new products seem to be the important factors responsible for poor economic development of biotechnology in India. With the liberalization of Indian economy, more and more imported biotechnology products will enter into the Indian market. The conditions of internal development of biotechnology are not likely to improve in the near future and it is destined to grow only very slowly. Even today biotechnology in India may be called to be in its infancy.

  18. Fungal biodiversity to biotechnology.

    Science.gov (United States)

    Chambergo, Felipe S; Valencia, Estela Y

    2016-03-01

    Fungal habitats include soil, water, and extreme environments. With around 100,000 fungus species already described, it is estimated that 5.1 million fungus species exist on our planet, making fungi one of the largest and most diverse kingdoms of eukaryotes. Fungi show remarkable metabolic features due to a sophisticated genomic network and are important for the production of biotechnological compounds that greatly impact our society in many ways. In this review, we present the current state of knowledge on fungal biodiversity, with special emphasis on filamentous fungi and the most recent discoveries in the field of identification and production of biotechnological compounds. More than 250 fungus species have been studied to produce these biotechnological compounds. This review focuses on three of the branches generally accepted in biotechnological applications, which have been identified by a color code: red, green, and white for pharmaceutical, agricultural, and industrial biotechnology, respectively. We also discuss future prospects for the use of filamentous fungi in biotechnology application.

  19. Les biotechnologies végétales appropriées dans le contexte du dialogue Nord-Sud

    Directory of Open Access Journals (Sweden)

    Lepoivre P.

    1999-01-01

    Full Text Available Appropriate plant biotechnology in the context of the dialogue between North and South. Appropriateness of any technology must take into consideration the ethical problems and the social, economical, scientific and ecological environment. For developing countries, plant biotechnologies definitely open interesting perspectives, but also raise potential problems, because their integration and valorisation require a progressive and adapted development. Biotechnologies depend on legal and physical infrastructures, as well as human skills for on-site control corresponding to the needs of the relevant populations and to the global environment.

  20. Biotechnology for energy

    International Nuclear Information System (INIS)

    Malik, K.A.; Naqvi, S.H.M.

    1991-01-01

    The present volume comprises paper presented and discussed in the symposium. The main purpose of this symposium was to collect researchers in the area of bioconversion of biomass into biofuels, petroleum biotechnology and biohydrometallurgy. This book has been divided into four main sections which includes molecular biology of biomass conversion, microbial conversion of biomass, petroleum biotechnology and biohydrometallurgy. It is becoming clear that biotechnology play a role in production and conservation of energy and can contribute to the overall energy situation. (A.B.)

  1. Har Gobind Khorana

    Indian Academy of Sciences (India)

    IAS Admin

    Har Gobind Khorana, whose scientific career spanned a period of more than sixty ... Vancouver to the Institute for Enzyme Research at the University of Wisconsin in .... Khorana was very excited at the opportunity ... development of simplified ...

  2. Traditional Chinese Biotechnology

    Science.gov (United States)

    Xu, Yan; Wang, Dong; Fan, Wen Lai; Mu, Xiao Qing; Chen, Jian

    The earliest industrial biotechnology originated in ancient China and developed into a vibrant industry in traditional Chinese liquor, rice wine, soy sauce, and vinegar. It is now a significant component of the Chinese economy valued annually at about 150 billion RMB. Although the production methods had existed and remained basically unchanged for centuries, modern developments in biotechnology and related fields in the last decades have greatly impacted on these industries and led to numerous technological innovations. In this chapter, the main biochemical processes and related technological innovations in traditional Chinese biotechnology are illustrated with recent advances in functional microbiology, microbial ecology, solid-state fermentation, enzymology, chemistry of impact flavor compounds, and improvements made to relevant traditional industrial facilities. Recent biotechnological advances in making Chinese liquor, rice wine, soy sauce, and vinegar are reviewed.

  3. Dine marker har DNA

    DEFF Research Database (Denmark)

    Eckholdt, Annette; Winding, Anne; Krogh, Paul Henning

    2017-01-01

    Ordet "biodiversitet" og at det er noget, vi skal have mere af, nævnes hyppigt. Men hvad er biodiversitet, og hvordan måles det? Agrologisk har bedt et par eksperter fra Aarhus Universitet forklare, hvordan et DNA-aftryk af jord og vand kan erstatte optællinger i felten og sige noget om biodivers......Ordet "biodiversitet" og at det er noget, vi skal have mere af, nævnes hyppigt. Men hvad er biodiversitet, og hvordan måles det? Agrologisk har bedt et par eksperter fra Aarhus Universitet forklare, hvordan et DNA-aftryk af jord og vand kan erstatte optællinger i felten og sige noget om...

  4. Nutrition by design: a review of biotechnology in functional food

    Directory of Open Access Journals (Sweden)

    Thomas Reynolds

    2016-02-01

    Full Text Available Medical institutions in industrial and developing countries are increasingly turning to functional foods as intervention in chronic disease. Advances in genetic engineering have provided methods of purposefully designing functional foods and bioactive compound-producing organisms. This literature review examines the recent history of biotechnological applications in functional food, the state of bioagricultural engineering for high-value compound production, and the challenges that developers face in promulgatingfunctional foods from biotechnological sources. Based on the literature reviewed, it is predicted that adding biotechnologically-produced compounds will be more successful in producing novel functional foods. Conclusion: Current functional food application is frequently hampered by a dearth of foods suitable to the purpose. The concurrent advent of biotechnology means that producers and clinicians are not constrained by limited and precarious natural development. Biotechnology has already produced altered dietary staples that can safely induce real health benefits, but the social approval of genetically modified foodstuffs is inconsistent at best. Modifying microalgae to produce micro and macronutrients, for harvest and incorporation into functional food products, provides the ideal specificity and reliability for bioactive compound use. However, its application in biomedical science is impeded by technical difficulty. It remains to be seen if microorganism engineering willbe able to meet the needs of its many stakeholders, including the functional food community. Nonetheless,the prospect of a flourishing functional food market, and the healthier population it will bring about, certainly makes it worth a try.

  5. Ethical principles for the use of human cellular biotechnologies

    DEFF Research Database (Denmark)

    Wolpe, Paul Root; Rommelfanger, Karen S.; Borenstein, Jason

    2017-01-01

    Recent developments in bioengineering promise the possibility of new diagnostic and treatment strategies, novel industrial processes, and innovative approaches to thorny problems in fields such as nutrition, agriculture, and biomanufacturing. As modern genetics has matured and developed technolog......-producing countries of the world, offers a set of ethical principles to contribute to the ethical conversation about human cellular biotechnological research moving forward....

  6. THE IMPORTANCE OF THE RELATIONSHIP BETWEEN COMPANY AND INCUBATOR FOR BIOTECHNOLOGY DEVELOPMENT

    Directory of Open Access Journals (Sweden)

    Ana Paula Ferreira Alves

    2014-01-01

    Full Text Available The biotechnology activities development demands an intense academic and scientific basis, a productive sector capable of transforming academic research in scientific products and services, and the creation of an institutional environment to promote the sector’s development. Moreover, many biotechnology companies establish formal partnerships with Universities (by technological incubator to expand innovative capacity coming into the market. The importance of biotechnology for developing countries is perceived by its ability to promote national development based on knowledge and innovation. In Brazil, the government establishes technological incubators to accelerate the company consolidation. In this way, it is important to study the relationship between the actors involved. In this context, this article aims to analyze the relationship between a technological incubator and a biotech company. To do so, the qualitative approach was adopted to reach the objective. Interviews with incubator’s employees of a Brazilian University and biotechnology company’s managers were conducted. The results show that the company-incubator interaction promoted projects approval which were able to support new researches development and to purchase production equipment. Incubated companies have higher chances of survival in the market from the interaction with University, through the technological incubator. The relationship between the incubator and the biotech company is considered a fundamental condition for biotechnology activities development.

  7. BIOTECHNOLOGY : AN OVERVIEW

    Directory of Open Access Journals (Sweden)

    John I. Bruce

    2012-09-01

    Full Text Available Biotechnology as a science includes various aspects of the management and manipulation of biological systems. Recent advances in immunology, molecular biology, cell culture and other associated areas provide an opportunity for scientists to move biology out of the laboratory and into the realms of society. This has many implications which mankind on a whole may not be prepared to cope with at this time. This new capability has been referred to as "Biotechnology". Biotechnology has also been defined as "the integrated use of biochemistry, microbiology, and chemical engineering in order to achieve the capacities of microbes and culture cells". Genetic engineering which includes gene splicing and recombinant DNA-cloning is an example of a recent offshoot of biotechnology. Because of the advent of biotechnology, one can now think of the prospect of engineering tomorrows vaccines. In the past, vaccine development has been laborious and in many instances an unrewarding task. After years of effort only a handful of safe, effective vaccines have emerged. In the biotechnology arena, new methodologies and strategies for immunizing humans and domestic animals against infectious diseases are providing new hope for discovering successful vaccines. While most of the effort in the past has focused on viral vaccine development, attention is now being directed towards vaccines for protection against parasitic diseases. Currently, considerable effort is being made to develop vaccines for malaria, coccidiosis (in fowl, cholera, malaria, schistosomiasis and trypanosomiasis among others.

  8. Har Gobind Khorana

    Indian Academy of Sciences (India)

    Home; Journals; Resonance – Journal of Science Education; Volume 17; Issue 12. Har Gobind Khorana - Early Years in Science and Transition from Chemistry to Chemical Biology. Uttam L Rajbhandary. General Article Volume 17 Issue 12 December 2012 pp 1125-1135 ...

  9. Biotechnology in Turkey: an overview.

    Science.gov (United States)

    Ozdamar, Tunçer H

    2009-07-01

    The term biotechnology first appeared in the programs of the Scientific and Technological Research Council of Turkey (TUBITAK) in 1982. The State Planning Organization (SPO) in 1988 defined biotechnology and the scientific fields. Moreover, it put forward an institutional framework and suggested priority areas for research and development. Turkey has been researching and investing in biotechnology for almost four decades. This review covers the development of science and technology policy with its history, consensus and consequences, bio-industries in Turkey, and research activities in biotechnology at Turkish Universities. Details are provided by the research groups in response to a common request for information on their activities and major publications in the field. The information provided has been grouped under thematic topics within the broad theme of biotechnology, and summarized within these topics. Although many aspects of biotechnological research are being pursued in Turkey, it appears that the most common research activities of the field are in fermentation processes, environmental biotechnology, and biomedical engineering.

  10. The potential impact of plant biotechnology on the Millennium Development Goals.

    Science.gov (United States)

    Yuan, Dawei; Bassie, Ludovic; Sabalza, Maite; Miralpeix, Bruna; Dashevskaya, Svetlana; Farre, Gemma; Rivera, Sol M; Banakar, Raviraj; Bai, Chao; Sanahuja, Georgina; Arjó, Gemma; Avilla, Eva; Zorrilla-López, Uxue; Ugidos-Damboriena, Nerea; López, Alberto; Almacellas, David; Zhu, Changfu; Capell, Teresa; Hahne, Gunther; Twyman, Richard M; Christou, Paul

    2011-03-01

    The eight Millennium Development Goals (MDGs) are international development targets for the year 2015 that aim to achieve relative improvements in the standards of health, socioeconomic status and education in the world's poorest countries. Many of the challenges addressed by the MDGs reflect the direct or indirect consequences of subsistence agriculture in the developing world, and hence, plant biotechnology has an important role to play in helping to achieve MDG targets. In this opinion article, we discuss each of the MDGs in turn, provide examples to show how plant biotechnology may be able to accelerate progress towards the stated MDG objectives, and offer our opinion on the likelihood of such technology being implemented. In combination with other strategies, plant biotechnology can make a contribution towards sustainable development in the future although the extent to which progress can be made in today's political climate depends on how we deal with current barriers to adoption.

  11. Biotechnology Industry, 2006

    Science.gov (United States)

    2006-01-01

    for commercial or other purposes. Because it is a process resting on the understanding of genetics, proteomics , and life science, biotechnology has...Luhnow & Samor, 2006). Novel biotechnologies could bring down the costs of making ethanol. Iogen Corporation has genetically modified a fungus to

  12. Cooperation Agreements in Biotechnology Companies: An Advantage for the Acquisition of New Capabilities and Growth?

    Directory of Open Access Journals (Sweden)

    Tomás Gabriel Bas

    2006-08-01

    Full Text Available Cooperation agreements in biotechnology allow us to observe the complexity surrounding alliances. The market globalization, the exorbitant costs of R&D and the rapid changes in technology, are arguably amongst the principal reasons that push companies to establish cooperation agreements. Biotechnology companies use this instrument to develop external features in the search for resources and missing expertise. This paper sets out to identify if such cooperation agreements in biotechnology companies are an advantage in themselves, sufficient for the acquisition of new capabilities and if they help the growth of these companies. For this approach, a private database of companies in the two most advanced countries in this sector: United States and United Kingdom, will be used.

  13. Biosafety Assessment of Microbial Strains Used in Biotechnology According to Their Taxonomy

    Directory of Open Access Journals (Sweden)

    Natalia I. Sheina

    2017-03-01

    Full Text Available A great variety of biotechnological products are now widely used in different ways in agriculture, medicine, food manufacturing and other areas of our life. Industrialized societies now more than ever depend on the use of genetically engineered products, with many of them synthesized using recombinant strains of microorganisms. There is an opinion that microbial strains used in biotechnology are potentially harmful for human health and the environment. Similar to many other countries, we have enacted environmental legislation in an effort to balance the risks and benefits of using biotechnological strains. Although environmental monitoring rules focus mainly on safety assessments of chemicals, the biosafety assessment of microbial strains used in biotechnology is a very important issue as well. This article summarizes 15 years of research on the biotechnological strains of microbes widely used as producers of various biological substances for industrial purposes, and their environmental and biotechnological applications. In our survey, we tried to evaluate possible adverse effects (general toxicity and damage to the immune system, potential sensitizing effects, and damage to normal microbiota caused by these microbes. It was shown that microscopical fungi of genera Aspergillus, Penicillium and Candida, and some gram-negative bacteria can affect the immune system and disrupt the normal balance of microbial flora of the intestinal tract in rats. The actinomycetes are less dangerous in that they cause fewer side effects. The investigation data obtained can be used to develop safety and hygienic standards for industrial microbes that will help decrease or minimize the occupational risk of infection or damage to the immune system when working with biotechnological strains of microbes.

  14. Biotechnology in China

    National Research Council Canada - National Science Library

    Hamer, Dean H; Kung, Shain-dow

    1989-01-01

    ... and Shain-dow Kung Center for Agricultural Biotechnology Maryland Biotechnology Institute Department of Botany University of Maryland College Park, Maryland Committee on Scholarly Communication with the People's Republic of China National Academy of Sciences National Academy Press Washington, DC 1989 i Copyrightthe cannot be not from bo...

  15. From the tumor-inducing principle to plant biotechnology and its importance for society.

    Science.gov (United States)

    Angenon, Geert; Van Lijsebettens, Mieke; Van Montagu, Marc

    2013-01-01

    This dialogue was held between the Guest Editors of the Special Issue on "Plant Transgenesis" of the Int. J. Dev. Biol. and Marc Van Montagu. Research in the group of Marc Van Montagu and Jeff Schell in the 1970s was essential to reveal how the phytopathogenic bacterium Agrobacterium tumefaciens transfers DNA to host plants to cause crown gall disease. Knowledge of the molecular mechanism underlying gene transfer, subsequently led to the development of plant transgene technology, an indispensable tool in fundamental plant research and plant improvement. In the early 1980s, Marc Van Montagu founded a start-up company, Plant Genetic Systems, which successfully developed insect-resistant plants, herbicide-tolerant plants and a hybrid seed production system based on nuclear male sterility. Even before the first transgenic plant had been produced, Marc Van Montagu realized that the less developed countries might benefit most from plant biotechnology and throughout his subsequent career, this remained a focus of his efforts. After becoming emeritus professor, he founded the Institute of Plant Biotechnology Outreach (IPBO), which aims to raise awareness of the major role that plant biotechnology can play in sustainable agricultural systems, especially in less developed countries. Marc Van Montagu has been honored with many prizes and awards, the most recent being the prestigious World Food Prize 2013. In this paper, we look to the past and present of plant biotechnology and to the promises this technology holds for the future, on the basis of the personal perspective of Marc Van Montagu.

  16. Biotechnology and Agriculture.

    Science.gov (United States)

    Kenney, Martin

    Even at this early date in the application of biotechnology to agriculture, it is clear that agriculture may provide the largest market for new or less expensive biotechnologically manufactured products. The chemical and pharmaceutical industries that hold important positions in agricultural inputs are consolidating their positions by purchasing…

  17. Is there a case to be made for a global patent system? The example of plant biotechnology

    OpenAIRE

    Jost, Dannie; Müller, Heinz; Foltea, Marina; Cottier, Thomas

    2012-01-01

    The assessment of patterns of patentability in plant biotechnology on the basis of existing statistics shows a considerable concentration of patents to a few countries, in particular the United States, Australia, Japan, China, Mexico, Brazil, Germany, Canada, New Zealand, South Korea, India, Spain and Hungary. These patterns suggest that there is a clear relationship between the choice of patent jurisdictions and the biotechnology regulatory framework. This observation of the geographic di...

  18. The rise (and decline?) of biotechnology.

    Science.gov (United States)

    Kinch, Michael S

    2014-11-01

    Since the 1970s, biotechnology has been a key innovator in drug development. An analysis of FDA-approved therapeutics demonstrates pharmaceutical companies outpace biotechs in terms of new approvals but biotechnology companies are now responsible for earlier-stage activities (patents, INDs or clinical development). The number of biotechnology organizations that contributed to an FDA approval began declining in the 2000s and is at a level not seen since the 1980s. Whereas early biotechnology companies had a decade from first approval until acquisition, the average acquisition of a biotechnology company now occurs months before their first FDA approval. The number of hybrid organizations that arise when pharmaceutical companies acquire biotechnology is likewise declining, raising questions about the sustainability of biotechnology. Copyright © 2014 Elsevier Ltd. All rights reserved.

  19. Harnessing Science and Technology for preservation and conservation of cultural heritage in Malaysia

    International Nuclear Information System (INIS)

    Adi Taha

    2005-04-01

    Malaysia's heritage is extraordinarily rich. Heritage links people, places and things from our history to the present and to the future. Department of Muzeums and Antiquities work diligently at collecting and preserving the artifacts, written records, oral traditions, special places and lands that make up the Malaysia's history. Over the years our concept of cultural heritage and its role as a central part of the experience of our communities has expanded from a focus on objects and monuments to include our social structures, ways of life, beliefs and systems of knowledge. We seek answers in our attempts to promote the understanding and unity among people that have made our country a nation regardless of ethnic origins and religious affiliations, and to prolong the life essence of our rich heritage. We found a simple but yet, a meaningful answer; Harnessing Science and Technology for Preservation and Conservation of Cultural Heritage in Malaysia. Conservation has gained an increasing importance world over, as there is greater awareness and a sense of urgency about the need to conserve and preserve cultural heritages. Recent years are witnessing unprecedented growth in various fields of science and technology in Malaysia, such as materials technology, medical sciences, biotechnology, information and communications technology. Whichever perspective is used, it is clear that science forms an integral part of Malaysia's culture, in the past as well as now. Fulfilling a vital function as a carrier of knowledge and methodology, sciences places on our shoulders a strong obligation towards future generations. As Malaysians, we have been formed by our cultural heritage. Clearly, we must protect that heritage and continue to enrich and develop it, incorporating new knowledge, new insights, new ideas and new experience. (Author)

  20. [Biotechnology's macroeconomic impact].

    Science.gov (United States)

    Dones Tacero, Milagros; Pérez García, Julián; San Román, Antonio Pulido

    2008-12-01

    This paper tries to yield an economic valuation of biotechnological activities in terms of aggregated production and employment. This valuation goes beyond direct estimation and includes the indirect effects derived from sectorial linkages between biotechnological activities and the rest of economic system. To deal with the proposed target several sources of data have been used, including official data from National Statistical Office (INE) such us national accounts, input-output tables, and innovation surveys, as well as, firms' level balance sheets and income statements and also specific information about research projects compiled by Genoma Spain Foundation. Methodological approach is based on the estimation of a new input-output table which includes the biotechnological activities as a specific branch. This table offers both the direct impact of these activities and the main parameters to obtain the induced effects over the rest of the economic system. According to the most updated available figures, biotechnological activities would have directly generated almost 1,600 millions of euros in 2005, and they would be employed more than 9,000 workers. But if we take into account the full linkages with the rest of the system, the macroeconomic impact of Biotechnological activities would reach around 5,000 millions euros in production terms (0.6% of total GDP) and would be responsible, directly or indirectly, of more than 44,000 employments.

  1. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.

    Science.gov (United States)

    Evens, R P; Kaitin, K I

    2014-05-01

    The marriage of biotechnology and the pharmaceutical industry (pharma) is predicated on an evolution in technology and product innovation. It has come as a result of advances in both the science and the business practices of the biotechnology sector in the past 30 years. Biotechnology products can be thought of as "intelligent pharmaceuticals," in that they often provide novel mechanisms of action, new approaches to disease control, higher clinical success rates, improved patient care, extended patent protection, and a significant likelihood of reimbursement. Although the first biotechnology product, insulin, was approved just 32 years ago in 1982, today there are more than 200 biotechnology products commercially available. Research has expanded to include more than 900 biotechnology products in clinical trials. Pharma is substantially engaged in both the clinical development of these products and their commercialization.

  2. Students' Knowledge of, and Attitudes towards Biotechnology Revisited, 1995-2014: Changes in Agriculture Biotechnology but Not in Medical Biotechnology

    Science.gov (United States)

    Chen, Shao-Yen; Chu, Yih-Ru; Lin, Chen-Yung; Chiang, Tzen-Yuh

    2016-01-01

    Modern biotechnology is one of the most important scientific and technological revolutions in the 21st century, with an increasing and measurable impact on society. Development of biotechnology curriculum has become important to high school bioscience classrooms. This study has monitored high school students in Taiwan on their knowledge of and…

  3. A Social Audit Model for Agro-biotechnology Initiatives in Developing Countries: Accounting for Ethical, Social, Cultural, and Commercialization Issues

    Directory of Open Access Journals (Sweden)

    Obidimma Ezezika

    2009-10-01

    Full Text Available There is skepticism and resistance to innovations associated with agro-biotechnology projects, leading to the possibility of failure. The source of the skepticism is complex, but partly traceable to how local communities view genetically engineered crops, public perception on the technology’s implications, and views on the role of the private sector in public health and agriculture, especially in the developing world. We posit that a governance and management model in which ethical, social, cultural, and commercialization issues are accounted for and addressed is important in mitigating risk of project failure and improving the appropriate adoption of agro-biotechnology in sub-Saharan Africa. We introduce a social audit model, which we term Ethical, Social, Cultural and Commercialization (ESC2 auditing and which we developed based on feedback from a number of stakeholders. We lay the foundation for its importance in agro-biotechnology development projects and show how the model can be applied to projects run by Public Private Partnerships. We argue that the implementation of the audit model can help to build public trust through facilitating project accountability and transparency. The model also provides evidence on how ESC2 issues are perceived by various stakeholders, which enables project managers to effectively monitor and improve project performance. Although this model was specifically designed for agro-biotechnology initiatives, we show how it can also be applied to other development projects.

  4. Current state of biotechnology in Turkey.

    Science.gov (United States)

    Dundar, Munis; Akbarova, Yagut

    2011-09-01

    Biotechnology is an interdisciplinary branch of science that encompasses a wide range of subjects like genetics, virology, microbiology, immunology, engineering to develop vaccines, and so on and plays a vital role in health systems, crop and seed management, yield improvement, agriculture, soil management, ecology, animal farming, cellular process, bio statistics, and so on. This article is about activities in medical and pharmaceutical biotechnology, environmental biotechnology, agricultural biotechnology and nanobiotechnology carried out in Turkey. Turkey has made some progress in biotechnology projects for research and development. Copyright © 2011 Elsevier Ltd. All rights reserved.

  5. Sustainable Use of Biotechnology for Bioenergy Feedstocks

    Science.gov (United States)

    Moon, Hong S.; Abercrombie, Jason M.; Kausch, Albert P.; Stewart, C. Neal

    2010-10-01

    Done correctly, cellulosic bioenergy should be both environmentally and economically beneficial. Carbon sequestration and decreased fossil fuel use are both worthy goals in developing next-generation biofuels. We believe that biotechnology will be needed to significantly improve yield and digestibility of dedicated perennial herbaceous biomass feedstocks, such as switchgrass and Miscanthus, which are native to the US and China, respectively. This Forum discusses the sustainability of herbaceous feedstocks relative to the regulation of biotechnology with regards to likely genetically engineered traits. The Forum focuses on two prominent countries wishing to develop their bioeconomies: the US and China. These two countries also share a political desire and regulatory frameworks to enable the commercialization and wide release of transgenic feedstocks with appropriate and safe new genetics. In recent years, regulators in both countries perform regular inspections of transgenic field releases and seriously consider compliance issues, even though the US framework is considered to be more mature and stringent. Transgene flow continues to be a pertinent environmental and regulatory issue with regards to transgenic plants. This concern is largely driven by consumer issues and ecological uncertainties. Regulators are concerned about large-scale releases of transgenic crops that have sexually compatible crops or wild relatives that can stably harbor transgenes via hybridization and introgression. Therefore, prior to the commercialization or extensive field testing of transgenic bioenergy feedstocks, we recommend that mechanisms that ensure biocontainment of transgenes be instituted, especially for perennial grasses. A cautionary case study will be presented in which a plant’s biology and ecology conspired against regulatory constraints in a non-biomass crop perennial grass (creeping bentgrass, Agrostis stolonifera), in which biocontainment was not attained. Appropriate

  6. ISS Biotechnology Facility - Overview of Analytical Tools for Cellular Biotechnology Investigations

    Science.gov (United States)

    Jeevarajan, A. S.; Towe, B. C.; Anderson, M. M.; Gonda, S. R.; Pellis, N. R.

    2001-01-01

    The ISS Biotechnology Facility (BTF) platform provides scientists with a unique opportunity to carry out diverse experiments in a microgravity environment for an extended period of time. Although considerable progress has been made in preserving cells on the ISS for long periods of time for later return to Earth, future biotechnology experiments would desirably monitor, process, and analyze cells in a timely way on-orbit. One aspect of our work has been directed towards developing biochemical sensors for pH, glucose, oxygen, and carbon dioxide for perfused bioreactor system developed at Johnson Space Center. Another aspect is the examination and identification of new and advanced commercial biotechnologies that may have applications to on-orbit experiments.

  7. Biotechnology organizations in action

    DEFF Research Database (Denmark)

    Norus, Jesper

    This volume analyzes the dynamics and interactive processes among the players (individuals, institutions, and organizations/firms) that have constituted and legitimized the development of the biotechnology industries. The unit of analysis is small entrepreneurial firms developing biotechnological...

  8. Food irradiation: an emerging opportunity for African countries

    International Nuclear Information System (INIS)

    Adu-Gyamfi, A.

    2004-01-01

    Full Text. The paper reviews the use of food irradiation technology and its potential in food processing and international trade for economic development of African countries. Provision of infrastructure along with technical expertise, private sector anticipation, effective collaborative ventures and networking with other countries and international agencies are considered crucial for Africa to harness the potential of food irradiation. (author)

  9. Factors Affecting the Survival of SMEs: A Study of Biotechnology Firms in South Korea

    Directory of Open Access Journals (Sweden)

    Kwangsoo Shin

    2017-01-01

    Full Text Available Past studies examining survival factors of biotechnology firms have focused on pioneer countries, such as the USA, the UK and Germany. However, as the biotechnology industry in Asia is reaching the take-off stage and showing a high growth rate, the research on survival factors in the context of Asian latecomers is needed. The present research investigates internal and external factors affecting the survival of SMEs (Small and Medium-sized Enterprises in the biotechnology industry in South Korea. The Cox hazard model was employed to perform a robust estimation in survival analysis. The analysis of internal factors showed that the origin of a firm (i.e., having prior experience or spin-offs and the business sub-sector (i.e., platform-based affect the hazard rates of biotechnology firms. In terms of external factors, unlike strategic alliances, government R&D funding lowered hazard rates for the firm’s survival. Additionally, considering that the reasons of firm exit can be divided into bankruptcy and M&A (Mergers and Acquisitions, the different effects of origins from other firms and strategic alliance for firm survival are confirmed. The results suggest that prior experience, platform-based and constant government R&D funding contribute to the sustainable development of SMEs in the biotechnology industry.

  10. Biotechnology education as social and cultural production/reproduction of the biotechnology community

    Science.gov (United States)

    Andrée, Maria

    2014-03-01

    This paper is a commentary to a paper by Anne Solli, Frank Bach and Björn Åkerman on how students at a technical university learn to argue as biotechnologists. Solli and her colleagues report from an ethnographic study performed during the first semester of a 5-year program in biotechnology at a technical university in Sweden. Their study demonstrates how students begin to acquire `the right way' of approaching the controversial issue of producing and consuming genetically modified organisms. In my response I discuss the ethnographic account of this particular educational practice in terms of social and cultural production/reproduction of a biotechnology community and how the participants (students and teaching professors) deal with the dialectic of individual and collective transformation. In the perspective of the biotechnology community, the work done by the teaching professor becomes a way of ensuring the future of the biotechnology community in terms of what values and objectives are held highly in the community of practice.

  11. The effect of biotechnology education on Australian high school students' understandings and attitudes about biotechnology processes

    Science.gov (United States)

    Dawson, Vaille; Soames, Christina

    2006-11-01

    Our education system aims to equip young people with the knowledge, problem-solving skills and values to cope with an increasingly technological society. The aim of this study was to determine the effect of biotechnology education on adolescents’ understanding and attitudes about processes associated with biotechnology. Data were drawn from teacher and student interviews and surveys in the context of innovative Year 10 biotechnology courses conducted in three Western Australian high schools. The results indicate that after completing a biotechnology course students’ understanding increased but their attitudes remained constant with the exception of their views about human uses of gene technology. The findings of this study have ramifications for the design and implementation of biotechnology education courses in high schools.

  12. World Biotechnology Leaders to Gather for Conference

    Science.gov (United States)

    Biotechnology Leaders to Gather for Conference For more information contact: e:mail: Public Affairs biotechnology leaders gather in Fort Collins, CO May 2-6 for the 21st Symposium on Biotechnology for Fuels and special session on funding opportunities for U.S. biotechnology projects. More than 175 presentations are

  13. Biotechnology : A Dutch perspective

    NARCIS (Netherlands)

    Van Apeldoorn, J.H.F.

    1981-01-01

    Biotechnology: a Dutch Perspective assesses the future potential of biotechnology in the Netherlands. It has been published in English because it is felt that the Dutch case could be of relevance to other industrialised nations. Although the report is aimed primarily at policy planners and decision

  14. Proceedings of the International Symposium on Biotechnology

    International Nuclear Information System (INIS)

    2008-01-01

    This is a book of abstracts of oral communications and posters that were presented during the International Symposium on Biotechnology that was held in Sfax, Tunisia from May 4th to 8th, 2008. The following themes were covered : - Biotechnology for animal and human health and biopharmaceuticals; - Microbial and environmental biotechnology; - Agricultural, Food and marine biotechnology

  15. Khorana, Prof. Har Gobind

    Indian Academy of Sciences (India)

    Elected: 1976 Honorary. Khorana, Prof. Har Gobind Nobel Laureate (Medicine) - 1968. Date of birth: 9 January 1922. Date of death: 9 November 2011. Last known address: Alfred P. Sloan Professor of, Biology and Chemistry, Massachusetts Institute of, Technology, 77 Massachusetts Ave., Cambridge, MA 02139, U.S.A..

  16. Environmental biotechnology: Reducing risks from environmental chemicals through biotechnology

    International Nuclear Information System (INIS)

    Omenn, G.S.

    1988-01-01

    This book contains 34 papers on various aspects of hazardous waste management through biotechnology. The articles stress the three basic strategies of waste management; minimize the amount of waste generated; reduce the toxicity of the wastes; and find more satisfactory ways of disposing of wastes. Part I of this collection describes the use of microbial ecology, molecular biology, and other scientific disciplines to combat these problems. Part II describes the application of present technology to current problems. Part III describes the effect of policy and regulations on biotechnology. Individual papers are processed separately for the data base

  17. Design Process Improvement for Electric CAR Harness

    Science.gov (United States)

    Sawatdee, Thiwarat; Chutima, Parames

    2017-06-01

    In an automobile parts design company, the customer satisfaction is one of the most important factors for product design. Therefore, the company employs all means to focus its product design process based on the various requirements of customers resulting in high number of design changes. The objective of this research is to improve the design process of the electric car harness that effects the production scheduling by using Fault Tree Analysis (FTA) and Failure Mode and Effect Analysis (FMEA) as the main tools. FTA is employed for root cause analysis and FMEA is used to ranking a High Risk Priority Number (RPN) which is shows the priority of factors in the electric car harness that have high impact to the design of the electric car harness. After the implementation, the improvements are realized significantly since the number of design change is reduced from 0.26% to 0.08%.

  18. The globalization of health research: harnessing the scientific diaspora.

    Science.gov (United States)

    Anand, Nalini P; Hofman, Karen J; Glass, Roger I

    2009-04-01

    The scientific diaspora is a unique resource for U.S. universities. By drawing on the expertise, experience, and catalytic potential of diaspora scientists, universities can capitalize more fully on their diverse intellectual resources to make lasting contributions to global health. This article examines the unique contributions of the diaspora in international research collaborations, advantages of harnessing the diaspora and benefits to U.S. universities of fostering these collaborations, challenges faced by scientists who want to work with their home countries, examples of scientists engaging with their home countries, and specific strategies U.S. universities and donors can implement to catalyze these collaborations. The contributions of the diaspora to the United States are immense: International students enrolled in academic year 2007-2008 contributed an estimated $15 billion to the U.S. economy. As scientific research becomes increasingly global, the percentage of scientific publications with authors from foreign countries has grown from 8% in 1988 to 20% in 2005. Diaspora scientists can help build trusting relationships with scientists abroad, and international collaborations may improve the health of underserved populations at home. Although opportunities for diaspora networks are increasing, most home countries often lack enabling policies, infrastructure, and resources to effectively utilize their diaspora communities abroad. This article examines how some governments have successfully mobilized their scientific diaspora to become increasingly engaged in their national research agendas. Recommendations include specific strategies, including those that encourage U.S. universities to promote mini-sabbaticals and provide seed funding and flexible time frames.

  19. Environmental Control Unit Harness Project

    Science.gov (United States)

    Oliva-Buisson, Yvette J.

    2014-01-01

    Testing four new Environmental Control Unit Harnesses for improved user comfort during SCAPE operations. Phase I, testing in a lab environment, Phase II will continue testing the best candidates in a field environment.

  20. Har vi en virkelighedssans?

    DEFF Research Database (Denmark)

    Trettvik, Johan

    2013-01-01

    Vores teoretiske forhold til virkeligheden er meget omdiskuteret, og særlig spørgsmålet om, hvorvidt vores viden afspejler noget virkeligt, er centralt i diskussionen af begrebet om virkelighed. I psykologien har det sat sine spor ved enten en reduktionistisk holdning til sit genstandsfelt eller ...

  1. Developing a TTCN-3 Test Harness for Legacy Software

    DEFF Research Database (Denmark)

    Okika, Joseph C.; Ravn, Anders Peter; Siddalingaiah, Lokesh

    2006-01-01

    We describe a prototype test harness for an embedded system which is the control software for a modern marine diesel engine. The operations of such control software requires complete certification. We adopt Testing and Test Control Notation (TTCN-3) to define test cases for this purpose. The main...... challenge in developing the test harness is to interface a generic test driver to the legacy software and provide a suitable interface for test engineers. The main contribution of this paper is a demonstration of a suitable design for such a test harness. It includes: a TTCN-3 test driver in C++, the legacy...

  2. Biotechnological production of pharmaceuticals and biopharmaceuticals in plant cell and organ cultures.

    Science.gov (United States)

    Hidalgo, Diego; Sanchez, Raul; Lalaleo, Liliana; Bonfill, Mercedes; Corchete, Purificacion; Palazon, Javier

    2018-03-09

    Plant biofactories are biotechnological platforms based on plant cell and organ cultures used for the production of pharmaceuticals and biopharmaceuticals, although to date only a few of these systems have successfully been implemented at an industrial level. Metabolic engineering is possibly the most straightforward strategy to boost pharmaceutical production in plant biofactories, but social opposition to the use of GMOs means empirical approaches are still being used. Plant secondary metabolism involves thousands of different enzymes, some of which catalyze specific reactions, giving one product from a particular substrate, whereas others can yield multiple products from the same substrate. This trait opens plant cell biofactories to new applications, in which the natural metabolic machinery of plants can be harnessed for the bioconversion of phytochemicals or even the production of new bioactive compounds. Synthetic biological pipelines involving the bioconversion of natural substrates into products with a high market value may be established by the heterologous expression of target metabolic genes in model plants. To summarize the state of the art of plant biofactories and their applications for the pipeline production of cosme-, pharma- and biopharmaceuticals. In order to demonstrate the great potential of plant biofactories for multiple applications in the biotechnological production of pharmaceuticals and biopharmaceuticals, this review broadly covers the following: plant biofactories based on cell and hairy root cultures; secondary metabolite production; biotransformation reactions; metabolic engineering tools applied in plant biofactories; and biopharmaceutical production. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

  3. Changing trends in biotechnology of secondary metabolism in medicinal and aromatic plants.

    Science.gov (United States)

    Gandhi, Sumit G; Mahajan, Vidushi; Bedi, Yashbir S

    2015-02-01

    Medicinal and aromatic plants are known to produce secondary metabolites that find uses as flavoring agents, fragrances, insecticides, dyes and drugs. Biotechnology offers several choices through which secondary metabolism in medicinal plants can be altered in innovative ways, to overproduce phytochemicals of interest, to reduce the content of toxic compounds or even to produce novel chemicals. Detailed investigation of chromatin organization and microRNAs affecting biosynthesis of secondary metabolites as well as exploring cryptic biosynthetic clusters and synthetic biology options, may provide additional ways to harness this resource. Plant secondary metabolites are a fascinating class of phytochemicals exhibiting immense chemical diversity. Considerable enigma regarding their natural biological functions and the vast array of pharmacological activities, amongst other uses, make secondary metabolites interesting and important candidates for research. Here, we present an update on changing trends in the biotechnological approaches that are used to understand and exploit the secondary metabolism in medicinal and aromatic plants. Bioprocessing in the form of suspension culture, organ culture or transformed hairy roots has been successful in scaling up secondary metabolite production in many cases. Pathway elucidation and metabolic engineering have been useful to get enhanced yield of the metabolite of interest; or, for producing novel metabolites. Heterologous expression of putative plant secondary metabolite biosynthesis genes in a microbe is useful to validate their functions, and in some cases, also, to produce plant metabolites in microbes. Endophytes, the microbes that normally colonize plant tissues, may also produce the phytochemicals produced by the host plant. The review also provides perspectives on future research in the field.

  4. Biotechnological Innovations in Aquaculture

    Directory of Open Access Journals (Sweden)

    Mangesh M. Bhosale

    2016-04-01

    Full Text Available Aquaculture is gaining commendable importance to meet the required protein source for ever increasing human population. The aquaculture industry is currently facing problems on developing economically viable production systems by reducing the impact on environment. Sustainable and enhanced fish production from aquaculture may be better achieved through application of recent biotechnological innovations. Utilisation of transgenic technology has led to production of fishes with faster growth rate with disease resistance. The full advantage of this technology could not be achieved due to concern of acceptance for Genetically Modified Organisms (GMOs. The biotechnological intervention in developing plant based feed ingredient in place of fish meal which contain high phosphorus is of prime area of attention for fish feed industry. The replacement of fish meal will also reduce fish feed cost to a greater extent. Year round fish seed production of carps through various biotechnological interventions is also need of the hour. This paper discusses technical, environmental and managerial considerations regarding the use of these biotechnological tools in aquaculture along with the advantages of research application and its commercialization.

  5. National Center for Biotechnology Information

    Science.gov (United States)

    ... to NCBI Sign Out NCBI National Center for Biotechnology Information Search database All Databases Assembly Biocollections BioProject ... Search Welcome to NCBI The National Center for Biotechnology Information advances science and health by providing access ...

  6. Biotechnology and human rights.

    Science.gov (United States)

    Feuillet-Le Mintier, B

    2001-12-01

    Biotechnology permits our world to progress. It's a tool to better apprehend the human being, but as well to let him go ahead. Applied to the living, biotechnologies present the same finality. But since their matter concerns effectively the living, they are the sources of specific dangers and particularly of that one to use the improvements obtained on the human to modify the human species. The right of the persons has to find its place to avoid that the fundamental rights of the human personality shall undergo harm. This mission assigned to the right of the persons is as so much invaluable that the economical stakes are particularly important in the domain of the biotechnologies.

  7. Current status of biotechnology in Slovakia.

    Science.gov (United States)

    Stuchlík, Stanislav; Turna, Ján

    2013-07-01

    The United Nations Convention on Biological Diversity defines biotechnology as: 'Any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.' In other words biotechnology is 'application of scientific and technical advances in life science to develop commercial products' or briefly 'the use of molecular biology for useful purposes'. This short overview is about different branches of biotechnology carried out in Slovakia and it shows that Slovakia has a good potential for further development of modern biotechnologies. Copyright © 2013 Elsevier Ltd. All rights reserved.

  8. Harnessing off-target effects

    DEFF Research Database (Denmark)

    Saginc, Gaye; Voellmy, Franziska; Linding, Rune

    2017-01-01

    The 'off-targets' of a drug are often poorly characterized yet could be harnessed in the treatment of complex diseases. A recent study used a small-molecule screening in non-small-cell lung cancer to repurpose an FDA-approved ALK/IGF1R inhibitor and uncover its mechanism of action....

  9. Industrial biotechnology for developing countries: The case for ...

    African Journals Online (AJOL)

    Attempts to diversify the energy portfolios of developed countries with green technologies have brought competition between food and fuel for crop production resources to the forefront of public policy debates. ... Keywords: Barriers to trade, energy policy, genetically modified (GM) crops, international trade, land-use policy

  10. Brief Note on the Development of Biotechnology

    OpenAIRE

    Karl Bayer

    2014-01-01

    Biotechnology, with the main applications in food and nutrition, dates back to the early times of mankind. In the recent decades the progress in natural sciences, mathematics and computer science has led to a new branch termed molecular biotechnology, which finally developed as an autonomous scientific discipline. The field of biotechnology, in the past generally empirically driven, now largely benefits from molecular biotechnology by improved systems, knowledge and understanding. Thereby, co...

  11. Biotechnological approaches to enhance salidroside, rosin and its derivatives production in selected Rhodiola spp. in vitro cultures.

    Science.gov (United States)

    Grech-Baran, Marta; Sykłowska-Baranek, Katarzyna; Pietrosiuk, Agnieszka

    Rhodiola (Crassulaceae) an arctic-alpine plant, is extensively used in traditional folk medicine in Asian and European countries. A number of investigations have demonstrated that Rhodiola preparations exhibit adaptogenic, neuroprotective, anti-tumour, cardioprotective, and anti-depressant effects. The main compounds responsible for these activities are believed to be salidroside, rosin and its derivatives which became the target of biotechnological investigations. This review summarizes the results of the diverse biotechnological approaches undertaken to enhance the production of salidroside, rosin and its derivatives in callus, cell suspension and organ in vitro cultures of selected Rhodiola species.

  12. Progress towards the 'Golden Age' of biotechnology.

    Science.gov (United States)

    Gartland, K M A; Bruschi, F; Dundar, M; Gahan, P B; Viola Magni, M p; Akbarova, Y

    2013-07-01

    Biotechnology uses substances, materials or extracts derived from living cells, employing 22 million Europeans in a € 1.5 Tn endeavour, being the premier global economic growth opportunity this century. Significant advances have been made in red biotechnology using pharmaceutically and medically relevant applications, green biotechnology developing agricultural and environmental tools and white biotechnology serving industrial scale uses, frequently as process feedstocks. Red biotechnology has delivered dramatic improvements in controlling human disease, from antibiotics to overcome bacterial infections to anti-HIV/AIDS pharmaceuticals such as azidothymidine (AZT), anti-malarial compounds and novel vaccines saving millions of lives. Green biotechnology has dramatically increased food production through Agrobacterium and biolistic genetic modifications for the development of 'Golden Rice', pathogen resistant crops expressing crystal toxin genes, drought resistance and cold tolerance to extend growth range. The burgeoning area of white biotechnology has delivered bio-plastics, low temperature enzyme detergents and a host of feedstock materials for industrial processes such as modified starches, without which our everyday lives would be much more complex. Biotechnological applications can bridge these categories, by modifying energy crops properties, or analysing circulating nucleic acid elements, bringing benefits for all, through increased food production, supporting climate change adaptation and the low carbon economy, or novel diagnostics impacting on personalized medicine and genetic disease. Cross-cutting technologies such as PCR, novel sequencing tools, bioinformatics, transcriptomics and epigenetics are in the vanguard of biotechnological progress leading to an ever-increasing breadth of applications. Biotechnology will deliver solutions to unimagined problems, providing food security, health and well-being to mankind for centuries to come. Copyright © 2013

  13. The costly benefits of opposing agricultural biotechnology.

    Science.gov (United States)

    Apel, Andrew

    2010-11-30

    Rigorous application of a simple definition of what constitutes opposition to agricultural biotechnology readily encompasses a wide array of key players in national and international systems of food production, distribution and governance. Even though the sum of political and financial benefits of opposing agricultural biotechnology appears vastly to outweigh the benefits which accrue to providers of agricultural biotechnology, technology providers actually benefit from this opposition. If these barriers to biotechnology were removed, subsistence farmers still would not represent a lucrative market for improved seed. The sum of all interests involved ensures that subsistence farmers are systematically denied access to agricultural biotechnology. Copyright © 2010 Elsevier B.V. All rights reserved.

  14. ENVIRONMENTAL RISK MANAGEMENT OF BIOTECHNOLOGY

    Science.gov (United States)

    The last two decades have shown remarkable advances in the field of biotechnology. We have processes using biotechnology to produce materials from commodity chemicals to pharmaceuticals. The application to agriculture has shown the introduction of transgenic crops with pesticidal...

  15. The current biotechnology outlook in Malaysia

    Directory of Open Access Journals (Sweden)

    Khairiah Salwa MOKHTAR

    2010-06-01

    Full Text Available Blessed with extremely rich biodiversity, Malaysia is all geared up to explore new high technology to utilize the advantage it possesses whilst to protect its environment. Biotechnology has been identified as an appropriate driver that can deliver economic gains through research and development, improvement of food security, creation of entrepreneurial opportunities for industrial growth, health and environmental sustainability. This paper attempts to address the evolution of biotechnology institutions and the stumbling blocks in developing the Malaysian biotechnology industry. This paper identifies three main impediments in the current Malaysian biotechnology, namely lack of skilled human capital; weak industrial base; and lack of commercialization effort. Besides, a set of strategies are discussed with aim to further improve and strengthen the Malaysian biotechnology industry. In general, the arguments are presented by mapping out the symbiotic relationship between data from elite interviews, archival data and observations.

  16. Healthcare biotechnology in India

    OpenAIRE

    Srivastava, L. M.

    2005-01-01

    Biotechnology in India has made great progress in the development of infrastructure, manpower, research and development and manufacturing of biological reagents, biodiagnostics, biotherapeutics, therapeutic and, prophylactic vaccines and biodevices. Many of these indigenous biological reagents, biodiagnostics, therapeutic and prophylactic vaccines and biodevices have been commercialized. Commercially when biotechnology revenue has reached $25 billions in the U.S. alone in 2000 excluding the r...

  17. Biotechnology in diagnostics

    International Nuclear Information System (INIS)

    Koprowski, H.; Ferrone, S.; Albertini, A.

    1985-01-01

    In recent years much progress has been made in the area of biotechnology. The cellular and molecular cloning methodology to develop monoclonal antibodies and DNA probes have been extensively utilized in basic and clinical research. These investigations have provided the necessary information to apply these reagents to diagnostic problems. The RIA 85 meeting focused on the application of monoclonal antibodies and DNA probes in laboratory medicine. The papers presented at this meeting clearly indicate that biotechnology has already had a significant impact on clinical medicine. (Auth.)

  18. Colloids in Biotechnology

    CERN Document Server

    Fanun, Monzer

    2010-01-01

    Colloids have come a long way from when Thomas Graham coined the term colloid to describe 'pseudo solutions'. This book enables scientists to close the gap between extensive research and translation into commercial options in biomedicine and biotechnology. It covers biosurfactants and surface properties, phase behavior, and orientational change of surfactant mixtures with peptides at the interface. It also covers adsorption of polymers and biopolymers on the surface and interface, discusses colloidal nanoparticles and their use in biotechnology, and delves into bioadhesion and microencapsulati

  19. Synthesis of Fluorescent Carbon Dots by Gastrointestinal Fluid Treatment of Mongolia Har Gabur

    Directory of Open Access Journals (Sweden)

    Tegexibaiyin Wang

    2017-01-01

    Full Text Available Har Gabur is the carbide obtained from pig manure by burning. The fluorescent carbon dots (CDs of Har Gabur were successfully synthesized through simulating the digestion process of human gastrointestinal tract. Transmission Electron Microscope (TEM analysis showed that the average size of the prepared Har Gabur CDs was 4 nm, with good solubility in water and strong fluorescence under UV irradiation. The X-ray and Raman results showed that the Har Gabur CDs were mainly composed of oxygen “O” and carbon “C” elements, in the forms of “C=O” and “C-O.” The bond energy results showed that the nitrogen “N” atom presented as “C-N” form, which indicated that Har Gabur CDs also contain “N.” In photobleaching assay, Har Gabur CDs showed excellent light stability compared with ordinary organic dye, fluorescein, and Rhodamine B. The fluorescence intensity of Har Gabur CDs was fairly stable within a wide pH range of 3–10. When L-lysine and L-cysteine were applied for the passivation stage, the relative quantum yields were improved by 1.53 and 3.68 times, respectively. Finally, the fluorescence properties of Har Gabur CDs were tested in cells and zebrafish, illustrating that Har Gabur CD has potential in the application of biological labeling and imaging.

  20. Avian Biotechnology.

    Science.gov (United States)

    Nakamura, Yoshiaki

    2017-01-01

    Primordial germ cells (PGCs) generate new individuals through differentiation, maturation and fertilization. This means that the manipulation of PGCs is directly linked to the manipulation of individuals, making PGCs attractive target cells in the animal biotechnology field. A unique biological property of avian PGCs is that they circulate temporarily in the vasculature during early development, and this allows us to access and manipulate avian germ lines. Following the development of a technique for transplantation, PGCs have become central to avian biotechnology, in contrast to the use of embryo manipulation and subsequent transfer to foster mothers, as in mammalian biotechnology. Today, avian PGC transplantation combined with recent advanced manipulation techniques, including cell purification, cryopreservation, depletion, and long-term culture in vitro, have enabled the establishment of genetically modified poultry lines and ex-situ conservation of poultry genetic resources. This chapter introduces the principles, history, and procedures of producing avian germline chimeras by transplantation of PGCs, and the current status of avian germline modification as well as germplasm cryopreservation. Other fundamental avian reproductive technologies are described, including artificial insemination and embryo culture, and perspectives of industrial applications in agriculture and pharmacy are considered, including poultry productivity improvement, egg modification, disease resistance impairment and poultry gene "pharming" as well as gene banking.

  1. Re-Framing Biotechnology Regulation.

    Science.gov (United States)

    Peck, Alison

    Biotechnology is about to spill the banks of federal regulation. New genetic engineering techniques like CRISPR-Cas9 promise revolutionary breakthroughs in medicine, agriculture, and public health—but those techniques would not be regulated under the terms of the Coordinated Framework for Regulation of Biotechnology. This revolutionary moment in biotechnology offers an opportunity to correct the flaws in the framework, which was hastily patched together at the advent of the technology. The framework has never captured all relevant technologies, has never satisfied the public that risk is being effectively managed, and has never been accessible to small companies and publicly-funded labs that increasingly are positioned to make radical, life-saving innovations. This Article offers a proposal for new legislation that would reshape biotechnology regulation to better meet these goals. Key reforms include tying regulation to risk rather than technology category; consolidating agency review; capturing distinct regulatory expertise through inter-agency consultations; creating a clearinghouse to help guide applicants and disseminate information; setting up more comprehensive monitoring of environmental effects; and providing federal leadership to fill key data gaps and address socio-economic impacts.

  2. State responses to biotechnology.

    Science.gov (United States)

    Harris, Rebecca C

    2015-01-01

    This article reviews biotechnology legislation in the 50 states for 11 policy areas spanning 1990-2010, an era of immense growth in biotechnology, genetic knowledge, and significant policy development. Policies regarding health insurance, life insurance, long-term care insurance, DNA data bank collection, biotech research protection, biotech promotion and support, employment discrimination, genetic counselor licensing, human cloning, and genetic privacy each represent major policy responses arising from biotechnology and coinciding with key areas of state regulation (insurance, criminal justice, economic development, labor law, health and safety, privacy, and property rights). This analysis seeks to answer three questions regarding biotechnology legislation at the state level: who is acting (policy adoption), when is policy adopted (policy timing), and what is policy doing (policy content). Theoretical concerns examine state ideology (conservative or liberal), policy type (economic or moral), and the role of external events (federal law, news events, etc.) on state policy adoption. Findings suggest ideological patterns in adoption, timing, and content of biotech policy. Findings also suggest economic policies tend to be more uniform in content than moral policies, and findings also document a clear link between federal policy development, external events, and state policy response.

  3. Biotechnology: An Era of Hopes and Fears

    Science.gov (United States)

    2016-01-01

    Strategic Studies Quarterly ♦ Fall 2016 23 Biotechnology An Era of Hopes and Fears LTC Douglas R. Lewis, PhD, US Army Abstract Biotechnology ......ignored. The idea of advances in biotechnology increasing the biological weapons threat is not new. In 2003 an analysis of gene sequencing and

  4. The potential impact of plant biotechnology on the Millennium Development Goals

    OpenAIRE

    Yuan, D. W.; Bassie, L.; Sabalza, M.; Miralpeix, B.; Dashevskaya, S.; Farre, G.; Rivera, S. M.; Banakar, R.; Bai, C.; Sanahuja, G.; Arjo, G.; Avilla, E.; Zorrilla-Lopez, U.; Ugidos-Damboriena, N.; Lopez, A.

    2011-01-01

    The eight Millennium Development Goals (MDGs) are international development targets for the year 2015 that aim to achieve relative improvements in the standards of health, socioeconomic status and education in the world’s poorest countries. Many of the challenges addressed by the MDGs reflect the direct or indirect consequences of subsistence agriculture in the developing world, and hence, plant biotechnology has an important role to play in helping to achieve MDG targ...

  5. Agricultural biotechnology and its contribution to the global knowledge economy.

    Science.gov (United States)

    Aerni, Philipp

    2007-01-01

    The theory of neoclassical welfare economics largely shaped international and national agricultural policies during the Cold War period. It treated technology as an exogenous factor that could boost agricultural productivity but not necessarily sustainable agriculture. New growth theory, the economic theory of the new knowledge economy, treats technological change as endogenous and argues that intangible assets such as human capital and knowledge are the drivers of sustainable economic development. In this context, the combined use of agricultural biotechnology and information technology has a great potential, not just to boost economic growth but also to empower people in developing countries and improve the sustainable management of natural resources. This article outlines the major ideas behind new growth theory and explains why agricultural economists and agricultural policy-makers still tend to stick to old welfare economics. Finally, the article uses the case of the Cassava Biotechnology Network (CBN) to illustrate an example of how new growth theory can be applied in the fight against poverty. CBN is a successful interdisciplinary crop research network that makes use of the new knowledge economy to produce new goods that empower the poor and improve the productivity and nutritional quality of cassava. It shows that the potential benefits of agricultural biotechnology go far beyond the already known productivity increases and pesticide use reductions of existing GM crops.

  6. Biotechnology Process Engineering Center at MIT Home

    Science.gov (United States)

    has provided a focal point for biotechnology research and education at MIT. Prominent examples include the NIH Training Program in Biotechnology and the NIH Training Program in Genomics; both of these are -genomic biology. Another example is the new DuPont-MIT Alliance (DMA), focused on materials biotechnology

  7. Biotechnology: Challenge for the food industry

    OpenAIRE

    Popov Stevan

    2007-01-01

    According to the broadest definition, biotechnology is the use of living matter (plants, animals and microorganisms) in industry, environment protection, medicine and agriculture. Biotechnology takes a key position in the field of food processing during thousands of years. Last about fifty years brought dynamical development of knowledges in the natural sciences especially in domain of genetics and manipulation of genes. Biotechnology for which active role in the on-coming times could be fore...

  8. Ethical perception of modern biotechnology

    African Journals Online (AJOL)

    Jane

    2011-09-30

    Sep 30, 2011 ... 1Social Impact of Biotechnology Development in Malaysia Research ... purpose of this paper is to examine the ethical perception of modern ... and social benefits of modern biotechnology, consumer .... Company or organisation directly involved in the production of ...... Food safety battle: organic vs. biotech.

  9. Biotechnology in Switzerland and a glance at Germany.

    Science.gov (United States)

    Fiechter, A

    2000-01-01

    The roots of biotechnology go back to classic fermentation processes, which starting from spontaneous reactions were developed by simple means. The discovery of antibiotics made contamination-free bioprocess engineering indispensable, which led to a further step in technology development. On-line analytics and the use of computers were the basis of automation and the increase in quality. On both sides of the Atlantic, molecular biology emerged at the same time, which gave genetic engineering in medicine, agriculture, industry and environment new opportunities. The story of this new advanced technology in Switzerland, with a quick glance at Germany, is followed back to the post-war years. The growth of research and teaching and the foundation of the European Federation of Biotechnology (EFB) are dealt with. The promising phase of the 1960s and 1970s soon had to give way to a restrictive policy of insecurity and anxiousness, which, today, manifests itself in the rather insignificant contributions of many European countries to the new sciences of genomics, proteomics and bioinformatics, as well as in the resistance to the use of transgenic agricultural crops and their products in foods.

  10. Public Acceptance of Plant Biotechnology and GM Crops.

    Science.gov (United States)

    Lucht, Jan M

    2015-07-30

    A wide gap exists between the rapid acceptance of genetically modified (GM) crops for cultivation by farmers in many countries and in the global markets for food and feed, and the often-limited acceptance by consumers. This review contrasts the advances of practical applications of agricultural biotechnology with the divergent paths-also affecting the development of virus resistant transgenic crops-of political and regulatory frameworks for GM crops and food in different parts of the world. These have also shaped the different opinions of consumers. Important factors influencing consumer's attitudes are the perception of risks and benefits, knowledge and trust, and personal values. Recent political and societal developments show a hardening of the negative environment for agricultural biotechnology in Europe, a growing discussion-including calls for labeling of GM food-in the USA, and a careful development in China towards a possible authorization of GM rice that takes the societal discussions into account. New breeding techniques address some consumers' concerns with transgenic crops, but it is not clear yet how consumers' attitudes towards them will develop. Discussions about agriculture would be more productive, if they would focus less on technologies, but on common aims and underlying values.

  11. Editorial: from plant biotechnology to bio-based products.

    Science.gov (United States)

    Stöger, Eva

    2013-10-01

    From plant biotechnology to bio-based products - this Special Issue of Biotechnology Journal is dedicated to plant biotechnology and is edited by Prof. Eva Stöger (University of Natural Resources and Life Sciences, Vienna, Austria). The Special Issue covers a wide range of topics in plant biotechnology, including metabolic engineering of biosynthesis pathways in plants; taking advantage of the scalability of the plant system for the production of innovative materials; as well as the regulatory challenges and society acceptance of plant biotechnology. Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  12. Biotechnological research in Europe

    Energy Technology Data Exchange (ETDEWEB)

    Rehm, H J

    1982-01-01

    The current research possibilities in the expanding field of biotechnology in Europe are very briefly described. Remarks on research and development are limited to six topics: fermented food products; biomass production; product formation; bioreactors; waste-water treatment, environmental processes and methane formation; central research institutions. It is summarised that increased efforts at co-operation on all levels are vital for an improved development in the field of biotechnology throughout Europe.

  13. Algorithm of automatic generation of technology process and process relations of automotive wiring harnesses

    Institute of Scientific and Technical Information of China (English)

    XU Benzhu; ZHU Jiman; LIU Xiaoping

    2012-01-01

    Identifying each process and their constraint relations from the complex wiring harness drawings quickly and accurately is the basis for formulating process routes. According to the knowledge of automotive wiring harness and the characteristics of wiring harness components, we established the model of wiring harness graph. Then we research the algorithm of identifying technology processes automatically, finally we describe the relationships between processes by introducing the constraint matrix, which is in or- der to lay a good foundation for harness process planning and production scheduling.

  14. Environmental biotechnology: concepts and applications

    National Research Council Canada - National Science Library

    Winter, Josef; Jördening, Hans-Joachim

    2005-01-01

    ... for the - development of new and environmentally improved production technologies with less purified substrates and generation of fewer by-products - bioproducts as non-toxic matters, mostly recyclable. Some impressive studies on industrial applications of biotechnology are published in two OECD reports, which summarized, that biotechnology has the potential o...

  15. Advances and limitations of visual conditioning protocols in harnessed bees.

    Science.gov (United States)

    Avarguès-Weber, Aurore; Mota, Theo

    2016-10-01

    Bees are excellent invertebrate models for studying visual learning and memory mechanisms, because of their sophisticated visual system and impressive cognitive capacities associated with a relatively simple brain. Visual learning in free-flying bees has been traditionally studied using an operant conditioning paradigm. This well-established protocol, however, can hardly be combined with invasive procedures for studying the neurobiological basis of visual learning. Different efforts have been made to develop protocols in which harnessed honey bees could associate visual cues with reinforcement, though learning performances remain poorer than those obtained with free-flying animals. Especially in the last decade, the intention of improving visual learning performances of harnessed bees led many authors to adopt distinct visual conditioning protocols, altering parameters like harnessing method, nature and duration of visual stimulation, number of trials, inter-trial intervals, among others. As a result, the literature provides data hardly comparable and sometimes contradictory. In the present review, we provide an extensive analysis of the literature available on visual conditioning of harnessed bees, with special emphasis on the comparison of diverse conditioning parameters adopted by different authors. Together with this comparative overview, we discuss how these diverse conditioning parameters could modulate visual learning performances of harnessed bees. Copyright © 2016 Elsevier Ltd. All rights reserved.

  16. Biotechnology information service of the GDR

    International Nuclear Information System (INIS)

    Poetzsch, E.

    1990-05-01

    The paper gives a survey of the biotechnology information in the GDR and describes the establishment of the Biotechnology Information Service of the GDR (BioInfo GDR). BioInfo GDR is a referral database and is to provide information on information sources available in the GDR, and on institutions working in the various fields of biotechnology in the GDR. In addition, some general problems of the building and use of databases are discussed. (author). 8 refs

  17. Biotechnology information service of the GDR

    Energy Technology Data Exchange (ETDEWEB)

    Poetzsch, E [Academy of Sciences, Berlin (Germany). Scientific Information Center

    1990-05-01

    The paper gives a survey of the biotechnology information in the GDR and describes the establishment of the Biotechnology Information Service of the GDR (BioInfo GDR). BioInfo GDR is a referral database and is to provide information on information sources available in the GDR, and on institutions working in the various fields of biotechnology in the GDR. In addition, some general problems of the building and use of databases are discussed. (author). 8 refs.

  18. An assessment of the use of molecular markers in developing countries

    International Nuclear Information System (INIS)

    Sonnino, A.; Carena, M.J.; Guimaraes, E.P.; Baumung, R.; Pilling, D.; Rischkowsky, B.

    2007-01-01

    Four different sources of information were analysed to assess the current uses of molecular markers in crops, forest trees and livestock in developing countries: the FAO Biotechnology in Developing Countries (FAO-BioDeC) database of biotechnology in developing countries; country reports evaluating the current status of applied plant breeding and related biotechnologies; country reports on animal genetic resources management for preparing the First Report on the State of the World's Animal Genetic Resources (SoW-AnGR); and the results of a questionnaire survey on animal genetic diversity studies. Even if still largely incomplete, the current data show that molecular markers are widely used for plant breeding in the developing world and most probably their use will increase in the future. In the animal sector the use of molecular markers seems less developed and limited or absent in most developing countries. Major differences exist among and within regions regarding the application of molecular marker techniques in plant and animal breeding and genetics. These can be explained by the relatively high investments in infrastructure and human resources necessary to undertake research in these fields. The spectrum of application of molecular markers in crop plants is quite wide, covering many plants relevant to the enhancement of food security, but other important plant species are still neglected. The practical results of marker-assisted selection (MAS) in the field are disappointingly modest, possibly due to: low levels of investment; limited coordination between biotechnologists and practical breeders; instable, non-focused or ill-addressed research projects; and the lack of linkages between research and farmers. Partnerships between developed and developing countries may be a means of better realizing the potential of molecular marker techniques for improving both animal and crop production. (author)

  19. Molecular mapping of a sunflower rust resistance gene from HAR6.

    Science.gov (United States)

    Bulos, Mariano; Ramos, María L; Altieri, Emiliano; Sala, Carlos A

    2013-03-01

    Sunflower rust, caused by Puccinia helianthi Schw., can result in significant yield losses in cultivated sunflower (Helianthus annuus L. var. macrocarpus Ckll.). HAR6 is a germplasm population resistant to most predominant rust races. The objectives of this study were to map the resistance factor present in HAR6 (R HAR6 ), and to provide and validate molecular tools for the identification of this gene for marker assisted selection purposes. Virulence reaction of seedlings for the F2 population and F2:3 families suggested that a single dominant gene confers rust resistance in HAR6-1, a selected rust resistance line from the original population. Genetic mapping with eight markers covered 97.4 cM of genetic distance on linkage group 13 of the sunflower consensus map. A co-dominant marker ZVG61 is the closest marker distal to R HAR6 at a genetic distance of 0.7 cM, while ORS581, a dominant marker linked in the coupling phase, is proximal to R HAR6 at a genetic distance of 1.5 cM. Validation of these markers was assessed by converting a susceptible line into a rust resistant isoline by means of marker assisted backcrossing. The application of these results to assist the breeding process and to design new strategies for rust control in sunflower is discussed.

  20. Role of biotechnology in future agriculture. Korekarano nogyo to biotechnology eno kitai

    Energy Technology Data Exchange (ETDEWEB)

    Komano, T. (Kyoto Univ., Kyoto (Japan). Faculty of Agriculture)

    1992-09-01

    In comparison with ancient times when everything is handled empirically, biological matter suitable for purposes can be produced and utilized faster and more reliably these days when life science has made a great advance. The advancement is related to new breeding technology and production means, and those means offer the point of contact between biotechnology and agriculture. The application fields of biotechnology are microbiology, cell technology, enzyme technology (bioreactor), and gene engineering. High yield, high content of high value ingredients as foods, adaptability to environment, resistance to disease and insect damage, etc. may be the subjects expected for future agricultural organisms. There may be many areas where biotechnology is related to those organisms, but a discussion is made in this report centering around the problem in breeding. Outlines are given on the applied cases of cell technological method, gene engineering method, and recombinant DNA technology, as well as on gene engineering for plants and animals. 10 refs., 7 figs.

  1. Brief Note on the Development of Biotechnology

    Directory of Open Access Journals (Sweden)

    Karl Bayer

    2014-01-01

    Full Text Available Biotechnology, with the main applications in food and nutrition, dates back to the early times of mankind. In the recent decades the progress in natural sciences, mathematics and computer science has led to a new branch termed molecular biotechnology, which finally developed as an autonomous scientific discipline. The field of biotechnology, in the past generally empirically driven, now largely benefits from molecular biotechnology by improved systems, knowledge and understanding. Thereby, compliance with the recently published initiatives of the regulatory authorities to accelerate the approval process for the manufacturing of biopharmaceuticals can be gained.

  2. [The past 30 years of Chinese Journal of Biotechnology].

    Science.gov (United States)

    Jiang, Ning

    2015-06-01

    This review addresses the association of "Chinese Journal of Biotechnology" and the development of biotechnology in China in the past 30 years. Topics include relevant awards and industrialization, development of the biotechnology discipline, and well know scientists in biotechnology, as well as perspectives on the journal.

  3. Teachers' Concerns about Biotechnology Education

    Science.gov (United States)

    Borgerding, Lisa A.; Sadler, Troy D.; Koroly, Mary Jo

    2013-01-01

    The impacts of biotechnology are found in nearly all sectors of society from health care and food products to environmental issues and energy sources. Despite the significance of biotechnology within the sciences, it has not become a prominent trend in science education. In this study, we seek to more fully identify biology teachers' concerns…

  4. Global unbalance in seaweed production, research effort and biotechnology markets.

    Science.gov (United States)

    Mazarrasa, Inés; Olsen, Ylva S; Mayol, Eva; Marbà, Núria; Duarte, Carlos M

    2014-01-01

    Exploitation of the world's oceans is rapidly growing as evidenced by a booming patent market of marine products including seaweed, a resource that is easily accessible without sophisticated bioprospecting technology and that has a high level of domestication globally. The investment in research effort on seaweed aquaculture has recently been identified to be the main force for the development of a biotechnology market of seaweed-derived products and is a more important driver than the capacity of seaweed production. Here, we examined seaweed patent registrations between 1980 and 2009 to assess the growth rate of seaweed biotechnology, its geographic distribution and the types of applications patented. We compare this growth with scientific investment in seaweed aquaculture and with the market of seaweed production. We found that both the seaweed patenting market and the rate of scientific publications are rapidly growing (11% and 16.8% per year respectively) since 1990. The patent market is highly geographically skewed (95% of all registrations belonging to ten countries and the top two holding 65% of the total) compared to the distribution of scientific output among countries (60% of all scientific publications belonging to ten countries and the top two countries holding a 21%), but more homogeneously distributed than the production market (with a 99.8% belonging to the top ten countries, and a 71% to the top two). Food industry was the dominant application for both the patent registrations (37.7%) and the scientific publications (21%) followed in both cases by agriculture and aquaculture applications. This result is consistent with the seaweed taxa most represented. Kelp, which was the target taxa for 47% of the patent registrations, is a traditional ingredient in Asian food and Gracilaria and Ulva, which were the focus of 15% and 13% of the scientific publications respectively, that are also used in more sophisticated applications such as cosmetics, chemical

  5. IMPACT OF AGRICULTURAL BIOTECHNOLOGY ON ENVIRONMENT AND FOOD SECURITY

    Directory of Open Access Journals (Sweden)

    Marijan Jošt

    2003-12-01

    Full Text Available The application of modern biotechnology in agricultural production processes has generated new ethical, economic, social and environmental dilemmas confronting scientists all over the world. While current knowledge is insufficient for assessing the promised benefits and possible risks of genetically modified organisms (GMOs, the principle of “substantial equivalence” in comparing GM and conventional food is profoundly flawed and scientifically insupportable. The current generation of GMOs provide small benefits except corporate profit and marginally improved grower returns. The TRIPS agreement has allowed worldwide patenting of genes and microorganisms, as well as genetically engineered organisms. Granting patents on life encourages biopiracy and the theft of genetic resources belonging to the local community. At the same time, the patented products are sold at relatively high prices to developing countries – the same countries from which the product originated.

  6. Risk, regulation and biotechnology: the case of GM crops.

    Science.gov (United States)

    Smyth, Stuart J; Phillips, Peter W B

    2014-07-03

    The global regulation of products of biotechnology is increasingly divided. Regulatory decisions for genetically modified (GM) crops in North America are predictable and efficient, with numerous countries in Latin and South America, Australia and Asia following this lead. While it might have been possible to argue that Europe's regulations were at one time based on real concerns about minimizing risks and ensuring health and safety, it is increasingly apparent that the entire European Union (EU) regulatory system for GM crops and foods is now driven by political agendas. Countries within the EU are at odds with each other as some have commercial production of GM crops, while others refuse to even develop regulations that could provide for the commercial release of GM crops. This divide in regulatory decision-making is affecting international grain trade, creating challenges for feeding an increasing global population.

  7. Biotechnology, nanotechnology, and pharmacogenomics and pharmaceutical compounding, Part 1.

    Science.gov (United States)

    Allen, Loyd V

    2015-01-01

    The world of pharmaceuticals is changing rapidly as biotechnology continues to grow and nanotechnology appears on the horizon. Biotechnology is gaining in importance in extemporaneous pharmaceutical compounding, and nanotechnology and pharmacogenomics could drastically change the practice of pharmacy. This article discusses biotechnology and the factors to consider when compounding biotechnology drugs.

  8. A Case for Teaching Biotechnology

    Science.gov (United States)

    Lazaros, Edward; Embree, Caleb

    2016-01-01

    Biotechnology is an innovative field that is consistently growing in popularity. It is important that students are taught about this technology at an early age, so they are motivated to join the field, or at least motivated to become informed citizens and consumers (Gonzalez, et al, 2013). An increase in biotechnology knowledge can result in an…

  9. Can plant biotechnology help break the HIV-malaria link?

    Science.gov (United States)

    Vamvaka, E; Twyman, R M; Christou, P; Capell, T

    2014-01-01

    The population of sub-Saharan Africa is at risk from multiple, poverty-related endemic diseases. HIV and malaria are the most prevalent, but they disproportionately affect different groups of people, i.e. HIV predominantly affects sexually-active adults whereas malaria has a greater impact on children and pregnant women. Nevertheless, there is a significant geographical and epidemiological overlap which results in bidirectional and synergistic interactions with important consequences for public health. The immunosuppressive effects of HIV increase the risk of infection when individuals are exposed to malaria parasites and also the severity of malaria symptoms. Similarly, acute malaria can induce a temporary increase in the HIV viral load. HIV is associated with a wide range of opportunistic infections that can be misdiagnosed as malaria, resulting in the wasteful misuse of antimalarial drugs and a failure to address the genuine cause of the disease. There is also a cumulative risk of toxicity when antiretroviral and antimalarial drugs are given to the same patients. Synergistic approaches involving the control of malaria as a strategy to fight HIV/AIDS and vice versa are therefore needed in co-endemic areas. Plant biotechnology has emerged as a promising approach to tackle poverty-related diseases because plant-derived drugs and vaccines can be produced inexpensively in developing countries and may be distributed using agricultural infrastructure without the need for a cold chain. Here we explore some of the potential contributions of plant biotechnology and its integration into broader multidisciplinary public health programs to combat the two diseases in developing countries. Copyright © 2014 Elsevier Inc. All rights reserved.

  10. Environmental Biotechnology Research and Development Program 1989-1992

    NARCIS (Netherlands)

    Brinkman J; Rulkens WH; Visscher K

    1989-01-01

    This report is an English translation of the Dutch Research and Development Program on environmental biotechnology 1989-1992. In this program an overview is given of the recent developments in environmental biotechnology. Based on this overview, the possibilities of biotechnology for management

  11. A single Danio rerio hars gene encodes both cytoplasmic and mitochondrial histidyl-tRNA synthetases.

    Directory of Open Access Journals (Sweden)

    Ashley L Waldron

    Full Text Available Histidyl tRNA Synthetase (HARS is a member of the aminoacyl tRNA synthetase (ARS family of enzymes. This family of 20 enzymes is responsible for attaching specific amino acids to their cognate tRNA molecules, a critical step in protein synthesis. However, recent work highlighting a growing number of associations between ARS genes and diverse human diseases raises the possibility of new and unexpected functions in this ancient enzyme family. For example, mutations in HARS have been linked to two different neurological disorders, Usher Syndrome Type IIIB and Charcot Marie Tooth peripheral neuropathy. These connections raise the possibility of previously undiscovered roles for HARS in metazoan development, with alterations in these functions leading to complex diseases. In an attempt to establish Danio rerio as a model for studying HARS functions in human disease, we characterized the Danio rerio hars gene and compared it to that of human HARS. Using a combination of bioinformatics, molecular biology, and cellular approaches, we found that while the human genome encodes separate genes for cytoplasmic and mitochondrial HARS protein, the Danio rerio genome encodes a single hars gene which undergoes alternative splicing to produce the respective cytoplasmic and mitochondrial versions of Hars. Nevertheless, while the HARS genes of humans and Danio differ significantly at the genomic level, we found that they are still highly conserved at the amino acid level, underscoring the potential utility of Danio rerio as a model organism for investigating HARS function and its link to human diseases in vivo.

  12. Frontiers in biomedical engineering and biotechnology.

    Science.gov (United States)

    Liu, Feng; Goodarzi, Ali; Wang, Haifeng; Stasiak, Joanna; Sun, Jianbo; Zhou, Yu

    2014-01-01

    The 2nd International Conference on Biomedical Engineering and Biotechnology (iCBEB 2013), held in Wuhan on 11–13 October 2013, is an annual conference that aims at providing an opportunity for international and national researchers and practitioners to present the most recent advances and future challenges in the fields of Biomedical Information, Biomedical Engineering and Biotechnology. The papers published by this issue are selected from this conference, which witnesses the frontier in the field of Biomedical Engineering and Biotechnology, which particularly has helped improving the level of clinical diagnosis in medical work.

  13. Advancement of Marketing Developing Biotechnology-Based Business

    OpenAIRE

    Vilmantas, Vaidas; Melnikas, Borisas

    2014-01-01

    The article, in a complex way, analyzes the needs of marketing improvement in developing biotechnology-based business and highlights its role in the context of modern society and globalization challenges. The article distinguishes between the existing problems of biotechnology business, the present perspectives and specific characteristics of developing the marketing of biotechnological business. The paper represents the possibility of the substantial modernization of marketing tools with reg...

  14. Public submissions on the Uganda national biotechnology and biosafety bill, 2012 reveal consensus for Uganda legislators to pass the bill

    Directory of Open Access Journals (Sweden)

    Clet Wandui Masiga

    2015-10-01

    Full Text Available The Cartagena Protocol on Biosafety to the Convention on Biological Diversity is an internationally binding instrument addressing issues of biosafety. Biosafety refers to the need to protect human health and the environment from the possible adverse effects of the products of modern biotechnology. Accordingly all countries to the convention are required to put in place regulatory mechanisms to enhance the safety of biotechnology in the context of the Convention’s overall goal of reducing all potential threats to biological diversity, while taking into account the risks to human health. Therefore each country party to the convention has its own procedures to enact laws to guide the safe use of biotechnology. In Uganda the process involves the drafting of the bill by the first parliamentary counsel, approval by cabinet, first reading at the parliament, committal to the responsible parliamentary sessional committee, tabling of the bill for public hearing, consultations, and final approval. In Uganda, the Committee on Science and Technology is responsible for the Biosafety Bill. In March 2013, the Committee tabled the bill for public hearing and submissions from public institutions. There were comments supporting the passage of the Bill and comments in objection.The reasons for objection are mainly due to precaution, speculation, lack of knowledge about biotechnology and biosafety, and alleged influence from biosafety entrepreneurs. This article reviews these public views, revealing controversy and possible consensus to pass the bill.

  15. Termites as targets and models for biotechnology.

    Science.gov (United States)

    Scharf, Michael E

    2015-01-07

    Termites have many unique evolutionary adaptations associated with their eusocial lifestyles. Recent omics research has created a wealth of new information in numerous areas of termite biology (e.g., caste polyphenism, lignocellulose digestion, and microbial symbiosis) with wide-ranging applications in diverse biotechnological niches. Termite biotechnology falls into two categories: (a) termite-targeted biotechnology for pest management purposes, and (b) termite-modeled biotechnology for use in various industrial applications. The first category includes several candidate termiticidal modes of action such as RNA interference, digestive inhibition, pathogen enhancement, antimicrobials, endocrine disruption, and primer pheromone mimicry. In the second category, termite digestomes are deep resources for host and symbiont lignocellulases and other enzymes with applications in a variety of biomass, industrial, and processing applications. Moving forward, one of the most important approaches for accelerating advances in both termite-targeted and termite-modeled biotechnology will be to consider host and symbiont together as a single functional unit.

  16. Integration of a Copper-Containing Biohybrid (CuHARS with Cellulose for Subsequent Degradation and Biomedical Control

    Directory of Open Access Journals (Sweden)

    Anik Karan

    2018-04-01

    Full Text Available We previously described the novel synthesis of a copper high-aspect ratio structure (CuHARS biohybrid material using cystine. While extremely stable in water, CuHARS is completely (but slowly degradable in cellular media. Here, integration of the CuHARS into cellulose matrices was carried out to provide added control for CuHARS degradation. Synthesized CuHARS was concentrated by centrifugation and then dried. The weighed mass was re-suspended in water. CuHARS was stable in water for months without degradation. In contrast, 25 μg/mL of the CuHARS in complete cell culture media was completely degraded (slowly in 18 days under physiological conditions. Stable integration of CuHARS into cellulose matrices was achieved through assembly by mixing cellulose micro- and nano-fibers and CuHARS in an aqueous (pulp mixture phase, followed by drying. Additional materials were integrated to make the hybrids magnetically susceptible. The cellulose-CuHARS composite films could be transferred, weighed, and cut into usable pieces; they maintained their form after rehydration in water for at least 7 days and were compatible with cell culture studies using brain tumor (glioma cells. These studies demonstrate utility of a CuHARS-cellulose biohybrid for applied applications including: (1 a platform for biomedical tracking and (2 integration into a 2D/3D matrix using natural products (cellulose.

  17. Which is the better forecasting model? A comparison between HAR-RV and multifractality volatility

    Science.gov (United States)

    Ma, Feng; Wei, Yu; Huang, Dengshi; Chen, Yixiang

    2014-07-01

    In this paper, by taking the 5-min high frequency data of the Shanghai Composite Index as example, we compare the forecasting performance of HAR-RV and Multifractal volatility, Realized volatility, Realized Bipower Variation and their corresponding short memory model with rolling windows forecasting method and the Model Confidence Set which is proved superior to SPA test. The empirical results show that, for six loss functions, HAR-RV outperforms other models. Moreover, to make the conclusions more precise and robust, we use the MCS test to compare the performance of their logarithms form models, and find that the HAR-log(RV) has a better performance in predicting future volatility. Furthermore, by comparing the two models of HAR-RV and HAR-log(RV), we conclude that, in terms of performance forecasting, the HAR-log(RV) model is the best model among models we have discussed in this paper.

  18. Kyllinger har effektivt immunforsvar mod herpes

    DEFF Research Database (Denmark)

    Buchmann, Kurt

    2008-01-01

    Forskere ved Københavns Universitet, Fakultet for Biovidenskab har studeret kyllingens MHC molekyler og kan derigennem forklare hvorfor en særlig stamme indenfor denne art er modstandsdygtige mod en særlig herpesvirus. Udgivelsesdato: 18. januar 2008...

  19. Public Acceptance of Plant Biotechnology and GM Crops

    Directory of Open Access Journals (Sweden)

    Jan M. Lucht

    2015-07-01

    Full Text Available A wide gap exists between the rapid acceptance of genetically modified (GM crops for cultivation by farmers in many countries and in the global markets for food and feed, and the often-limited acceptance by consumers. This review contrasts the advances of practical applications of agricultural biotechnology with the divergent paths—also affecting the development of virus resistant transgenic crops—of political and regulatory frameworks for GM crops and food in different parts of the world. These have also shaped the different opinions of consumers. Important factors influencing consumer’s attitudes are the perception of risks and benefits, knowledge and trust, and personal values. Recent political and societal developments show a hardening of the negative environment for agricultural biotechnology in Europe, a growing discussion—including calls for labeling of GM food—in the USA, and a careful development in China towards a possible authorization of GM rice that takes the societal discussions into account. New breeding techniques address some consumers’ concerns with transgenic crops, but it is not clear yet how consumers’ attitudes towards them will develop. Discussions about agriculture would be more productive, if they would focus less on technologies, but on common aims and underlying values.

  20. Public Acceptance of Plant Biotechnology and GM Crops

    Science.gov (United States)

    Lucht, Jan M.

    2015-01-01

    A wide gap exists between the rapid acceptance of genetically modified (GM) crops for cultivation by farmers in many countries and in the global markets for food and feed, and the often-limited acceptance by consumers. This review contrasts the advances of practical applications of agricultural biotechnology with the divergent paths—also affecting the development of virus resistant transgenic crops—of political and regulatory frameworks for GM crops and food in different parts of the world. These have also shaped the different opinions of consumers. Important factors influencing consumer’s attitudes are the perception of risks and benefits, knowledge and trust, and personal values. Recent political and societal developments show a hardening of the negative environment for agricultural biotechnology in Europe, a growing discussion—including calls for labeling of GM food—in the USA, and a careful development in China towards a possible authorization of GM rice that takes the societal discussions into account. New breeding techniques address some consumers’ concerns with transgenic crops, but it is not clear yet how consumers’ attitudes towards them will develop. Discussions about agriculture would be more productive, if they would focus less on technologies, but on common aims and underlying values. PMID:26264020

  1. Biotechnologies based on simple and structured superlight water for use in biopharmaceutical and biocosmetic field

    International Nuclear Information System (INIS)

    Manzatu, I.; Olariu, L.; Rusu, M.; Zamfir, S.

    2000-01-01

    S.C. Biotehnos S.A. has developed studies to obtain structured aqueous solutions to find biotechnologies that were patented both in this country and abroad. An increasing interest concerning the action of superlight water on biological systems as well as the investigation of possibility of incorporating this type of water in pharmaceutical and cosmetic products encouraged research upon the processes of structuring the deuterium depleted water to establish non-conventional modern biotechnologies. Thus, physico-chemical parameters of interest (pH-value, conductivity, redox potential) were determined for the superlight water systems resulting from structuration process. Also, these studies have dealt with the effects of superlight water and structured aqueous solutions upon cellular breeding, studies of major importance in cell physiology

  2. Biotechnological production of vanillin.

    Science.gov (United States)

    Priefert, H; Rabenhorst, J; Steinbüchel, A

    2001-08-01

    Vanillin is one of the most important aromatic flavor compounds used in foods, beverages, perfumes, and pharmaceuticals and is produced on a scale of more than 10 thousand tons per year by the industry through chemical synthesis. Alternative biotechnology-based approaches for the production are based on bioconversion of lignin, phenolic stilbenes, isoeugenol, eugenol, ferulic acid, or aromatic amino acids, and on de novo biosynthesis, applying fungi, bacteria, plant cells, or genetically engineered microorganisms. Here, the different biosynthesis routes involved in biotechnological vanillin production are discussed.

  3. The Effect of Biotechnology Education on Australian High School Students' Understandings and Attitudes about Biotechnology Processes

    Science.gov (United States)

    Dawson, Vaille; Soames, Christina

    2006-01-01

    Our education system aims to equip young people with the knowledge, problem-solving skills and values to cope with an increasingly technological society. The aim of this study was to determine the effect of biotechnology education on adolescents' understanding and attitudes about processes associated with biotechnology. Data were drawn from…

  4. Når sex er en ret, hvem har så pligt?

    DEFF Research Database (Denmark)

    Munk-Madsen, Eva

    2007-01-01

    Socialministeriet har fastslået i en vejledning, at samfundet har omsorgspligt for funktionshæmmedes borgeres  seksuelle udfoldelsesmulighder. Tre grupper er udpeget som dem der skal varetage denne omsorgspligt på samfundets vegne: ansatte hjælpepersoner, seksualvejledere og prostituerede. I modt...

  5. Biotechnology Process Engineering Center at MIT - Overview

    Science.gov (United States)

    | Facsimile (617) 253-2400 | e-mail: bpec-www@mit.edu THERAPEUTIC GENE BIOTECHNOLOGY INDUSTRIAL CONSORTIUM Board (ICAB) in Therapeutic Gene Biotechnology. ICAB Member Representatives review our research progress

  6. Application of biotechnology to fossil fuels explored

    Energy Technology Data Exchange (ETDEWEB)

    Haggin, J

    1989-02-13

    A review is presented of the December 1988 symposium on coal, oil and gas biotechnology held in New Orleans, organised by the Institute of Gas Technology. Papers discussed include: opportunities for R D in desulfurization, coal gasification and environmental cleanup; an assessment of the economic constraints that new energy biotechnology must overcome; biotechnology research at EPRI; microbial conversion of coal; bioconversion of low rank coal; and bioremediation of ground containing PAHs. 2 figs.

  7. Harness the Power of Technology

    Science.gov (United States)

    Duncan, Arne

    2011-01-01

    Today, U.S. educators are teaching in the midst of a technological revolution. Technology promises to provide innovative solutions in the nation's classrooms, just as it has transformed the way people communicate, socialize, and conduct business. In this article, the author argues that now is the time to harness technology to revolutionize the way…

  8. Life sciences today and tomorrow: emerging biotechnologies.

    Science.gov (United States)

    Williamson, E Diane

    2017-08-01

    The purpose of this review is to survey current, emerging and predicted future biotechnologies which are impacting, or are likely to impact in the future on the life sciences, with a projection for the coming 20 years. This review is intended to discuss current and future technical strategies, and to explore areas of potential growth during the foreseeable future. Information technology approaches have been employed to gather and collate data. Twelve broad categories of biotechnology have been identified which are currently impacting the life sciences and will continue to do so. In some cases, technology areas are being pushed forward by the requirement to deal with contemporary questions such as the need to address the emergence of anti-microbial resistance. In other cases, the biotechnology application is made feasible by advances in allied fields in biophysics (e.g. biosensing) and biochemistry (e.g. bio-imaging). In all cases, the biotechnologies are underpinned by the rapidly advancing fields of information systems, electronic communications and the World Wide Web together with developments in computing power and the capacity to handle extensive biological data. A rationale and narrative is given for the identification of each technology as a growth area. These technologies have been categorized by major applications, and are discussed further. This review highlights: Biotechnology has far-reaching applications which impinge on every aspect of human existence. The applications of biotechnology are currently wide ranging and will become even more diverse in the future. Access to supercomputing facilities and the ability to manipulate large, complex biological datasets, will significantly enhance knowledge and biotechnological development.

  9. Biotechnology and species development in aquaculture

    African Journals Online (AJOL)

    STORAGESEVER

    2008-12-29

    Dec 29, 2008 ... The use of biotechnology in various aspects of human endeavour have obviously created a great ... the already adopted biotechnologies are being improved upon with lesser demerits. ... potential to improve the quality and quantity of fish reared .... become easier with the development of artificial breeding.

  10. Journal of Tropical Microbiology and Biotechnology

    African Journals Online (AJOL)

    The Journal of Tropical Microbiology and Biotechnology (JTMB) formerly Journal of Tropical Microbiology gives preeminence to the central role of modern biotechnology and microorganisms as tools and targets in current research, which is largely multidisciplinary. JTMB covers a broad range of topics, such as disease ...

  11. Opportunities for biotechnology and policy regarding mycotoxin issues in international trade.

    Science.gov (United States)

    Kendra, David F; Dyer, Rex B

    2007-10-20

    Despite being introduced more than a decade ago, agricultural biotechnology still remains framed in controversy impacting both the global economy and international regulations. Controversies surrounding agricultural biotechnology produced crops and foods commonly focus on human and environmental safety, intellectual property rights, consumer choice, ethics, food security, poverty reduction and environmental conservation. Originally, some consumers were reluctant to accept the first generation agricultural biotechnology products because they appeared to primarily benefit agricultural producers; however, it is clear from continued evaluations that these technologies also improved both the safety and wholesomeness of food and helped improve the environment. Plants engineered to resist insect pests and tolerate less toxic pesticides resulted in improved yields thereby enabling farmers to produce more food per acre while reducing the need for herbicides, pesticides, and water and tilling. An indirect benefit of reduced pest damage in transgenic corn expressing genes to control insect pests is lower levels of mycotoxins, most notably those caused by the genus Fusarium. Mycotoxins are an important regulatory issue globally because of their toxic and carcinogenic potential to humans and animals. Complicating this issue is the fact that toxicological databases for mycotoxins are relatively incomplete compared to other food contaminants. Current debates about agricultural biotechnology and mycotoxins reveal significant differences in perception of associated risks and benefits. When faced with uncertainty, regulators tend to set limits as low as possible. Additionally, some regulators invoke the "Precautionary Principle" when limited information is available or disputes over interpretation exist for possible contaminants, including mycotoxins. A major concern regarding use of the "Precautionary Principle" is the appearance that regulators can justify setting any limit on the

  12. Mechatronics design principles for biotechnology product development.

    Science.gov (United States)

    Mandenius, Carl-Fredrik; Björkman, Mats

    2010-05-01

    Traditionally, biotechnology design has focused on the manufacture of chemicals and biologics. Still, a majority of biotechnology products that appear on the market today is the result of mechanical-electric (mechatronic) construction. For these, the biological components play decisive roles in the design solution; the biological entities are either integral parts of the design, or are transformed by the mechatronic system. This article explains how the development and production engineering design principles used for typical mechanical products can be adapted to the demands of biotechnology products, and how electronics, mechanics and biology can be integrated more successfully. We discuss three emerging areas of biotechnology in which mechatronic design principles can apply: stem cell manufacture, artificial organs, and bioreactors. Copyright 2010 Elsevier Ltd. All rights reserved.

  13. Application of biotechnology to improve livestock products

    Directory of Open Access Journals (Sweden)

    Swati Gupta

    Full Text Available Biotechnological achievements of recent years have emerged as powerful tool to improve quality attributes of livestock products including milk and meat products. Biotechnological approaches can be employed for improving productivity, economy, physicochemical and nutritional attributes of a wide range of livestock products. The target areas of biotechnological research in the field of livestock products can be envisaged as production of high yielding food animal, improvement in quality of their products, enhanced production of natural food grade preservatives, efficient byproduct utilization and so forth. Many of the biotechnological techniques can be explored in the area of quality assurance programmes, which would be of great help to produce livestock products of assured quality and public health safety. [Vet World 2012; 5(10.000: 634-638

  14. Editorial: Latest methods and advances in biotechnology.

    Science.gov (United States)

    Lee, Sang Yup; Jungbauer, Alois

    2014-01-01

    The latest "Biotech Methods and Advances" special issue of Biotechnology Journal continues the BTJ tradition of featuring the latest breakthroughs in biotechnology. The special issue is edited by our Editors-in-Chief, Prof. Sang Yup Lee and Prof. Alois Jungbauer and covers a wide array of topics in biotechnology, including the perennial favorite workhorses of the biotech industry, Chinese hamster ovary (CHO) cell and Escherichia coli. Copyright © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

  15. Approaches to education of pharmaceutical biotechnology in faculties of pharmacy.

    Science.gov (United States)

    Calis, S; Oner, F; Kas, S; Hincal, A A

    2001-06-01

    Pharmaceutical biotechnology is developing rapidly both in academic institutions and in the biopharmaceutical industry. For this reason, FIP Special Interest Group of Pharmaceutical Biotechnology decided to develop a questionnaire concerning pharmaceutical biotechnology education. After preliminary studies were completed, questionnaires were sent to the leading scientists in academia and research directors or senior managers of various Pharmaceutical Biotechnology Companies in order to gather their views about how to create a satisfactory program. The objectives of this study were as follows: -To review all of the graduate and undergraduate courses which are presently available worldwide on pharmaceutical biotechnology in Faculties of Pharmacy. -To review all of the text books, references and scientific sources available worldwide in the area of pharmaceutical biotechnology. When replying to the questionnaires, the respondents were asked to consider the present status of pharmaceutical biotechnology education in academia and future learning needs in collaboration with the biotechnology industry. The data from various pharmacy faculties and biotechnology industry representatives from Asia, Europe and America were evaluated and the outcome of the survey showed that educational efforts in training qualified staff in the rapidly growing field of pharmaceutical biotechnology is promising. Part of the results of this questionnaire study have already been presented at the 57th International Congress of FIP Vancouver, Canada in 1997.

  16. Modernizing the Regulatory System for Biotechnology Products

    Science.gov (United States)

    This Web page describes the continuing effort to modernize the federal regulatory system for biotechnology products as well as clarify various roles of EPA, FDA and USDA in evaluating new biotechnology products.

  17. Linking Biotechnology and Agricultural Biodiversity Resources in ...

    African Journals Online (AJOL)

    komla

    on how to best manage the strategic interplay between biotechnology and diversity in ... Therefore, it is imperative that, in formulating a biotechnology ..... Acknowledgement, indicating the source of any financial support or personal assistance.

  18. Research status and prospects of the radiation food science and biotechnology in Korea

    International Nuclear Information System (INIS)

    Lee, Ju Woon; Kim, Jae Hun; Choi, Jong Il; Song, Byum Suk; Byun, Myung Woo

    2008-01-01

    Irradiation Food has been approved in 52 countries worldwide. In Korea, 26 food items have been approved since 1987. Recently, the irradiation technology with high dose was applied for the development of Korean space foods. Besides the sanitary purpose, the irradiation technology was used for elimination of undesired products such as food allergens, nitrite, biogenic amines, and so on. In this paper, the status of irradiation in the field of food and other biotechnology in Korea will be presented. Food irradiation is known to be the best method for controlling pathogenic microorganisms and one of the best alternatives to the chemical fumigants or preservatives usually used for a sanitation treatment for international trade. Also, there are larger industrial groups dedicated to radiation processing other than food irradiation industry. In this paper, the status of irradiation food science and biotechnology in Korea will be presented

  19. Biotechnology and Consumer Decision-Making.

    Science.gov (United States)

    Sax, Joanna K

    Society is facing major challenges in climate change, health care and overall quality of life. Scientific advances to address these areas continue to grow, with overwhelming evidence that the application of highly tested forms of biotechnology is safe and effective. Despite scientific consensus in these areas, consumers appear reluctant to support their use. Research that helps to understand consumer decision-making and the public’s resistance to biotechnologies such as vaccines, fluoridated water programs and genetically engineered food, will provide great social value. This article is forward-thinking in that it suggests that important research in behavioral decision-making, specifically affect and ambiguity, can be used to help consumers make informed choices about major applications of biotechnology. This article highlights some of the most controversial examples: vaccinations, genetically engineered food, rbST treated dairy cows, fluoridated water, and embryonic stem cell research. In many of these areas, consumers perceive the risks as high, but the experts calculate the risks as low. Four major thematic approaches are proposed to create a roadmap for policymakers to consider for policy design and implementation in controversial areas of biotechnology. This article articulates future directions for studies that implement decision-making research to allow consumers to appropriately assign risk to their options and make informed decisions.

  20. BIOTECHNOLOGY OF THE FISH AQUACULTURE

    Directory of Open Access Journals (Sweden)

    L. P. Buchatsky

    2013-12-01

    Full Text Available The latest progress in biotechnology on fish aquaculture and different modern methods of investigations for increasing of fish productivity in aquaculture are analyzed. Except for the applied aspect, the use of modern biotechnological methods of investigations opens new possibilities for fundamental researches of sex-determining mechanisms, polyploidy, distant hybridization, and developmental biology of bony fishes. Review contains examples of utilizing modern biotechnology methods to obtain transgenic fishes with accelerated growth and for designing surrogate fishes. Methods for receiving unisexual shoals of salmon and sturgeon female fishes with the view of obtaining a large quantity of caviar, as well as receiving sterile (triploid fishes are analyzed. Great attention is given to androgenesis, particularly to disperm one, in connection with the problem of conserving rare and vanishing fish species using only sperm genetic material. Examples how distant hybrids may be obtained with the use of disperm androgenesis and alkylated DNA are given. Methods of obtaining fish primordium germ cells, recent developments in cultivation of fish stem cells and their use in biotechnology, as well as ones of transplantation of oogonium and spermatogonium to obtain surrogate fishes. The examples of successful experiments on spermatogonial xenotransplantation and characteristic of antifreezing fish proteins and also the prospect of their practical usage are given.

  1. Sharing Malaysian experience with the development of biotechnology-derived food crops.

    Science.gov (United States)

    Abu Bakar, Umi K; Pillai, Vilasini; Hashim, Marzukhi; Daud, Hassan Mat

    2005-12-01

    Biotechnology-derived food crops are currently being developed in Malaysia mainly for disease resistance and improved post harvest quality. The modern biotechnology approach is adopted because of its potential to overcome constraints faced by conventional breeding techniques. Research on the development of biotechnology-derived papaya, pineapple, chili, passion fruit, and citrus is currently under way. Biotechnology-derived papaya developed for resistance to papaya ringspot virus (PRSV) and improved postharvest qualities is at the field evaluation stage. Pineapple developed for resistance to fruit black heart disorder is also being evaluated for proof-of-concept. Other biotechnology-derived food crops are at early stages of gene cloning and transformation. Activities and products involving biotechnology-derived crops will be fully regulated in the near future under the Malaysian Biosafety Law. At present they are governed only by guidelines formulated by the Genetic Modification Advisory Committee (GMAC), Malaysia. Commercialization of biotechnology-derived crops involves steps that require GMAC approval for all field evaluations and food-safety assessments before the products are placed on the market. Public acceptance of the biotechnology product is another important factor for successful commercialization. Understanding of biotechnology is generally low among Malaysians, which may lead to low acceptance of biotechnology-derived products. Initiatives are being taken by local organizations to improve public awareness and acceptance of biotechnology. Future research on plant biotechnology will focus on the development of nutritionally enhanced biotechnology-derived food crops that can provide more benefits to consumers.

  2. Biotechnology

    International Nuclear Information System (INIS)

    2008-01-01

    The guidelines of the Biotechnology Program are research and development aiming to develop and manufacture products of pharmaceutical interest. This program has two main research areas, namely Pituitary Hormones and Biopharmaceuticals. The first one comprises a group with a long experience on Recombinant Human Pituitary Hormone synthesis, purification and characterization. The Biopharmaceutical area is dedicated to the research of isolation, structural analysis and biological activities in different biological system of macromolecules

  3. Assessment of Biotechnology Policies and International Trade in Key Markets for U.S. Agriculture

    OpenAIRE

    Marchant, Mary A.; Song, Baohui

    2005-01-01

    The United States leads the world in agricultural biotechnology research, adoption, commercialization, and exports. Our biotech commodities are highly dependent on international markets. Thus, any biotech policy changes by key importing countries may affect U.S. agricultural biotech product exports. This article identifies key markets for U.S. agricultural exports including biotech commodities and discusses current and proposed biotech policies in key markets for U.S. agricultural exports foc...

  4. Har læreplanen (stadig) minimal betydning?

    DEFF Research Database (Denmark)

    Poulsen, Jens Aage

    2016-01-01

    Undervisningsministeriets læreplaner for skolens fag er centrale styredokumenter, der fastlægger formål og rammesætter indhold og form for undervisningen. Men hvilken betydning har de i praksis?...

  5. Biotechnology's foreign policy.

    Science.gov (United States)

    Feldbaum, Carl

    2002-01-01

    From its inception, biotechnology has been a uniquely international enterprise. An American and an Englishman working together elucidated the structure of DNA almost 50 years ago; more recently, the Human Genome Project linked researchers around the world, from the Baylor College of Medicine in Houston to the Beijing Human Genome Center. Today our industry's researchers hail from African villages and Manhattan high rises; from Munich and Melbourne; from London, Ontario, and London, England; from Scotland and Nova Scotia--New Scotland; from Calcutta and Calgary. But in the beginning, the infrastructure that supported these efforts--intellectual property, venture capital, streamlined technology transfer--was less widely dispersed and the world's brightest biotech researchers clustered in only half a dozen scientific Meccas. Previous technological revolutions have spread around the world. Following in their footsteps, biotechnology's global diaspora seems inevitable, especially since governments are promoting it. But as our science and business emigrate from early strongholds in the United States, Canada and Europe across oceans and borders and into new cultures, international tensions over biotechnology continue to grow. In just the last few years, controversies have rolled over R&D spending priorities, genetic patents, bioprospecting, transgenic agriculture and drug pricing. My premise today is that our industry needs to formulate its first foreign policy, one which is cognizant of the miserable judgments and mistakes of other industries--and avoids them.

  6. Calorimeters for biotechnology

    International Nuclear Information System (INIS)

    Russell, Donald J.; Hansen, Lee D.

    2006-01-01

    The isothermal and temperature scanning calorimeters manufactured by Calorimetry Sciences Corporation are briefly described. Applications of calorimetry to determine thermodynamics and kinetics of reactions of interest in biotechnology are described with illustrative examples

  7. UNCOVERING FACTORS INFLUENCING PUBLIC PERCEPTIONS OF FOOD BIOTECHNOLOGY

    OpenAIRE

    Hossain, Ferdaus; Onyango, Benjamin M.; Adelaja, Adesoji O.; Schilling, Brian J.; Hallman, William K.

    2002-01-01

    Significant divergence exists in public opinions about biotechnology. Although there is broad support for plant biotechnology for health benefits, opinions differ on the issue of animal genetics for pure economic benefits. While some are opposed to it, many are undecided about genetically modified foods. Considerable skepticism exists about scientists, corporations and government which have negative influence on public acceptance of food biotechnology. Consumers' personal attributes have sign...

  8. A Key Review of Non-Industrial Greywater Heat Harnessing

    Directory of Open Access Journals (Sweden)

    Abdur Rehman Mazhar

    2018-02-01

    Full Text Available The ever-growing concerns about making buildings more energy efficient and increasing the share of renewable energy used in them, has led to the development of ultra-low carbon buildings or passive houses. However, a huge potential still exists to lower the hot water energy demand, especially by harnessing heat from waste water exiting these buildings. Reusing this heat makes buildings more energy-efficient and this source is considered as a third-generation renewable energy technology, both factors conforming to energy policies throughout the world. Based on several theoretical and experimental studies, the potential to harness non-industrial waste water is quite high. As an estimate about 3.5 kWh of energy, per person per day could be harnessed and used directly, in many applications. A promising example of such an application, are low temperature fourth generation District Heating grids, with decentralized sources of heat. At the moment, heat exchangers and heat pumps are the only viable options to harness non-industrial waste heat. Both are used at different scales and levels of the waste-water treatment hierarchical pyramid. Apart from several unfavourable characteristics of these technologies, the associated exergetic efficiencies are low, in the range of 20–50%, even when cascaded combinations of both are used. To tackle these shortcomings, several promising trends and technologies are in the pipeline, to scavenge this small-scale source of heat to a large-scale benefit.

  9. Supporting Biotechnology Regulatory Policy Processes in Southeast ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    Supporting Biotechnology Regulatory Policy Processes in Southeast Asia. Biotechnology innovations or bio-innovations can provide solutions to problems associated with food security, poverty and environmental degradation. Innovations such as genetically engineered (GE) crops can increase food production and ...

  10. Harnessing solar heat

    CERN Document Server

    Norton, Brian

    2013-01-01

    Systems engineered by man to harness solar heat in a controlled manner now include a diverse range of technologies each serving distinctive needs in particular climate contexts. This text covers the breadth of solar energy technologies for the conversion of solar energy to provide heat, either as the directly-used output or as an intermediary to other uses such as power generation or cooling. It is a wholly updated, extended and revised version of “Solar Energy Thermal Technology” first published in 1992. The text draws on the own author’s research and that of numerous colleagues and

  11. Applied thermodynamics: A new frontier for biotechnology

    DEFF Research Database (Denmark)

    Mollerup, Jørgen

    2006-01-01

    The scientific career of one of the most outstanding scientists in molecular thermodynamics, Professor John M. Prausnitz at Berkeley, reflects the change in the agenda of molecular thermodynamics, from hydrocarbon chemistry to biotechnology. To make thermodynamics a frontier for biotechnology...

  12. Biotechnology in Georgia for Various Applications

    International Nuclear Information System (INIS)

    Mosulishvili, L.; Tsibakhashvili, N.; Kirkesali, E.; Tsertsvadze, L.; Frontasyeva, M.; Pavlov, S.

    2008-01-01

    The results of collaborative work carried out in the field of biotechnology at the Frank Laboratory of Neutron Physics (FLNP) of the Joint Institute for Nuclear Research (JINR) (Dubna, Russia) jointly with scientists from Georgia are presented. Using instrumental neutron activation analysis (NAA), significant results were ontained in the following directions - medical biotechnology, environmental biotechnology and industrial biotechnology. In the biomedical experiments a blue-green alga Spirulina platensis biomass has been used as a matrix for the development of pharmaceutical substances containing such vitally important trace elements as selenium, chromium and iodine. The feasibility of target-oriented introduction of these elements into Spirulina platensis biocomplexes retaining its protain composition and natural beneficial properties has been proved. The adsorption of such toxic metal as mercury by Spirulina platensis biomass in dynamics of growth has been studied also. NAA has been successfully applied to investigate the biotechnology of toxic Cr(VI) transformation into less toxic Cr(III) complexes by Cr(VI)-reducer bacteria isolated from polluted basalts in Georgia. This method was used to track accumulation of chromium in the bacterial cells. To monitor and identify Cr(III) complexes in these bacteria, electron spin resonance (ESR) spectrometry was employed. For the first time, the elemental composition of Cr(VI)-reducer bacteria has been studied using epithermal NAA. The natural organic mass of vegetal origin - peat - was applied as a source of microorganisms to study the bacterial leaching of some metals from lean ores, rocks and industrial wastes. (author)

  13. Acceptance of biotechnology and social-cultural implications in Ghana

    African Journals Online (AJOL)

    take pride in what they eat. A proposal is made to set biotechnology research agenda in the context of social choices; social scientific coalition of biotechnology with endogenous development pathways' as opposed to 'exogenous biotechnology research'. Also there is the need for adequate capacity building of the existing ...

  14. High School Students' Knowledge and Attitudes regarding Biotechnology Applications

    Science.gov (United States)

    Ozel, Murat; Erdogan, Mehmet; Usak, Muhammet; Prokop, Pavol

    2009-01-01

    The purpose of this study was to investigate high school students' knowledge and attitudes regarding biotechnology and its various applications. In addition, whether students' knowledge and attitudes differed according to age and gender were also explored. The Biotechnology Knowledge Questionnaire (BKQ) with 16 items and the Biotechnology Attitude…

  15. Environmental Biotechnology Research and Development Program 1989-1992

    OpenAIRE

    Brinkman J; Rulkens WH; Visscher K

    1989-01-01

    This report is an English translation of the Dutch Research and Development Program on environmental biotechnology 1989-1992. In this program an overview is given of the recent developments in environmental biotechnology. Based on this overview, the possibilities of biotechnology for management of the environment are evaluated. In this program two kinds of research are distinguished. Applied research directly focusses on specific environmental problems. Fundamental research aims at developing...

  16. Biotechnology 2000: a new German R&D programme

    OpenAIRE

    Ekkehard Warmuth

    1991-01-01

    Biotechnology 2000 is a German programme to continue the development of biotechnology started in 1982. It includes two new scientific fields for industrial innovation — genome research and neurobiology. Together with industry and the science community, the biotechnology programme will create a basis for future generations of biologically derived products and processes, including the development of safety precautions for the contained use of genetically modified organisms (GMOs) and of univers...

  17. [Social marketers' lack of success in using CSM discipline to harness commercial resources and increase contraceptive prevalence].

    Science.gov (United States)

    Davies, J

    1984-01-01

    Social marketers have certainly shown that the CSM discipline can quickly and cost-effectively harness commercial resources to increase contraceptive prevalence. But why hasn't the social marketing idea caught on in more countries? According to Social Marketing Forum, only a tiny number of countries have active programs after more than a decade of effort. The most likely reason for this lack of success is doubt and fear on the part of both developing countries' officials and donor agencies about allowing marketing enthusiasts--with our very noticeable advertising methods--to join the family planning fight. And what has our answer been? Usually, a head-on retort such as, "But look at all the condoms we've sold]" And that gets us nowhere, because the successful peddling of 1 not-so-impressive method doesn't begin to balance the fears of a possible backlash that brash condom promotions could bring down on official heads. The lesson we should be learning is that social marketers possess to narrow an outlook and promote a small range of products that don't enthuse decisionmakers. Hence, we are often perceived as condom salesmen--and not much more. What should we be doing? We should be selling the idea of using private sector experience to assist national development. That means social development, particularly improved health, family planning and women's education. These 3 activities have proven effective in reducing fertility and would add up to a marketing opportunity--a longterm challenge that should enthuse dicisionmakers, private sector entrepreneurs and donor agencies alike. Further, our model--the commercial sector--is renowned for branching out and secceeding in a broad range of endeavors. As an example, Procter and Gamble uses separate divisions to market different products. Initiatives already exist in many countries to harness the private sector as a development tool. Social marketers should be leading the initiative--and benefitting from it, too. full text

  18. Harnessing Intellectual Property for Development: Some Thoughts ...

    African Journals Online (AJOL)

    Harnessing Intellectual Property for Development: Some Thoughts on an Appropriate ... This will be achieved through the creation of an IP system that provides ... the good being protected and the manner in which the creative process unfolds.

  19. Biotechnology in maize breeding

    Directory of Open Access Journals (Sweden)

    Mladenović-Drinić Snežana

    2004-01-01

    Full Text Available Maize is one of the most important economic crops and the best studied and most tractable genetic system among monocots. The development of biotechnology has led to a great increase in our knowledge of maize genetics and understanding of the structure and behaviour of maize genomes. Conventional breeding practices can now be complemented by a number of new and powerful techniques. Some of these often referred to as molecular methods, enable scientists to see the layout of the entire genome of any organism and to select plants with preferred characteristics by "reading" at the molecular level, saving precious time and resources. DNA markers have provided valuable tools in various analyses ranging from phylogenetic analysis to the positional cloning of genes. Application of molecular markers for genetic studies of maize include: assessment of genetic variability and characterization of germ plasm, identification and fingerprinting of genotypes, estimation of genetic distance, detection of monogamic and quantitative trait loci, marker assisted selection, identification of sequence of useful candidate genes, etc. The development of high-density molecular maps which has been facilitated by PCR-based markers, have made the mapping and tagging of almost any trait possible and serve as bases for marker assisted selection. Sequencing of maize genomes would help to elucidate gene function, gene regulation and their expression. Modern biotechnology also includes an array of tools for introducing or deieting a particular gene or genes to produce plants with novel traits. Development of informatics and biotechnology are resulted in bioinformatic as well as in expansion of microarrey technique. Modern biotechnologies could complement and improve the efficiency of traditional selection and breeding techniques to enhance agricultural productivity.

  20. Membrane engineering in biotechnology: quo vamus?

    Science.gov (United States)

    Rios, Gilbert M; Belleville, Marie-Pierre; Paolucci-Jeanjean, Delphine

    2007-06-01

    Membranes are essential to a range of applications, including the production of potable water, energy generation, tissue repair, pharmaceutical production, food packaging, and the separations needed for the manufacture of chemicals, electronics and a range of other products. Therefore, they are considered to be "dominant technologies" by governments and industry in several prominent countries--for example, USA, Japan and China. When combined with catalysts, membranes are at the basis of life, and membrane-based biomimetism is a key tool to obtain better quality products and environmentally friendly developments for our societies. Biology has a main part in this global landscape because it simultaneously provides the "model" (with natural biological membranes) and represents a considerable field of applications for new artificial membranes (biotreatments, bioconversions and artificial organs). In this article, our objective is to open up this enthralling area and to give our views about the future of membranes in biotechnology.

  1. Cancer Biotechnology | Center for Cancer Research

    Science.gov (United States)

    Biotechnology advances continue to underscore the need to educate NCI fellows in new methodologies. The Cancer Biotechnology course will be held on the NCI-Frederick campus on January 29, 2016 (Bldg. 549, Main Auditorium) and the course will be repeated on the Bethesda campus on February 9, 2016 (Natcher Balcony C). The latest advances in DNA, protein and image analysis will

  2. Vi har brug for dystopierne - men de kan ikke stå alene

    DEFF Research Database (Denmark)

    Baron, Christian

    2017-01-01

    Filmatiseringen af Margaret Atwoods »The Handmaid’s Tale« har aktualiseret dystopiens potentiale som samfundskritisk betydningsbærer. I sagens natur er dystopiens evne til at formulere alternativer til den udvikling, den advarer imod, imidlertid begrænsede. Vi har brug for litteratur, der tager...

  3. Perspectives on biotechnological applications of archaea

    Science.gov (United States)

    Schiraldi, Chiara; Giuliano, Mariateresa; De Rosa, Mario

    2002-01-01

    Many archaea colonize extreme environments. They include hyperthermophiles, sulfur-metabolizing thermophiles, extreme halophiles and methanogens. Because extremophilic microorganisms have unusual properties, they are a potentially valuable resource in the development of novel biotechnological processes. Despite extensive research, however, there are few existing industrial applications of either archaeal biomass or archaeal enzymes. This review summarizes current knowledge about the biotechnological uses of archaea and archaeal enzymes with special attention to potential applications that are the subject of current experimental evaluation. Topics covered include cultivation methods, recent achievements in genomics, which are of key importance for the development of new biotechnological tools, and the application of wild-type biomasses, engineered microorganisms, enzymes and specific metabolites in particular bioprocesses of industrial interest. PMID:15803645

  4. State regulation of the biotechnology (GM agricultural products: analysis of different approaches in the world

    Directory of Open Access Journals (Sweden)

    Irina Vladimirovna Yakovleva

    2015-06-01

    Full Text Available Although GM crops are cultivated on 175 million hectares in 27 countries, the regulation of agricultural biotechnology is in its becoming. In the future, many countries, of course, will lead to market biotech products, and the main focus will be biosafety issues for humans and the environment. Some countries have special regulatory mechanisms, others do not have the original national regulatory system, but their actions are under the provisions of international treaties for the production and handling of GM products. What are the main components of a strict but not stifling regulatory system? What are the disadvantages of existing systems? The article presents an overview of the state regulation systems of biotech agricultural products in the US, the EU, Argentina, South Africa and Brazil.

  5. Biotechnology bibliographies

    Energy Technology Data Exchange (ETDEWEB)

    Beaudette, L.A.; McCready, R.G.L.

    1986-01-01

    This bibliography consists of articles and scientific papers on biotechnology in areas in which BIOMINET is currently involved. The reports are categorized in four areas: 1) acid mine drainage (coals and metals) and bioadsorption of metals; 2) solution mining; 3) metabolism and physiology of Thiobacillus and other microorganisms; and 4) bacterial leaching of metals.

  6. Science har fundet løsning på CURIS-registrering

    DEFF Research Database (Denmark)

    Mørch, Frede

    2012-01-01

    Fakultetsbibliotekar Frede Mørch fortæller her om den løsning, som Science har indført for at sikre at alle forskningspublikationer bliver registreret i databasen, CURIS, uden at forskerne skal spilde tid på det.......Fakultetsbibliotekar Frede Mørch fortæller her om den løsning, som Science har indført for at sikre at alle forskningspublikationer bliver registreret i databasen, CURIS, uden at forskerne skal spilde tid på det....

  7. Proteomics: A Biotechnology Tool for Crop Improvement

    Directory of Open Access Journals (Sweden)

    Moustafa eEldakak

    2013-02-01

    Full Text Available A sharp decline in the availability of arable land and sufficient supply of irrigation water along with a continuous steep increase in food demands have exerted a pressure on farmers to produce more with fewer resources. A viable solution to release this pressure is to speed up the plant breeding process by employing biotechnology in breeding programs. The majority of biotechnological applications rely on information generated from various -omic technologies. The latest outstanding improvements in proteomic platforms and many other but related advances in plant biotechnology techniques offer various new ways to encourage the usage of these technologies by plant scientists for crop improvement programs. A combinatorial approach of accelerated gene discovery through genomics, proteomics, and other associated -omic branches of biotechnology, as an applied approach, is proving to be an effective way to speed up the crop improvement programs worldwide. In the near future, swift improvements in -omic databases are becoming critical and demand immediate attention for the effective utilization of these techniques to produce next-generation crops for the progressive farmers. Here, we have reviewed the recent advances in proteomics, as tools of biotechnology, which are offering great promise and leading the path towards crop improvement for sustainable agriculture.

  8. An intellectual property sharing initiative in agricultural biotechnology: development of broadly accessible technologies for plant transformation.

    Science.gov (United States)

    Chi-Ham, Cecilia L; Boettiger, Sara; Figueroa-Balderas, Rosa; Bird, Sara; Geoola, Josef N; Zamora, Pablo; Alandete-Saez, Monica; Bennett, Alan B

    2012-06-01

    The Public Intellectual Property Resource for Agriculture (PIPRA) was founded in 2004 by the Rockefeller Foundation in response to concerns that public investments in agricultural biotechnology benefiting developing countries were facing delays, high transaction costs and lack of access to important technologies due to intellectual property right (IPR) issues. From its inception, PIPRA has worked broadly to support a wide range of research in the public sector, in specialty and minor acreage crops as well as crops important to food security in developing countries. In this paper, we review PIPRA's work, discussing the failures, successes, and lessons learned during its years of operation. To address public sector's limited freedom-to-operate, or legal access to third-party rights, in the area of plant transformation, we describe PIPRA's patent 'pool' approach to develop open-access technologies for plant transformation which consolidate patent and tangible property rights in marker-free vector systems. The plant transformation system has been licensed and deployed for both commercial and humanitarian applications in the United States (US) and Africa, respectively. © 2012 The Authors. Plant Biotechnology Journal © 2012 Society for Experimental Biology, Association of Applied Biologists and Blackwell Publishing Ltd.

  9. Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.

    Science.gov (United States)

    Huzair, Farah; Sturdy, Steve

    2017-08-01

    The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we show how the early development of the hepatitis B vaccines was shaped by a political and economic context that newly favoured commercialisation of academic research, including the appropriation and management of intellectual property; we elucidate the contingent interests and motivations that led new biotechnology companies and established pharmaceutical businesses to invest in developing recombinant vaccines specifically against hepatitis B; and we show how these and other factors combined to make those vaccines an unexpected commercial success. Broadening the scope of our analysis to include not just North America and Europe but also low- and middle-income countries, we show how the development of the hepatitis B vaccines facilitated the emergence of a two-tier innovation system structured by tensions between the demands for commercial profitability on the one hand, and the expectation of public health benefit for low- and middle-income countries on the other. Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

  10. Biotechnology of non-Saccharomyces yeasts-the basidiomycetes.

    Science.gov (United States)

    Johnson, Eric A

    2013-09-01

    Yeasts are the major producer of biotechnology products worldwide, exceeding production in capacity and economic revenues of other groups of industrial microorganisms. Yeasts have wide-ranging fundamental and industrial importance in scientific, food, medical, and agricultural disciplines (Fig. 1). Saccharomyces is the most important genus of yeast from fundamental and applied perspectives and has been expansively studied. Non-Saccharomyces yeasts (non-conventional yeasts) including members of the Ascomycetes and Basidiomycetes also have substantial current utility and potential applicability in biotechnology. In an earlier mini-review, "Biotechnology of non-Saccharomyces yeasts-the ascomycetes" (Johnson Appl Microb Biotechnol 97: 503-517, 2013), the extensive biotechnological utility and potential of ascomycetous yeasts are described. Ascomycetous yeasts are particularly important in food and ethanol formation, production of single-cell protein, feeds and fodder, heterologous production of proteins and enzymes, and as model and fundamental organisms for the delineation of genes and their function in mammalian and human metabolism and disease processes. In contrast, the roles of basidiomycetous yeasts in biotechnology have mainly been evaluated only in the past few decades and compared to the ascomycetous yeasts and currently have limited industrial utility. From a biotechnology perspective, the basidiomycetous yeasts are known mainly for the production of enzymes used in pharmaceutical and chemical synthesis, for production of certain classes of primary and secondary metabolites such as terpenoids and carotenoids, for aerobic catabolism of complex carbon sources, and for bioremediation of environmental pollutants and xenotoxicants. Notwithstanding, the basidiomycetous yeasts appear to have considerable potential in biotechnology owing to their catabolic utilities, formation of enzymes acting on recalcitrant substrates, and through the production of unique primary

  11. Harnessing the Power of Information Technology: Open Business Models in Higher Education

    Science.gov (United States)

    Sheets, Robert G.; Crawford, Stephen

    2012-01-01

    Higher education is under enormous pressure to improve outcomes and reduce costs. Information technology can help achieve these goals, but only if it is properly harnessed. This article argues that one key to harnessing information technology is business model innovation that results in more "open" and "unbundled" operations in learning and…

  12. Food biotechnology's challenge to cultural integrity and individual consent.

    Science.gov (United States)

    Thompson, P B

    1997-01-01

    Consumer response to genetically altered foods has been mixed in the United States. While transgenic crops have entered the food supply with little comment, other foods, such as the bioengineered tomato, have caused considerable controversy. Objections to genetically engineered food are varied, ranging from the religious to the aesthetic. One need not endorse these concerns to conclude that food biotechnology violates procedural protections of consumer sovereignty and religious liberty. Consumer sovereignty, a principle especially valued in this country, requires that information be made available so each individual or group may make food choices based on their own values. And as yet, there is no policy provision for informing consumers about the degree to which food has been genetically engineered.

  13. Measuring the Contribution of Modern Biotechnology to the Canadian Economy

    OpenAIRE

    Ricardo de Avillez

    2011-01-01

    The role of modern biotechnology in agriculture, medicine, and industry has increased dramatically since the 1970s. Despite its growing importance, few efforts have been made so far to estimate the economic contribution of modern biotechnology to the Canadian economy. This report provides an overview of biotechnology activities in Canada, and, using an income-based approach, estimates that biotechnology activities accounted for approximately $15 billion in 2005, equivalent to 1.19 per cent of...

  14. BIOTECHNOLOGY BIOPRODUCTS "HEALING-1"

    Directory of Open Access Journals (Sweden)

    S. I. Artiukhova

    2014-01-01

    Full Text Available Summary. The article presents data on the development of technology and qualitative research, bio-products «Healing-1». One of the promising directions in food biotechnology is the development of new integrated starter-based consortia of microorganisms, which have higher activity compared with cultures prepared using pure cultures. So it was interesting studies on the development of new biotechnology and bio-based microbial consortium of lactic acid bacteria. Based on the analysis of biotechnological properties of native cultures created a new consortium of microorganisms containing lactic acid streptococci and bacilli, allowing the maximum extent possible to implement the physiological, biochemical and technological potential of microorganisms. Scientifically substantiated and experimentally developed a new biotechnology production of bioproducts «Healing-1», obtained on the basis of microbial consortium with broad spectrum antimicrobial activity. Experimentally investigated quality parameters of organic food «Healing-1» using a new microbial consortium as freshly prepared and during storage. Found that antagonistic activity of microflora bio «Healing-1» with respect to pathogenic and conditionally pathogenic bacteria, as well as its resistance to substances in the gastrointestinal tract of man is more pronounced compared to bioproducts obtained using a separate starter, members of the microbial consortium. It should be noted a more pronounced synthesis of exopolysaccharides in bioproduct «Healing-1», which leads to increased viscosity of the system and improves the consistency of bio. New bioproducts have good organoleptic characteristics and contain a high number of viable cells of lactic acid bacteria. High stability and survival of lactic acid bacteria during storage. In the study of attacked proteins bioproducts digestive proteinases «in vitro» found that the fermentation of milk microbial consortium increases the digestibility

  15. Biotechnology: Health care, agriculture, industry, environment

    Energy Technology Data Exchange (ETDEWEB)

    Sikyta, B; Pavlasova, E; Stejskalova, E

    1986-01-01

    New developments in different branches of biotechnology are discussed. The production of peptide hormones, new interferons and other lymphokines by the microbial and cell cultures, and new enzyme inhibitors of microbial origin are the most important for health care and pharmacy. The main direction in research in the agriculture represents the development of the new, very effective methods of nitrogen fixation and the production of animal growth hormones by gene manipulated microorganisms. One of the most important field of application of biotechnology is the chemical industry, c.f. microbial production of polymers and biotransformation of compounds previously produced by chemical methods (acrylamide, adipic acid, naphthalene conversion, etc.). Several novel methods of degradation of the cellulosic materials are mentioned and exploitation of biotechnology in environmental protection is also discussed.

  16. Undergraduate Biotechnology Students' Views of Science Communication

    Science.gov (United States)

    Edmondston, Joanne Elisabeth; Dawson, Vaille; Schibeci, Renato

    2010-01-01

    Despite rapid growth of the biotechnology industry worldwide, a number of public concerns about the application of biotechnology and its regulation remain. In response to these concerns, greater emphasis has been placed on promoting biotechnologists' public engagement. As tertiary science degree programmes form the foundation of the biotechnology…

  17. Electron shuttles in biotechnology.

    Science.gov (United States)

    Watanabe, Kazuya; Manefield, Mike; Lee, Matthew; Kouzuma, Atsushi

    2009-12-01

    Electron-shuttling compounds (electron shuttles [ESs], or redox mediators) are essential components in intracellular electron transfer, while microbes also utilize self-produced and naturally present ESs for extracellular electron transfer. These compounds assist in microbial energy metabolism by facilitating electron transfer between microbes, from electron-donating substances to microbes, and/or from microbes to electron-accepting substances. Artificially supplemented ESs can create new routes of electron flow in the microbial energy metabolism, thereby opening up new possibilities for the application of microbes to biotechnology processes. Typical examples of such processes include halogenated-organics bioremediation, azo-dye decolorization, and microbial fuel cells. Herein we suggest that ESs can be applied widely to create new microbial biotechnology processes.

  18. Biotechnology opportunities on Space Station

    Science.gov (United States)

    Deming, Jess; Henderson, Keith; Phillips, Robert W.; Dickey, Bernistine; Grounds, Phyllis

    1987-01-01

    Biotechnology applications which could be implemented on the Space Station are examined. The advances possible in biotechnology due to the favorable microgravity environment are discussed. The objectives of the Space Station Life Sciences Program are: (1) the study of human diseases, (2) biopolymer processing, and (3) the development of cryoprocessing and cryopreservation methods. The use of the microgravity environment for crystal growth, cell culturing, and the separation of biological materials is considered. The proposed Space Station research could provide benefits to the fields of medicine, pharmaceuticals, genetics, agriculture, and industrial waste management.

  19. Biotechnology Education and the Internet. ERIC Digest.

    Science.gov (United States)

    Lee, Thomas

    The world of modern biotechnology is based on recent developments in molecular biology, especially those in genetic engineering. Since this is a relatively new and rapidly advancing field of study, there are few traditional sources of information and activities. This digest highlights biotechnology resources including those that can be found on…

  20. Appropriate administrative structures in harnessing water resources ...

    African Journals Online (AJOL)

    Appropriate administrative structures in harnessing water resources for sustainable growth in Nigeria. Lekan Oyebande. Abstract. No Abstract. Journal of Mining and Geology Vol. 42(1) 2006: 21-30. Full Text: EMAIL FULL TEXT EMAIL FULL TEXT · DOWNLOAD FULL TEXT DOWNLOAD FULL TEXT.

  1. Jagttider: Hare, agerhøne og ederfugl har behov for mere beskyttelse

    DEFF Research Database (Denmark)

    Pedersen, Jens Christian

    2009-01-01

    De fleste bestande af de jagtbare arter har det rigtigt godt, men tre af de klassiske vildtarter, hare, agerhøne og ederfugl, er i problemer. Det fremgår af en 284-siders udredning som Danmarks Miljøundersøgelser ved Aarhus Universitet (DMU) har udarbejdet som fagligt grundlag for revisionen af...

  2. Oil and biotechnology

    Energy Technology Data Exchange (ETDEWEB)

    Yasui, Yoshiaki

    1988-06-01

    The secondary oil recovery due to microorganisms and the production of useful substances from oil distillates using microorganisms are described as examples to solidify the relationship between oil and biotechnology. The secondary crude-oil recovery has been carried out due to the microorganism drive process, which includes the on-the-ground and underground processes. Although the microorganism drive process has been investigated for many years, the selection of the microorganisms is not completely established. Many uncertainties still remain regarding the technical and economic aspects. The single cell protein (SCP) is an example of industrial success in the production of useful substances from the oil. Rumania has produced SCP from normal paraffin and the U. K. from the methanol and the products are used as the protein source for animals. Remarkable progress in the functional efficiency of microorganisms is expected due to the biotechnology for both applications. (4 tabs)

  3. Photovoltaic marketing in developing countries

    International Nuclear Information System (INIS)

    Muntasser, M.A.; Bara, M.F.; Quadri, H.A.; El-Tarabelsi, R.; La-azebi, I.F.

    2000-01-01

    Photovoltaic (PV) insolation-harnessing is acknowledged as the most practical economic solution to meet the requirements of one hundred million people without electricity in the developing countries. Industrialised countries in particular, have been active in utilising such technologies because they can afford the current peak watt prices of US $3-15 for such systems. The market in those countries will soon be close to saturation and attention by suppliers will have to be shifted to the already established larger market in less developed countries (LDCs). PV marketing in these developing countries, i.e. ability to penetrate the potential market, is facing tremendous hurdles. This paper reviews the present status and future directions of the PV market in developing countries as well as discusses the current technical, social, financial or geopolitical barriers and constraints, which are in line with the trends in the world. The paper concludes by making a global policy package proposal, in terms of an appeal on the global community concerned with PV to propagate proposal, in terms of an appeal on the global community concerned with PV to propagate this proposal more convincingly, perhaps to emanate from an internationally recognised 'forum', like a PV conference and exhibition, with cooperation and participation of PV manufacturers, suppliers, industrialised countries, NGOs, financial institutions and developing countries. (Author)

  4. Fossil energy biotechnology: A research needs assessment. Final report

    Energy Technology Data Exchange (ETDEWEB)

    1993-11-01

    The Office of Program Analysis of the US Department of Energy commissioned this study to evaluate and prioritize research needs in fossil energy biotechnology. The objectives were to identify research initiatives in biotechnology that offer timely and strategic options for the more efficient and effective uses of the Nation`s fossil resource base, particularly the early identification of new and novel applications of biotechnology for the use or conversion of domestic fossil fuels. Fossil energy biotechnology consists of a number of diverse and distinct technologies, all related by the common denominator -- biocatalysis. The expert panel organized 14 technical subjects into three interrelated biotechnology programs: (1) upgrading the fuel value of fossil fuels; (2) bioconversion of fossil feedstocks and refined products to added value chemicals; and, (3) the development of environmental management strategies to minimize and mitigate the release of toxic and hazardous petrochemical wastes.

  5. The role of biotechnology in combating climate change

    DEFF Research Database (Denmark)

    Aerni, Philipp; Gagalac, Florabelle; Scholderer, Joachim

    2016-01-01

    on biotechnology and climate change was conducted with 55 representatives of 44 institutions. The results of a perception pattern analysis show that the majority of stakeholder representatives had a neutral or positive attitude towards the use of biotechnology and regarded its potential to address climate change...... problems as significant. The survey results further reveal a significant relationship between a representative’s institutional and disciplinary background and his or her attitude. The respective background appears to determine to a considerable extent whether biotechnology is framed as a risk...

  6. Biotechnology issues in four Malaysian mainstream newspapers

    African Journals Online (AJOL)

    Jane

    2011-09-30

    Sep 30, 2011 ... Biotechnology has been identified as the new engine of growth for the transformation of Malaysia into a developed nation by 2020. The objective of this paper is to analyze the impact of National Policy on biotechnology on media reporting in four Malaysian newspapers. Towards this end, a content analysis.

  7. Biotechnology issues in four Malaysian mainstream newspapers ...

    African Journals Online (AJOL)

    Biotechnology has been identified as the new engine of growth for the transformation of Malaysia into a developed nation by 2020. The objective of this paper is to analyze the impact of National Policy on biotechnology on media reporting in four Malaysian newspapers. Towards this end, a content analysis of four Malaysian ...

  8. [Health risks in the biotechnological industry].

    Science.gov (United States)

    Colombi, A; Maroni, M; Foà, V

    1989-01-01

    Biotechnology has been defined as the application of biological organisms, systems or processes to manufacturing and service industries. In considering health aspects of biotechnological development it must be underlined that the use of microorganisms in traditional industries, such as the production of food, bread, beer and dairy products, has not added significantly to the more usual industrial hazards. The risk factors encountered in the biotechnology industry can be defined as general, i.e., common to other industrial activities, and specific, i.e., depending on the presence of microorganisms and/or their metabolic products. The specific health risks vary according to the type of process, but can be grouped into three main categories: immunological diseases, toxic effects; pathological effects of microorganisms. Allergic immunological diseases such as bronchial asthma, contact dermatitis, oculo-rhinitis and extrinsic allergic alveolitis are by far the most frequent and well known diseases occurring among workers employed on biotechnological production. Toxic effects were observed among workers employed on the production of antibiotics and hormones or single cell proteins, where absorption of endotoxins has been described. Infectious diseases may arise from uncontrolled dissemination of pathogenic microorganisms through aerosols, dusts, aqueous and semisolid sludge effluents from biotechnological plants. The greatest risks occur in the production of antiviral vaccines, in research laboratories and in waste-water treatment plants. Risk of pathogenic effects has also been speculated from exposure to engineered microorganisms in laboratory and environmental or agricultural applications. Safety precautions consisting of protective measures, and effective barriers of containment (both physical and biological) have to be advised according to the hazardous characteristics of the organisms.(ABSTRACT TRUNCATED AT 250 WORDS)

  9. Application of agricultural biotechnology to improve food nutrition and healthcare products.

    Science.gov (United States)

    Sun, Samuel S M

    2008-01-01

    Crop plants provide essential food nutrients to humans and livestock, including carbohydrates, lipids, proteins, minerals and vitamins, directly or indirectly. The level and composition of food nutrients vary significantly in different food crops. As a result, plant foods are often deficient in certain nutrient components. Relying on a single food crop as source of nutrients thus will not achieve a balanced diet and results in malnutrition and deficiency diseases, especially in the developing countries, due mainly to poverty. The development and application of biotechnology offers opportunities and novel possibilities to enhance the nutritional quality of crops, particularly when the necessary genetic variability is not available. While initial emphasis of agricultural biotechnology has been placed on input traits of crops such as herbicide tolerance, insect resistance and virus resistance, increasing effort and promising proof-of-concept products have been made in output traits including enhancing the nutritional quality of crops since 1990s. Advancements in plant transformation and transgene expression also allow the use of plants as bioreactors to produce a variety of bio-products at large scale and low cost. Many proof-of-concept plant-derived healthcare products have been generated and several commercialized.

  10. Analytical assessments on the potential of harnessing tidal currents for electricity generation in Malaysia

    Energy Technology Data Exchange (ETDEWEB)

    Lim, Yun Seng; Koh, Siong Lee [Department of Physical Science, Electrical and Electronic Engineering, Tunku Abdul Rahman University (Malaysia)

    2010-05-15

    Malaysia is heavily dependent on fossil fuel for electricity generation. With the rapidly diminishing of its fuel reserve and the increasingly negative effects of fossil fuels to the environment, the government has begun to utilise bio-fuel and solar radiation for electricity generation. However, the potential of harnessing other renewable sources, particular ocean energy, in Malaysia has not been fully realised. Therefore, studies were carried out to identify the potential of harnessing ocean energy for electricity generation. The Princeton Ocean Model was used to create a three-dimensional numerical ocean model for Malaysia which was calibrated against measurement by a means of adjoint data assimilation approach. A set of reliable tidal speed and tidal elevation data was therefore generated to determine the types of tides available in Malaysia, the potential areas of installing marine current turbines (MCTs), the total amount of electricity to be generated by MCT, the economical viability and the environmental benefits of using MCT in Malaysia. This paper presents the findings on the studies, encompassing the technical, economical and environmental aspects of installing MCT in Malaysia. The results are critical to policy makers and the potential investors on tidal energy in Malaysia for decision making. It may also help the neighboring countries to realize the possible potential of their ocean energy for electricity generation. (author)

  11. Biotechnology for site restoration: scope of the problem

    Energy Technology Data Exchange (ETDEWEB)

    Bitchaeva, O

    1996-09-18

    The potential of modern biotechnology for solving problems related with the nuclear industry, especially site restoration, are investigated. The advantages of biotechnology, the current applications in Russia, main points of international collaboration, and political considerations are discussed.

  12. Harnessing two language games to enhance students' achievement ...

    African Journals Online (AJOL)

    Harnessing two language games to enhance students' achievement in English vocabulary: implications for ... This study investigated the use of games strategies on Senior Secondary One (SS1) students' ... AJOL African Journals Online.

  13. Harnessing a methane-fueled, sediment-free mixed microbial community for utilization of distributed sources of natural gas.

    Science.gov (United States)

    Marlow, Jeffrey J; Kumar, Amit; Enalls, Brandon C; Reynard, Linda M; Tuross, Noreen; Stephanopoulos, Gregory; Girguis, Peter

    2018-06-01

    Harnessing the metabolic potential of uncultured microbial communities is a compelling opportunity for the biotechnology industry, an approach that would vastly expand the portfolio of usable feedstocks. Methane is particularly promising because it is abundant and energy-rich, yet the most efficient methane-activating metabolic pathways involve mixed communities of anaerobic methanotrophic archaea and sulfate reducing bacteria. These communities oxidize methane at high catabolic efficiency and produce chemically reduced by-products at a comparable rate and in near-stoichiometric proportion to methane consumption. These reduced compounds can be used for feedstock and downstream chemical production, and at the production rates observed in situ they are an appealing, cost-effective prospect. Notably, the microbial constituents responsible for this bioconversion are most prominent in select deep-sea sediments, and while they can be kept active at surface pressures, they have not yet been cultured in the lab. In an industrial capacity, deep-sea sediments could be periodically recovered and replenished, but the associated technical challenges and substantial costs make this an untenable approach for full-scale operations. In this study, we present a novel method for incorporating methanotrophic communities into bioindustrial processes through abstraction onto low mass, easily transportable carbon cloth artificial substrates. Using Gulf of Mexico methane seep sediment as inoculum, optimal physicochemical parameters were established for methane-oxidizing, sulfide-generating mesocosm incubations. Metabolic activity required >∼40% seawater salinity, peaking at 100% salinity and 35 °C. Microbial communities were successfully transferred to a carbon cloth substrate, and rates of methane-dependent sulfide production increased more than threefold per unit volume. Phylogenetic analyses indicated that carbon cloth-based communities were substantially streamlined and were

  14. Har jeg forstået det rigtigt?

    DEFF Research Database (Denmark)

    Horsted, Mette Wenzel; Herly, Lene

    2009-01-01

    Interviews med sygeplejestuderende, der har problemer i forhold til biokemi, anatomi og fysiologi, gav indsigt i disse studerendes læringsstrategier i undervisningen. Ved bevidst at inddrage motiverende faktorer som inklusion, attitude, mening og kompetence (1), kan der skabes et læringsmiljø, hvor...

  15. Harnessing Collaborative Annotations on Online Formative Assessments

    Science.gov (United States)

    Lin, Jian-Wei; Lai, Yuan-Cheng

    2013-01-01

    This paper harnesses collaborative annotations by students as learning feedback on online formative assessments to improve the learning achievements of students. Through the developed Web platform, students can conduct formative assessments, collaboratively annotate, and review historical records in a convenient way, while teachers can generate…

  16. Biotechnology for the extractive metals industries

    Science.gov (United States)

    Brierley, James A.

    1990-01-01

    Biotechnology is an alternative process for the extraction of metals, the beneficiation of ores, and the recovery of metals from aqueous systems. Currently, microbial-based processes are used for leaching copper and uranium, enhancing the recovery of gold from refractory ores, and treating industrial wastewater to recover metal values. Future developments, emanating from fundamental and applied research and advances through genetic engineering, are expected to increase the use and efficiency of these biotechnological processes.

  17. Understanding development trajectories for biotechnology governance frameworks in sub-Saharan Africa: the policy kinetics model

    OpenAIRE

    Mugwagwa, Julius; King'Iri, Ann; Muraguri, Lois

    2014-01-01

    Using case studies on development and implementation of biotechnology governance frameworks in four African countries, we introduce and build the case for a policy kinetics (PK) approach to analysing and unpacking complex policy processes. The PK approach proposes a comprehensive approach to understanding how various ‘pieces of the policy puzzle’ interact in arenas to facilitate or constrain attainment of desired outputs. Borrowing from reaction kinetics in chemistry, which is the study of ra...

  18. Biotechnology and species development in aquaculture | Ayoola ...

    African Journals Online (AJOL)

    The use of biotechnology in various aspects of human endeavour have obviously created a great impact but not without some risks. Not withstanding, there is still the need for its adoption as more of the already adopted biotechnologies are being improved upon with lesser demerits. Aquaculture is not also left out in the ...

  19. "FACILS 2014: Microbially-driven facilitation systems in environmental biotechnology" (hereafter "FACILS") presented here by the European Commission (EC)-United States (US) Task Force on Biotechnology Research

    Energy Technology Data Exchange (ETDEWEB)

    Methe, Barbara

    2016-02-03

    As we enter the 21st century, the sustainability of the biosphere is a global challenge that can best be met with a global response. This includes how we train and promote our next generation of research scientists in the emerging arenas of genome-enabled biology and a bio-based economy. It is this fundamental issue that formed the motivation for designing and conducting a shortcourse entitled “FACILIS 2014: Microbially-driven facilitation systems in environmental biotechnology” (hereafter “FACILIS”) presented here by the European Commission (EC)-United States (US) Task Force on Biotechnology Research. This WG was established in 1994 under the umbrella of the US-EC Task Force on Biotechnology Research, a transatlantic collaborative group overseen by the US Office of Science and Technology Policy (OSTP) and the EC. The Environmental Biotechnology Working Group maintains several goals, including establishing research links between scientists in EU countries and the US and fostering the careers of junior scientists from both sides of the Atlantic to the global nature of scientific cooperation. To that end, a shortcourse was held at the University of Milan in Italy on July 12-25 2014 organized around cross-cutting themes of genomic science and designed to attract a stellar group of interdisciplinary early carrier researchers. A total of 22 students, 10 from the US and 12 from the EU participated. The course provided them with hands-on experience with the latest scientific methods in genomics and bioinformatics; using a format that combines lectures, laboratory research and field work with the final goal to enable researchers to finally turn data into knowledge.

  20. Advancement of Marketing Developing Biotechnology-Based Business

    Directory of Open Access Journals (Sweden)

    Vaidas Vilmantas

    2014-09-01

    Full Text Available The article, in a complex way, analyzes the needs of marketing improvement in developing biotechnology­based business and highlights its role in the context of modern society and globalization challenges. The article distinguishes between the existing problems of biotechnology business, the present perspectives and specific characteristics of developing the marketing of biotechnological business. The paper represents the possibility of the substantial modernization of marketing tools with regard to modelling user’s behaviour, improvement in marketing strategy for the company, the correction of the elements of the marketing complex, changes in the marketing conception inside the company, product and service differentiation and renewal, the encouragement of expansion into other markets, variations in or the expansion of the target market, alternatives to the positioning strategy for the company, an increase in competitive ability and an internal impact of marketing on the varying elements. The article has referred to the analysis of scientific literature and research on the opinions of consumers and experts in the field in the context of biotechnology­based businesses.

  1. Introduction to Pharmaceutical Biotechnology, Volume 1; Basic techniques and concepts

    Science.gov (United States)

    Bhatia, Saurabh; Goli, Divakar

    2018-05-01

    Animal biotechnology is a broad field including polarities of fundamental and applied research, as well as DNA science, covering key topics of DNA studies and its recent applications. In Introduction to Pharmaceutical Biotechnology, DNA isolation procedures followed by molecular markers and screening methods of the genomic library are explained. Interesting areas like isolation, sequencing and synthesis of genes, with the broader coverage on synthesis of genes, are also described. The book begins with an introduction to biotechnology and its main branches, explaining both the basic science and the applications of biotechnology-derived pharmaceuticals, with special emphasis on their clinical use. It then moves on to historical development and scope of biotechnology with an overall review of early applications that scientists employed long before the field was defined.

  2. Microbial biotechnology and circular economy in wastewater treatment.

    Science.gov (United States)

    Nielsen, Per Halkjaer

    2017-09-01

    Microbial biotechnology is essential for the development of circular economy in wastewater treatment by integrating energy production and resource recovery into the production of clean water. A comprehensive knowledge about identity, physiology, ecology, and population dynamics of process-critical microorganisms will improve process stability, reduce CO2 footprints, optimize recovery and bioenergy production, and help finding new approaches and solutions. Examples of research needs and perspectives are provided, demonstrating the great importance of microbial biotechnology. © 2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.

  3. Yeast biotechnology: teaching the old dog new tricks.

    Science.gov (United States)

    Mattanovich, Diethard; Sauer, Michael; Gasser, Brigitte

    2014-03-06

    Yeasts are regarded as the first microorganisms used by humans to process food and alcoholic beverages. The technology developed out of these ancient processes has been the basis for modern industrial biotechnology. Yeast biotechnology has gained great interest again in the last decades. Joining the potentials of genomics, metabolic engineering, systems and synthetic biology enables the production of numerous valuable products of primary and secondary metabolism, technical enzymes and biopharmaceutical proteins. An overview of emerging and established substrates and products of yeast biotechnology is provided and discussed in the light of the recent literature.

  4. White House Announcement on the Regulation of Biotechnology

    Science.gov (United States)

    The White House posted a blog unveiling documents as part of the Administration’s continuing effort to modernize the federal regulatory system for biotechnology products as well as clarify various roles of the EPA, FDA in evaluating new biotechnologies.

  5. Biotechnological Aspects of Microbial Extracellular Electron Transfer

    Science.gov (United States)

    Kato, Souichiro

    2015-01-01

    Extracellular electron transfer (EET) is a type of microbial respiration that enables electron transfer between microbial cells and extracellular solid materials, including naturally-occurring metal compounds and artificial electrodes. Microorganisms harboring EET abilities have received considerable attention for their various biotechnological applications, in addition to their contribution to global energy and material cycles. In this review, current knowledge on microbial EET and its application to diverse biotechnologies, including the bioremediation of toxic metals, recovery of useful metals, biocorrosion, and microbial electrochemical systems (microbial fuel cells and microbial electrosynthesis), were introduced. Two potential biotechnologies based on microbial EET, namely the electrochemical control of microbial metabolism and electrochemical stimulation of microbial symbiotic reactions (electric syntrophy), were also discussed. PMID:26004795

  6. The effect of spatial confinement on the noble-gas HArF molecule: structure and electric properties

    International Nuclear Information System (INIS)

    Kozłowska, Justyna; Bartkowiak, Wojciech

    2014-01-01

    Highlights: • The structure and electrical properties of HArF in spatial confinement are analyzed. • Orbital compression leads to decrease of bond lengths in the HArF molecule. • Spatial restriction causes a drop of the molecular (hyper)polarizabilities. • Spatial confinement reduces the electron correlation contribution to μ, α and β. - Abstract: A systematic study on the dipole moment and (hyper)polarizabilities of argon fluorohydride under spatial restriction was performed. Detailed analysis of the confinement induced changes in the structure of HArF is also presented. In order to render the influence of chemical compression on the properties in question a two-dimensional harmonic oscillator potential, mimicking a cylindrical confinement, was applied. Through the comparison of the results obtained for HArF with those of HF the effect of Ar insertion on the above properties was discussed. A hierarchy of ab initio methods including HF, MP2, CCSD and CCSD(T), has been employed to investigate the effect of orbital compression on the electron correlation contribution to the studied electric properties. It was observed that the external confining potential modifies the electronic contributions to the dipole moment and (hyper)polarizabilities of HArF. In particular, the first hyperpolarizability of HArF is remarkably smaller than that of the unconfined HArF molecule

  7. The effect of spatial confinement on the noble-gas HArF molecule: structure and electric properties

    Energy Technology Data Exchange (ETDEWEB)

    Kozłowska, Justyna; Bartkowiak, Wojciech, E-mail: wojciech.bartkowiak@pwr.edu.pl

    2014-09-30

    Highlights: • The structure and electrical properties of HArF in spatial confinement are analyzed. • Orbital compression leads to decrease of bond lengths in the HArF molecule. • Spatial restriction causes a drop of the molecular (hyper)polarizabilities. • Spatial confinement reduces the electron correlation contribution to μ, α and β. - Abstract: A systematic study on the dipole moment and (hyper)polarizabilities of argon fluorohydride under spatial restriction was performed. Detailed analysis of the confinement induced changes in the structure of HArF is also presented. In order to render the influence of chemical compression on the properties in question a two-dimensional harmonic oscillator potential, mimicking a cylindrical confinement, was applied. Through the comparison of the results obtained for HArF with those of HF the effect of Ar insertion on the above properties was discussed. A hierarchy of ab initio methods including HF, MP2, CCSD and CCSD(T), has been employed to investigate the effect of orbital compression on the electron correlation contribution to the studied electric properties. It was observed that the external confining potential modifies the electronic contributions to the dipole moment and (hyper)polarizabilities of HArF. In particular, the first hyperpolarizability of HArF is remarkably smaller than that of the unconfined HArF molecule.

  8. MPACT OF GENETIC BIOTECHNOLOGIES ON BIOSECURITY AND FOOD SAFETY

    Directory of Open Access Journals (Sweden)

    NICA-BADEA DELIA

    2014-05-01

    Full Text Available Biosecurity is a relatively new area global, being promoted by the significant results, particularly in the last 20 years, fundamental and applied research. Biotechnology is a collection of techniques that can be used in the agro-food, medical and industrial. The paper examines the potential impact of transgenic biotechnology, vulnerabilities, implications, benefits and risks, quality of life and health. Introduction into the environment, cross-border trade and use of GMOs resulting from modern biotechnology can untoward effects on the conservation and sustainable use of biological diversity, food security and safety. It is openly acknowledged that modern biotechnology has great potential to promote human welfare, in particular, to overcome the critical needs in food, agriculture and human health. Establish appropriate safety measures when using genetically modified organisms (biosecurity policy, regulatory regime, scientific and technical measures is a highly sensitive process, aiming both to maximize the benefits of modern biotechnology and to minimize potential risk

  9. Environmental Biotechnology in China

    Science.gov (United States)

    Liu, Shuang Jiang; Liu, Lei; Chaudhry, Muhammad Tausif; Wang, Lei; Chen, Ying Guang; Zhou, Qi; Liu, He; Chen, Jian

    Environmental biotechnology has emerged as an important measure to tackle the environmental pollution as China experiences great economic success. Over the past decade, much emphasis has been paid to the following fields in environmental biotechnology: microbial degradation of toxic and organic chemicals, bio-treatment of wastewater, waste recycling. The Chinese researchers have done a lot of work to understand the natural degradation processes for organic and toxic compounds and finally to clean these compounds from polluted environments. For the treatment of wastewater, many new processes were proposed and optimized to meet the more strict effluent standards in China. Finally, more and more attention has been paid to the reuse of discharged wastes. In this chapter we review the development in the above fields.

  10. Open source biotechnology : A drug for developing countries' health problems?

    NARCIS (Netherlands)

    Schellekens, M.H.M.

    2008-01-01

    In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the

  11. International Trade in Biotechnology Products and Strategic Mandatory Labelling

    OpenAIRE

    Jinji, Naoto

    2003-01-01

    This paper examines strategic motives to impose mandatory labelling of biotechnology products when consumers perceive these products as being of lower quality. When a foreign dominant firm produces a biotechnology product, it is shown that without mandatory labelling fringe firms, which produce a conventional product, provide voluntary labelling as long as voluntary labelling is fully credible. Information on which product is biotechnologically engineered is hence completely disclosed without...

  12. Applications of Novel Techniques to Health Foods, Medical and Agricultural Biotechnology

    OpenAIRE

    Baianu, I. C.; Lozano, P. R.; Prisecaru, V. I.; Lin, H. C.

    2004-01-01

    Selected applications of novel techniques in Agricultural Biotechnology, Health Food formulations and Medical Biotechnology are being reviewed with the aim of unraveling future developments and policy changes that are likely to open new niches for Biotechnology and prevent the shrinking or closing the existing ones. Amongst the selected novel techniques with applications to both Agricultural and Medical Biotechnology are: immobilized bacterial cells and enzymes, microencapsulation and liposom...

  13. Nigerian Journal of Biotechnology

    African Journals Online (AJOL)

    Nigerian Journal of Biotechnology is a publisher of multidisciplinary ... Assessment of microalgae-influenced biodeterioration of concrete structures · EMAIL FREE ... A study on 3-mercaptopyruvate sulphurtransferase (3-MST) produced under ...

  14. Developing countries' motivation to use nuclear technology

    International Nuclear Information System (INIS)

    Ratsch, U.

    1990-01-01

    Governments of various developing countries see nuclear energy as an important tool for at least three political goals: Firstly, the expected rise in future energy demand, so they argue, can only be met if nuclear electricity production in the Third World is expanded. Fossil sources are supposed to become increasingly scarce and expensive, and they are also seen to be ecologically damaging. Technologies to harness renewable energy sources are not yet mature and still too costly. Secondly, nuclear technology is seen as one of the most advanced technologies. Mastering of it might help to diminish the technological gap between the First and the Third World. Thirdly, scientific progress in developing countries is hoped to be accelerated by operating research reactors in these countries. All of these arguments ought to be taken as serious motivations. (orig./HSCH) [de

  15. Opportunities in biotechnology.

    Science.gov (United States)

    Gartland, Kevan M A; Gartland, Jill S

    2018-06-08

    Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and the creation of centres of excellence. By considering recent progress in areas such as genomics, healthcare diagnostics, synthetic biology, gene editing and bio-digital technologies, opportunities for smart, strategic and specialised investment are discussed. These opportunities often involve convergent or disruptive technologies, combining for example elements of pharma-science, molecular biology, bioinformatics and novel device development to enhance biotechnology and the life sciences. Analytical applications use novel devices in mobile health, predictive diagnostics and stratified medicine. Synthetic biology provides opportunities for new product development and increased efficiency for existing processes. Successful centres of excellence should promote public-private business partnerships, clustering and global collaborations based on excellence, smart strategies and innovation if they are to remain sustainable in the longer term. Copyright © 2018. Published by Elsevier B.V.

  16. Biosafety considerations for selectable and scorable markers used in cassava (Manihot esculenta Crantz) biotechnology.

    Science.gov (United States)

    Petersen, William; Umbeck, Paul; Hokanson, Karen; Halsey, Mark

    2005-01-01

    Cassava is an important subsistence crop grown only in the tropics, and represents a major source of calories for many people in developing countries. Improvements in the areas of resistance to insects and viral diseases, enhanced nutritional qualities, reduced cyanogenic content and modified starch characteristics are urgently needed. Traditional breeding is hampered by the nature of the crop, which has a high degree of heterozygosity, irregular flowering, and poor seed set. Biotechnology has the potential to enhance crop improvement efforts, and genetic engineering techniques for cassava have thus been developed over the past decade. Selectable and scorable markers are critical to efficient transformation technology, and must be evaluated for biosafety, as well as efficiency and cost-effectiveness. In order to facilitate research planning and regulatory submission, the literature on biosafety aspects of the selectable and scorable markers currently used in cassava biotechnology is surveyed. The source, mode of action and current use of each marker gene is described. The potential for toxicity, allergenicity, pleiotropic effects, horizontal gene transfer, and the impact of these on food or feed safety and environmental safety is evaluated. Based on extensive information, the selectable marker genes nptII, hpt, bar/pat, and manA, and the scorable marker gene uidA, all have little risk in terms of biosafety. These appear to represent the safest options for use in cassava biotechnology available at this time.

  17. A New Harness For Use with Exercise Countermeasures-Validation of Improved Comfort and Loading with the Center for Space Medicine (CSM) Harness

    Data.gov (United States)

    National Aeronautics and Space Administration — The on-orbit treadmill harness Station Development Test Objective (SDTO) evaluation ran from Increment 21 through 25 aboard the International Space Station...

  18. Biotechnology

    International Nuclear Information System (INIS)

    2011-01-01

    The guidelines of the Biotechnology Program are research and development aiming to develop and manufacture products of pharmaceutical interest. This Program has two main research areas, namely Pituitary Hormones and Biopharmaceuticals. The first one comprises a group with a long experience on Recombinant Human Pituitary Hormone synthesis, purification and characterization. The Biopharmaceutical area is dedicated to the research of isolation, structural analysis and biological activities in different biological system of macromolecules. The Animal Laboratory Division of IPEN is responsible for the breeding and production of small laboratory animal.

  19. Biotechnology of marine fungi

    Digital Repository Service at National Institute of Oceanography (India)

    Damare, S.R.; Singh, P.; Raghukumar, S.

    Filamentous fungi are the most widely used eukaryotes in industrial and pharmaceutical applications. Their biotechnological uses include the production of enzymes, vitamins, polysaccharides, pigments, lipids and others. Marine fungi are a still...

  20. Ethical limitations in patenting biotechnological inventions.

    Science.gov (United States)

    Lugagnani, V

    1999-01-01

    In order to connect ethical considerations with practical limits to patentability, the moral judgement should possibly move from the exploitation of the invention to the nature and/or objectives of Research and Development (R&D) projects which have produced it: in other words, it appears quite reasonable and logical that Society is not rewarding unethical R&D activities by granting intellectual property rights. As far as biotechnology R&D is concerned, ethical guidance can be derived from the 1996 Council of EuropeOs OConvention for the protection of human rights and dignity of the human being with regard to the application of biology and medicineO, whose Chapter V - Scientific research - provides guidelines on: i. protection of persons undergoing research (e.g. informed consent); ii. protection of persons not able to consent to research; iii. research on embryos in vitro. As far as the specific point of patenting biotechnology inventions is concerned, the four exclusions prescribed by Directive 98/44/EC (i.e. human cloning, human germ-line gene therapy, use of human embryos for commercial purposes, unjustified animal suffering for medical purposes) are all we have in Europe in terms of ethical guidance to patentability. In Italy, in particular, we certainly need far more comprehensive legislation, expressing SocietyOs demand to provide ethical control of modern biotechnology. However it is quite difficult to claim that ethical concerns are being raised by currently awarded biotechnology patents related to living organisms and material thereof; they largely deal with the results of genomic R&D, purposely and usefully oriented toward improving health-care and agri-food processes, products and services. ONo patents on lifeOO can be an appealing slogan of militants against modern biotechnology, but it is far too much of an over-simplified abstraction to become the Eleventh Commandment our Society.

  1. Sectoral Innovation Watch Biotechnology Sector. Final sector report

    NARCIS (Netherlands)

    Enzing, C.

    2011-01-01

    Biotechnology has evolved from a single set of technologies in the mid 1970s into a full grown technological field that is the driving force in innovation processes in many industrial sectors (pharmaceutical, medical, agriculture, food, chemical, environment, instruments). Nowadays, biotechnology is

  2. BIOFAC-An investment in space infrastructure for biotechnology

    Science.gov (United States)

    Deuser, Mark S.; Vellinger, John C.

    2000-01-01

    During the last half century, biotechnology has contributed to the development of many important new and useful products that have improved our quality of life. To a large extent, these contributions are attributable to advances in cellular and molecular biology that can be traced to the discovery of DNA. What began as a science involved with manipulations of whole organisms has transcended into an ability to influence organisms at the cellular and molecular levels with greater speed, flexibility and precision than ever before. This has produced significantly improved pharmaceutical, textile, diagnostic, and environmental products, to name just a few. Early in this new century, biotechnology research is expected to literally explode with exciting new and promising opportunities. More importantly, biotechnology research in the low gravity environment of space is expected to play a significant part in this biotechnology revolution by expediting the discovery of important new medical, agricultural and environmental products. .

  3. The role of plant biotechnology methods in sustainable agriculture

    OpenAIRE

    Koleva Gudeva, Liljana; Trajkova, Fidanka

    2016-01-01

    Plant biotechnology is set of different scientific approaches and methods that are utilized to improve and modify plants for human and environmental benefit. Plant biotechnology can be used to meet the increasing need for food by improving yields, improving the nutritional quality of crops and recuing the impact on the environment. Plant biotechnology can assist to creation of varieties resistant to frost, droughts and floods, pests and disease, and other abiotic and biotic stresses. Similarl...

  4. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.

    Science.gov (United States)

    Kang, Kyung-Nam; Lee, Yoon-Sik

    2008-10-01

    Research-intensive small and medium-sized enterprises (SMEs) play a crucial role in the advancement of the biotechnology industry. This paper explored the impacts of internal and contextual variables on innovative activity in Korea and compared the results of this analysis with previous studies of other countries. Our analysis of 149 Korean biotech SMEs showed that the ratio of R&D expenditure to sales, the ratio of R&D employees to total employees, CEO characteristics, governmental support and international networking are positively correlated with a firm's innovation performance. The results may help decision makers to better foster SMEs in the Korean biotechnology industry.

  5. Microbial photosynthesis in the harnessing of solar energy

    Energy Technology Data Exchange (ETDEWEB)

    Pirt, S J

    1982-01-01

    The shortage of fossil fuels restricts the world supply of reduced carbon compounds and energy sources. Biotechnology offers the most feasible route to renewing the supplies of reduced carbon compounds. This involves recycling of CO/sub 2/ through photosynthesis. Conventional agriculture has little or no potential for supplying biomass and its derivatives on sufficient scale to offer an alternative to the fossil fuels. The agricultural wastes, on the whole, are intractable to conversion into useful carbon and energy sources and in any case are not available in amounts to provide a significant alternative to the fossil fuels. In contrast, microbial photosynthesis, optimised in photobioreactors, has vast potential to provide organic matter on a scale to match the consumption of fossil fuels. The quantative study of microbial photosynthesis as a biotechnological route to biomass has been neglected. As a result there is a chaos of conflicting data on fundamental parameters, for example, the photosynthetic efficiency of biomass production. New photosynthetic biotechnology with fully controlled continuous-culture systems is providing unequivocal values for the parameters. For the scale-up of microbial photosynthesis a tubular-loop reactor is proposed. (Refs. 14).

  6. Current and Future Leaders' Perceptions of Agricultural Biotechnology

    Science.gov (United States)

    Wingenbach, Gary J.; Miller, Rene P.

    2009-01-01

    Were elected state FFA officers' attitudes toward agricultural biotechnology significantly different from elected Texas legislators' attitudes about the same topic? The purpose of this study was to determine if differences existed in agricultural biotechnology perceptions or information source preferences when compared by leadership status:…

  7. Perceptions and attitudes of geography teachers to biotechnology: A ...

    African Journals Online (AJOL)

    STORAGESEVER

    2008-12-03

    Dec 3, 2008 ... perceptions of geography teachers towards biotechnology and GM foods but also provided an ... Key words: Biotechnology, GM foods, perceptions, attitudes, geography education, Turkey. ..... Brazilian high school students.

  8. En analyse av prestasjonsbasert belønning og hvilken effekt den har i Flytoget

    OpenAIRE

    Stousland, Kine

    2013-01-01

    Prestasjonsbasert belønning har vært i vinden de siste årene, og stadig flere bedrifter har tatt i bruk denne lønnsmetoden for å motivere ansatte til høyere effektivitet og bedre prestasjoner. Flytoget har kastet seg på denne bølgen og laget en medarbeiderbonus med samme kriterier for hele bedriften. Bonusen blir utbetalt en gang per år, og for å få full bonus må Flytoget oppnå 97% kundetilfredshet og fastsatt budsjett. Flytoget er en relativt liten bedrift med 334 ansatte. Hovedoppgaven t...

  9. Yeast biotechnology: teaching the old dog new tricks

    Science.gov (United States)

    2014-01-01

    Yeasts are regarded as the first microorganisms used by humans to process food and alcoholic beverages. The technology developed out of these ancient processes has been the basis for modern industrial biotechnology. Yeast biotechnology has gained great interest again in the last decades. Joining the potentials of genomics, metabolic engineering, systems and synthetic biology enables the production of numerous valuable products of primary and secondary metabolism, technical enzymes and biopharmaceutical proteins. An overview of emerging and established substrates and products of yeast biotechnology is provided and discussed in the light of the recent literature. PMID:24602262

  10. The impact of plant biotechnology on food allergy.

    Science.gov (United States)

    Herman, Eliot M; Burks, A Wesley

    2011-04-01

    Concerns about food allergy and its societal growth are intertwined with the growing advances in plant biotechnology. The knowledge of plant genes and protein structures provides the key foundation to understanding biochemical processes that produce food allergy. Biotechnology offers the prospect of producing low-allergen or allergen null plants that could mitigate the allergic response. Modified low-IgE binding variants of allergens could be used as a vaccine to build immunotolerance in sensitive individuals. The potential to introduce new allergens into the food supply by biotechnology products is a regulatory concern. Copyright © 2010 Elsevier Ltd. All rights reserved.

  11. Applications of radiations, radioisotopes and nuclear techniques in biotechnology

    International Nuclear Information System (INIS)

    Bhatia, C.R.

    1994-01-01

    Applications of radiations, radioisotopes and other nuclear techniques has contributed a great deal in our understanding of microbial plant and animal biochemistry and molecular biology. Electron microscopy has provided visual evidence for molecular events. Developments in cell tissue culture of both plants and animals and immunology have contributed to advances in what we now refer as biotechnology. This paper focuses on the applications in the high-tech end of biotechnology, limited to the use of recombinant-DNA techniques. Molecular identification of the genes, their cloning and horizontal transfer across the species of microbes, plants and animals and expression of the transferred genes is the major strength of modern biotechnology. The techniques described in this paper have played a significant role in the development of biotechnology. 6 refs

  12. Biotechnology--Biotechnical Systems.

    Science.gov (United States)

    Ruggles, Stanford

    1990-01-01

    The perspective of biotechnology and its development in the K-12 technology education curriculum are described. The content curriculum development and implications for activities are discussed. The difference between a curriculum focused on the activities of industry compared to one that addresses technology as it pervades all human endeavors is…

  13. Harnessing the Potential of Additive Manufacturing

    Science.gov (United States)

    2016-12-01

    31 Defense AT&L: November-December 2016 Harnessing the Potential of Additive Manufacturing Bill Decker Decker is director of Technology...achieve its goal of competition throughout the acquisition life cycle. When we look at additive manufacturing , we have a much different environment. To...Titanium-6 Aluminum-4 Vanadium with Powder Bed Fusion. This specification covers additively manufactured titanium-6 aluminum-4 vanadium (Ti-6Al-4V

  14. [Biotechnological aspects in "loco" larvae].

    Science.gov (United States)

    Inestrosa, N C; Labarca, R; Perelman, A; Campos, E O; Araneda, R; González, M; Brandan, E; Sánchez, J P; González-Plaza, R

    1990-10-01

    The biology of planktotrophic larvae of Concholepas concholepas is the main bottleneck towards developing biotechnologies to rear this muricid. Data concerning planktonic larvae development, diets and environmental signals triggering larval settlement and recruitment is scarce. We have begun the study of the molecular and cell biology of embryos, larvae and recruits having as a final goal, the development of appropriate biotechnologies to rear this gastropod. First, an inverse ratio between BuChE and AChE enzyme activities was established. This ratio may be a precise developmental marker for this species. Second, for the first time a phosphoinositide related regulatory pathway is reported in a muricid, opening a new approach to the biotechnological management of larvae. Third, the relation between sulfate in sea water and larval motility was studied. Concentrations below 125 microM sulfate decreases larval motility. The sulfate is incorporated in proteoglycans which participate in different developmental phenomena. Lastly, a genomic Concholepas concholepas DNA sequence, similar to that of a human growth hormone probe was detected. This is very interesting since growth factors are key molecules during development, growth and are involved in food conversion rates in fish and also, in a variety of marine invertebrates.

  15. Harnessing indigenous knowledge for sustainable forest management in Ghana

    Directory of Open Access Journals (Sweden)

    Margaret Sraku-Lartey

    2015-01-01

    Full Text Available This paper makes a case for harnessing indigenous knowledge (IK for sustainable national development in Ghana. IK according to the World Bank is the basic component of any country’s knowledge system and it is upon this knowledge that scientific research builds. In Ghana the Government has recognized the need to harness IK for sustainable national development and has therefore incorporated it into the National Science, Technology and Innovation Development Programme. But there is no evidence however that scientific research in Ghana actually takes IK into consideration during the research process. This paper discusses the concept of indigenous knowledge, its relevance in scientific discourse and the need for harnessing it for national development in Ghana. A desk study was conducted using journal publications, research and technical reports, online databases and the internet. About sixty articles were analysed using the thematic synthesis method under the following broad headings: Importance of Indigenous knowledge, Indigenous forest foods, Indigenous medicines, IK and food security, the management and processing of IK and the protection of Indigenous Knowledge.The results of the study established the need to document the local knowledge using appropriate procedures and strategies. It also concludes by suggesting that IK in Ghana must be protected by law and integrated into formal science.

  16. Dendritic platforms for biomimicry and biotechnological applications.

    Science.gov (United States)

    Nagpal, Kalpana; Mohan, Anand; Thakur, Sourav; Kumar, Pradeep

    2018-02-15

    Dendrimers, commonly referred to as polymeric trees, offer endless opportunities for biotechnological and biomedical applications. By controlling the type, length, and molecular weight of the core, branches and end groups, respectively, the chemical functionality and topology of dendrimeric archetypes can be customized which further can be applied to achieve required solubility, biodegradability, diagnosis and other applications. Given the physicochemical variability of the dendrimers and their hybrids, this review attempts to discuss a full spectrum of recent advances and strides made by these "perfectly designed structures". An extensive biotech/biomimicry application profiling of dendrimers is provided with focus on complex archetypical designs such as protein biomimicry (angiogenic inhibitors, regenerative hydroxyapatite and collagen) and biotechnology applications. In terms of biotechnological advances, dendrimers have provided distinctive advantages in the fields of biocatalysis, microbicides, artificial lights, mitochondrial function modulation, vaccines, tissue regeneration and repair, antigen carriers and even biosensors. In addition, this review provides overview of the extensive chemo-functionalization opportunities available with dendrimers which makes them a perfect candidate for forming drug conjugates, protein hybrids, bio mimics, lipidic derivatives, metal deposits and nanoconjugates thereby making them the most multifunctional platforms for diverse biotechnological applications.

  17. Organisation of biotechnological information into knowledge.

    Science.gov (United States)

    Boh, B

    1996-09-01

    The success of biotechnological research, development and marketing depends to a large extent on the international transfer of information and on the ability to organise biotechnology information into knowledge. To increase the efficiency of information-based approaches, an information strategy has been developed and consists of the following stages: definition of the problem, its structure and sub-problems; acquisition of data by targeted processing of computer-supported bibliographic, numeric, textual and graphic databases; analysis of data and building of specialized in-house information systems; information processing for structuring data into systems, recognition of trends and patterns of knowledge, particularly by information synthesis using the concept of information density; design of research hypotheses; testing hypotheses in the laboratory and/or pilot plant; repeated evaluation and optimization of hypotheses by information methods and testing them by further laboratory work. The information approaches are illustrated by examples from the university-industry joint projects in biotechnology, biochemistry and agriculture.

  18. Patenting Biotechnological Inventions in Europe

    Directory of Open Access Journals (Sweden)

    Peter Raspor

    2002-01-01

    Full Text Available The patent system has been able to provide the protection for the achievements of different technologies and in that way it has supported further development and growth of the industry where those achievements were implemented. Modern technologies like information technology and biotechnology with genetic engineering that appeared in the 70s have overgrown the frames of the existing patent system because of their exponential development during the last thirty years. Industry that invests a huge amount of money in these technologies, especially in the field of biotechnology, where the results are very uncertain, has started to claim changes in the patent system.

  19. Management in biophotonics and biotechnologies

    Science.gov (United States)

    Meglinski, I. V.; Tuchin, V. V.

    2005-10-01

    Biophotonics, one of the most exciting and rapidly growing areas, offers vast potential for changing traditional approaches to meeting many critical needs in medicine, biology, pharmacy, food, health care and cosmetic industries. Follow the market trends we developed new MSc course Management in Biophotonics and Biotechnologies (MBB) that provide students of technical disciplines with the necessary training, education and problem-solving skills to produce professionals and managers who are better equipped to handle the challenges of modern science and business in biophotonics and biotechnology. A major advantage of the course is that it provides skills not currently available to graduates in other Master programs.

  20. Medicinalindustrien har brug for diagnoser som ADHD

    DEFF Research Database (Denmark)

    Fugl, Marie

    2008-01-01

    Det er ikke første gang, at medicinalindustriens evne til at finde nye markeder har medført nye eller bredere diagnoser. I det forrige årti så vi et parallelt forløb mellem et boom i antallet af depressionsdiagnoser og forbruget af lykkepiller. Interview med sociolog Thomas Brante. Udgivelsesdato...

  1. Plant biotechnology for food security and bioeconomy.

    Science.gov (United States)

    Clarke, Jihong Liu; Zhang, Peng

    2013-09-01

    This year is a special year for plant biotechnology. It was 30 years ago, on January 18 1983, one of the most important dates in the history of plant biotechnology, that three independent groups described Agrobacterium tumefaciens-mediated genetic transformation at the Miami Winter Symposium, leading to the production of normal, fertile transgenic plants (Bevan et al. in Nature 304:184-187, 1983; Fraley et al. in Proc Natl Acad Sci USA 80:4803-4807, 1983; Herrera-Estrella et al. in EMBO J 2:987-995, 1983; Vasil in Plant Cell Rep 27:1432-1440, 2008). Since then, plant biotechnology has rapidly advanced into a useful and valuable tool and has made a significant impact on crop production, development of a biotech industry and the bio-based economy worldwide.

  2. Advanced health biotechnologies in Thailand: redefining policy directions.

    Science.gov (United States)

    Velasco, Román Pérez; Chaikledkaew, Usa; Myint, Chaw Yin; Khampang, Roongnapa; Tantivess, Sripen; Teerawattananon, Yot

    2013-01-02

    Thailand faces a significant burden in terms of treating and managing degenerative and chronic diseases. Moreover, incidences of rare diseases are rising. Many of these-such as diabetes, cancer, and inherited inborn metabolic diseases-have no definite treatments or cure. Meanwhile, advanced health biotechnology has been found, in principle, to be an effective solution for these health problems. Qualitative approaches were employed to analyse the current situation and examine existing public policies related to advanced health biotechnologies in Thailand. The results of this analysis were then used to formulate policy recommendations. Our research revealed that the system in Thailand in relation to advanced health biotechnologies is fragmented, with multiple unaddressed gaps, underfunding of research and development (R&D), and a lack of incentives for the private sector. In addition, there are no clear definitions of advanced health biotechnologies, and coverage pathways are absent. Meanwhile, false advertising and misinformation are prevalent, with no responsible bodies to actively and effectively provide appropriate information and education (I&E). The establishment of a specialised institution to fill the gaps in this area is warranted. The development and implementation of a comprehensive national strategic plan related to advanced health biotechnologies, greater investment in R&D and I&E for all stakeholders, collaboration among agencies, harmonisation of reimbursement across public health schemes, and provision of targeted I&E are specifically recommended.

  3. Intellectual property rights and gene-based technologies for animal production and health. Issues for developing countries

    International Nuclear Information System (INIS)

    Dutfield, G.

    2005-01-01

    Intellectual property rights (IPR) are legal and institutional devices to protect creations of the mind. With respect to gene-based innovation, the most significant IPR is patents. Appropriate patent regimes have the potential to foster innovation in animal biotechnology and the transfer of gene-based technologies. Inappropriate patent systems may be counter-productive. Indeed, many critics are doubtful that the current international patent standards, based as they are on a combination of the United States of America' and European regimes, can help countries that lack the capacity to do much life science and biotechnology research to become more innovative o r contribute to the acquisition, absorption and, where desirable, the adaptation of new gene-based technologies from outside. Present legislation in Europe, North America and internationally is considered, together with the controversies and important policy questions for developing countries, and the choices facing countries seeking to enhance their scientific and technological capacities in these areas. (author)

  4. Biotechnology for renewable chemicals

    DEFF Research Database (Denmark)

    Borodina, Irina; Kildegaard, Kanchana Rueksomtawin; Jensen, Niels Bjerg

    2014-01-01

    The majority of the industrial organic chemicals are derived from fossil sources. With the oil and gas resources becoming limiting, biotechnology offers a sustainable alternative for production ofchemicals from renewable feedstocks. Yeast is an attractive cell factory forsustainable production...

  5. The present status and perspectives of Biotechnology in Cameroon ...

    African Journals Online (AJOL)

    ... for the rapid exploitation of biotechnology for the socioeconomic development of Cameroon, subject to the mobilization of the necessary venture capital. Keywords: Cameroon, Biotechnology, GMO, Biodiversity, Economic Development, Recombinant DNA JOURNAL OF THE CAMEROON ACADEMY OF SCIENCES Vol.

  6. Biotechnology awareness study, Part 2: Meeting the information needs of biotechnologists.

    Science.gov (United States)

    Cunningham, D; Grefsheim, S; Simon, M; Lansing, P S

    1991-01-01

    The second part of the biotechnology awareness study focused on health sciences libraries and how well they are meeting the needs of biotechnologists working in the study's nine medical centers. A survey was conducted over a three-month period to assess the demand for biotechnology-related reference services at nine libraries and the sources the librarians used to answer the questions. Data on monographic and current serial holdings were also collected. At the end of the survey period, librarians were asked for their perceptions about biotechnology research at their institutions and in their geographic areas. Their responses were compared to the responses the scientists at the nine schools gave to the same or similar questions. Results showed few biotechnology-related reference questions were asked of the librarians. The recorded questions dealt with a range of biotechnology subjects. MEDLINE was used to answer 77% of the questions received during the survey period. More detailed notes in MeSH and a guide to online searching for biotechnology topics were suggested by the librarians as ways to improve reference service to this group of researchers. Journal collections were generally strong, with libraries owning from 50% to 87% of the titles on a core list of biotechnology journals compiled for this study. All libraries subscribed to the five titles most often cited by the scientists surveyed. Generally, librarians were unaware of the biotechnology-related research being done on their campuses or in their geographic areas. PMID:1998819

  7. Religious voices in biotechnology: the case of gene patenting.

    Science.gov (United States)

    Hanson, M J

    1999-01-01

    On 18 May 1995, nearly 200 religious leaders joined with leading biotechnology critic Jeremy Rifkin in a press conference named the "Joint Appeal against Human and Animal Patenting," a move that many within the biotechnology industry could only interpret as seeking to inhibit biotechnological advance. What moral and religious concerns motivated this challenge to patenting? How could the biotechnology industry understand and respectfully attend to these concerns? What values were at play in the debates that followed the joint appeal? What lessons for future dialogue can be learned from attempts at conversation between the opposing positions? This essay is a report from a Hastings Center research project that accepted the task of addressing these questions. Specifically, the project focused on the patenting of human genetic material, a subset of the issues raised by the joint appeal.

  8. PLANT BIOTECHNOLOGY IN THE 21ST CENTURY: THE CHALLENGES AHEAD

    OpenAIRE

    Altman, Arie

    1999-01-01

    In a world where population growth is outstripping food supply agricultural -and especially plant-biotechnology, needs to be swiftly implemented in all walks of life. Achievements today in plant biotechnology have already surpassed all previous expectations, and the future is even more promising. The full realisation of the agricultural biotechnology revolution depends on both continued successful and innovative research and development activities and on a favourable regulatory climate and pu...

  9. Biotechnological Applications of Microbial (Per)chlorate Reduction.

    Science.gov (United States)

    Wang, Ouwei; Coates, John D

    2017-11-24

    While the microbial degradation of a chloroxyanion-based herbicide was first observed nearly ninety years ago, only recently have researchers elucidated the underlying mechanisms of perchlorate and chlorate [collectively, (per)chlorate] respiration. Although the obvious application of these metabolisms lies in the bioremediation and attenuation of (per)chlorate in contaminated environments, a diversity of alternative and innovative biotechnological applications has been proposed based on the unique metabolic abilities of dissimilatory (per)chlorate-reducing bacteria (DPRB). This is fueled in part by the unique ability of these organisms to generate molecular oxygen as a transient intermediate of the central pathway of (per)chlorate respiration. This ability, along with other novel aspects of the metabolism, have resulted in a wide and disparate range of potential biotechnological applications being proposed, including enzymatic perchlorate detection; gas gangrene therapy; enhanced xenobiotic bioremediation; oil reservoir bio-souring control; chemostat hygiene control; aeration enhancement in industrial bioreactors; and, biogenic oxygen production for planetary exploration. While previous reviews focus on the fundamental science of microbial (per)chlorate reduction (for example see Youngblut et al., 2016), here, we provide an overview of the emerging biotechnological applications of (per)chlorate respiration and the underlying organisms and enzymes to environmental and biotechnological industries.

  10. Strategic Partnerships and Open Innovation in the Biotechnology Industry in Belgium

    Directory of Open Access Journals (Sweden)

    Jean-Pierre Segers

    2013-04-01

    Full Text Available Strategic partnerships in the biotechnology industry allow new technology-based firms to gain a foothold in this high-cost, high-risk industry. In this article, we examine the impact of strategic partnerships and open innovation on the success of new biotechnology firms in Belgium by developing multiple case studies of firms in regional biotechnology clusters. We find that, despite their small size and relative immaturity, new biotechnology firms are able to adopt innovative business models by providing R&D and services to larger firms and openly cooperating with them through open innovation.

  11. Tosprogede har en trumf i ærmet

    DEFF Research Database (Denmark)

    Henriksen, Carsten

    2010-01-01

    Solstrålehistorier om afghanske superstudenter ændrer ikke ved det faktum, at tosprogede børns faglige niveau halter bagefter deres danske klassekammeraters. Vi har brug for at skrue op for den pædagogiske målrettethed og ned for skrækken for andre sprog, hvis vi skal rette op på skævheden, mener...

  12. Multidimensional Analysis of High-School Students' Perceptions about Biotechnology

    Science.gov (United States)

    Fonseca, Maria Joao; Costa, Patricio; Lencastre, Leonor; Tavares, Fernando

    2012-01-01

    Concerns about public understanding of biotechnology have motivated educational initiatives to improve students' competency to make scientifically sustained decisions regarding controversial issues. Understanding students' perceptions about biotechnology is essential to determine the effectiveness of these programmes. To assess how students'…

  13. Biotechnology Commercialization Strategies: Risk and Return in interfirm cooperation.

    NARCIS (Netherlands)

    Fernald, K.D.S.; Pennings, e; Claassen, E.

    2014-01-01

    The management and exploitation of biotechnological product innovation have proven to be more difficult than initially expected because the number of currently marketed biotechnological products is far from sufficient to counter deficits in pharmaceutical innovation. This study provides insight into

  14. Biotechnology Commercialization Strategies: Risk and Return in Interfirm Cooperation

    NARCIS (Netherlands)

    Fernald, K.D.S.; Pennings, H.P.G.; Claassen, E.

    2015-01-01

    The management and exploitation of biotechnological product innovation have proven to be more difficult than initially expected because the number of currently marketed biotechnological products is far from sufficient to counter deficits in pharmaceutical innovation. This study provides insight into

  15. Proteomics: a biotechnology tool for crop improvement

    OpenAIRE

    Eldakak, Moustafa; Milad, Sanaa I. M.; Nawar, Ali I.; Rohila, Jai S.

    2013-01-01

    A sharp decline in the availability of arable land and sufficient supply of irrigation water along with a continuous steep increase in food demands have exerted a pressure on farmers to produce more with fewer resources. A viable solution to release this pressure is to speed up the plant breeding process by employing biotechnology in breeding programs. The majority of biotechnological applications rely on information generated from various -omic technologies. The latest outstanding improve...

  16. Comprehensive biotechnology education and rural economic development

    OpenAIRE

    Holmes, L.; Brooks, J.

    2006-01-01

    North Carolina is home to the third largest biotechnology industry in the United States. With over 200 companies involved in manufacturing, research, testing or services and growing at a rate of 12 % per year, this North Carolina industry is aggressively expanding its biotechnology efforts in all domains: pharmaceuticals, agriculture, environment, foods and energy. The North Carolina Department of Commerce along with other state and regional entities are developing strategies to attract new c...

  17. Harness: Development of a multifunctional protective ship bulkhead

    NARCIS (Netherlands)

    Wal, R. van der; Meuers, R.J.C.

    2016-01-01

    HARNESS is a joint project between governments, industry and TNO with the objective to develop a multifunctional protective bulkhead for application on naval vessels. The multifunctional bulkhead aims at increasing the resilience of naval vessels, reduce damage and repair time and provide a safer

  18. Independent Biotechnology: The Innovation-Regulation Dilemma

    Energy Technology Data Exchange (ETDEWEB)

    Althouse, P. [Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States); Prosnitz, D. [Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States); Velsko, S. [Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)

    2016-11-03

    The Center for Global Security Research at Lawrence Livermore National Laboratory convened a workshop on August 19, 2016 to consider “Independent Biotechnology: The Innovation-­Regulation Dilemma”. The topic was motivated by the observation that non-­government funded biotechnology research and development activities have grown and diversified tremendously over the past decade. This sector encompasses a broad range of actors and activities: individuals with private laboratories, community “hackerspaces,” biotechnology incubators, and individual startups. Motivations and aspirations are diverse and include such things as personal curiosity, community education, the invention of new products or services, and even the realization of certain economic, political, or social goals. One driving force is the “democratization” of ever more powerful biological technologies, allowing individual citizens and groups access to capabilities that have traditionally only been available to researchers in universities, research institutes, national laboratories, and large commercial concerns. Another is the rise of alternative financing mechanisms such as “crowdsourcing,” which ostensibly provide greater freedom to innovate, and greater public visibility, but entail looser management oversight and transparency.

  19. Of Apples and Animals: An Introduction to Biotechnology.

    Science.gov (United States)

    Mourad, Teresa M.; And Others

    This guide is designed to foster an understanding of the basic concepts underlying biotechnology through simple activities that are fun and creative for students in grades 3-5. It contains four units that will lead young students to an appreciation of how biotechnology is possible and some of its applications. The process of learning is intended…

  20. Ethnophytotechnology: Harnessing the Power of Ethnobotany with Biotechnology.

    Science.gov (United States)

    de la Parra, John; Quave, Cassandra L

    2017-09-01

    Ethnobotany (the scientific study of traditional plant knowledge) has aided the discovery of important medicines. However, as single-molecule drugs or synergistic mixtures, these remedies have faced obstacles in production and analysis. Now, advances in bioreactor technology, metabolic engineering, and analytical instrumentation are improving the production, manipulation, and scientific understanding of such remedies. Copyright © 2017 Elsevier Ltd. All rights reserved.

  1. Biotechnology as a competitive edge for the Finnish forest cluster

    OpenAIRE

    Hakala, Terhi

    2007-01-01

    In this study we have collected information by interviewing all identified parties within the Finnish forest sector who might have a potential biotechnology connection : university research groups, research institutions, small and medium-sized biotechnology-companies and up to the largest forest companies. The ultimate goal was to assess how resources have been allocated and biotechnologies utilized within the value chain of the entire forest sector. This study aimed at providing answers to t...

  2. Biotechnology as a Competitive Edge for the Finnish Forest Cluster

    OpenAIRE

    Hakala, Terhi; Haltia, Olli; Hermans, Raine; Kulvik, Martti; Nikinmaa, Hanna; Porcar-Castell, Albert; Pursula, Tiina

    2007-01-01

    In this study we have collected information by interviewing all identified parties within the Finnish forest sector who might have a potential biotechnology connection : university research groups, research institutions, small and medium-sized biotechnology-companies and up to the largest forest companies. The ultimate goal was to assess how resources have been allocated and biotechnologies utilized within the value chain of the entire forest sector. This study aimed at providing answers to t...

  3. TSCA Biotechnology Notifications Status

    Science.gov (United States)

    This Notifications Table lists only those submissions received under the Biotechnology Regulation, beginning in 1998. From the Table, you can link to a brief summary of select submission and, in many cases, to a fact sheet on the decision reached by OPPT.

  4. Advanced health biotechnologies in Thailand: redefining policy directions

    Directory of Open Access Journals (Sweden)

    Velasco Román Pérez

    2013-01-01

    Full Text Available Abstract Background Thailand faces a significant burden in terms of treating and managing degenerative and chronic diseases. Moreover, incidences of rare diseases are rising. Many of these—such as diabetes, cancer, and inherited inborn metabolic diseases—have no definite treatments or cure. Meanwhile, advanced health biotechnology has been found, in principle, to be an effective solution for these health problems. Methods Qualitative approaches were employed to analyse the current situation and examine existing public policies related to advanced health biotechnologies in Thailand. The results of this analysis were then used to formulate policy recommendations. Results Our research revealed that the system in Thailand in relation to advanced health biotechnologies is fragmented, with multiple unaddressed gaps, underfunding of research and development (R&D, and a lack of incentives for the private sector. In addition, there are no clear definitions of advanced health biotechnologies, and coverage pathways are absent. Meanwhile, false advertising and misinformation are prevalent, with no responsible bodies to actively and effectively provide appropriate information and education (I&E. The establishment of a specialised institution to fill the gaps in this area is warranted. Conclusion The development and implementation of a comprehensive national strategic plan related to advanced health biotechnologies, greater investment in R&D and I&E for all stakeholders, collaboration among agencies, harmonisation of reimbursement across public health schemes, and provision of targeted I&E are specifically recommended.

  5. Emerging Agricultural Biotechnologies for Sustainable Agriculture and Food Security.

    Science.gov (United States)

    Anderson, Jennifer A; Gipmans, Martijn; Hurst, Susan; Layton, Raymond; Nehra, Narender; Pickett, John; Shah, Dilip M; Souza, Thiago Lívio P O; Tripathi, Leena

    2016-01-20

    As global populations continue to increase, agricultural productivity will be challenged to keep pace without overtaxing important environmental resources. A dynamic and integrated approach will be required to solve global food insecurity and position agriculture on a trajectory toward sustainability. Genetically modified (GM) crops enhanced through modern biotechnology represent an important set of tools that can promote sustainable agriculture and improve food security. Several emerging biotechnology approaches were discussed in a recent symposium organized at the 13th IUPAC International Congress of Pesticide Chemistry meeting in San Francisco, CA, USA. This paper summarizes the innovative research and several of the new and emerging technologies within the field of agricultural biotechnology that were presented during the symposium. This discussion highlights how agricultural biotechnology fits within the context of sustainable agriculture and improved food security and can be used in support of further development and adoption of beneficial GM crops.

  6. BIOTECHNOLOGIES OF MEAT PRODUCTS MANUFACTURE. CURRENT STATE

    OpenAIRE

    Bal-Prilipko L. V.; Leonova B. I.

    2014-01-01

    The analysis of literature and patents related to the possibilities of biotechnology for optimizing the domestic meat processing plants was the aim of the article. The analysis of the results of the use of biotechnological methods in the meat processing industry is given. The prospects for their implementation are evaluated. The main development strategy of technological meat processing to develop the methods of obtaining high quality and safe meat products is highlighted. Targeted use of spe...

  7. BIOTECHNOLOGICAL ASPECTS ANALYSIS OF AGRICULTURAL POULTRY MICROFLORA

    OpenAIRE

    Garda S. A.; S. G. Danilenko; G. S. Litvinov

    2014-01-01

    Probiotics based on normal microflora of the birds using perspective strains become increasingly popular for treatment and prophylaxis of dysbacteriosis in poultry. The purpose of the work is the biotechnological data analysis of the composition and functions of the microflora of different birds’ biotopes. One of biotechnological methods for the study of bacterial flora in the birds is a method of in vivo bacteriological control — analysis of group samples of fresh droppings. To study bir...

  8. Outer Limits of Biotechnologies: A Jewish Perspective

    Directory of Open Access Journals (Sweden)

    John D. Loike

    2018-01-01

    Full Text Available A great deal of biomedical research focuses on new biotechnologies such as gene editing, stem cell biology, and reproductive medicine, which have created a scientific revolution. While the potential medical benefits of this research may be far-reaching, ethical issues related to non-medical applications of these technologies are demanding. We analyze, from a Jewish legal perspective, some of the ethical conundrums that society faces in pushing the outer limits in researching these new biotechnologies.

  9. Uncovering Listeria monocytogenes hypervirulence by harnessing its biodiversity

    Science.gov (United States)

    Charlier, Caroline; Touchon, Marie; Chenal-Francisque, Viviane; Leclercq, Alexandre; Criscuolo, Alexis; Gaultier, Charlotte; Roussel, Sophie; Brisabois, Anne; Disson, Olivier; Rocha, Eduardo P. C.; Brisse, Sylvain; Lecuit, Marc

    2016-01-01

    Microbial pathogenesis studies are typically performed with reference strains, thereby overlooking microbial intra-species virulence heterogeneity. Here we integrated human epidemiological and clinical data with bacterial population genomics to harness the biodiversity of the model foodborne pathogen Listeria monocytogenes and decipher the basis of its neural and placental tropisms. Taking advantage of the clonal structure of this bacterial species, we identify clones epidemiologically associated with either food or human central nervous system (CNS) and maternal-neonatal (MN) listeriosis. The latter are also most prevalent in patients without immunosuppressive comorbidities. Strikingly, CNS and MN clones are hypervirulent in a humanized mouse model of listeriosis. By integrating epidemiological data and comparative genomics, we uncovered multiple novel putative virulence factors and demonstrated experimentally the contribution of the first gene cluster mediating Listeria monocytogenes neural and placental tropisms. This study illustrates the exceptional power of harnessing microbial biodiversity to identify clinically relevant microbial virulence attributes. PMID:26829754

  10. Application of biotechnology for the domestication of Dacryodes edulis

    African Journals Online (AJOL)

    Biotechnology applications give a scope for rapid improvement and also facilitate the breeding program. Advantages of biotechnology application using molecular markers in breeding programs includes: study of genetic diversity, DNA fingerprinting of individuals, easy identification of specific traits or genes of interest, rapid ...

  11.   Biotechnology in Danish forestry - Christmas trees and Biofuels

    DEFF Research Database (Denmark)

    Find, Jens

    for development of additional biotechnological breeding technologies as e.g. genetic transformation, and because SE allows for storage of elite germ plasm over extended periods in liquid nitrogen. The combination of SE and other biotechnological breeding tools permit for relative fast and market oriented breeding...

  12. Advances in biomedical engineering and biotechnology during 2013-2014.

    Science.gov (United States)

    Liu, Feng; Wang, Ying; Burkhart, Timothy A; González Penedo, Manuel Francisco; Ma, Shaodong

    2014-01-01

    The 3rd International Conference on Biomedical Engineering and Biotechnology (iCBEB 2014), held in Beijing from the 25th to the 28th of September 2014, is an annual conference that intends to provide an opportunity for researchers and practitioners around the world to present the most recent advances and future challenges in the fields of biomedical engineering, biomaterials, bioinformatics and computational biology, biomedical imaging and signal processing, biomechanical engineering and biotechnology, amongst others. The papers published in this issue are selected from this conference, which witnesses the advances in biomedical engineering and biotechnology during 2013-2014.

  13. Biotechnology in weed control

    Science.gov (United States)

    Biotechnology can be used to enhance the management of weeds in several ways. Crops have been made resistant to herbicides by inserting transgenes that impart herbicide resistance into the plant genome. Glyphosate and glufosinate-resistant crops are commercialized in North America and crops made res...

  14. MHSS 2020 Focused Study on Biotechnology & Nanotechnology, 29 July 1997

    National Research Council Canada - National Science Library

    1998-01-01

    .... This focused study on biotechnology and nanotechnology has two primary goals: (1) examine the future strategic impact of biotechnology and nanotechnology as it relates to the military health system, and (2...

  15. Biodiesel production by microalgal biotechnology

    Energy Technology Data Exchange (ETDEWEB)

    Huang, GuanHua [School of Chemical Engineering and Technology, China University of Mining and Technology (China); Chen, Feng [School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong (China); College of Light Industry and Food Sciences, South China University of Technology, Guangzhou (China); Wei, Dong; Zhang, XueWu; Chen, Gu [College of Light Industry and Food Sciences, South China University of Technology, Guangzhou (China)

    2010-01-15

    Biodiesel has received much attention in recent years. Although numerous reports are available on the production of biodiesel from vegetable oils of terraneous oil-plants, such as soybean, sunflower and palm oils, the production of biodiesel from microalgae is a newly emerging field. Microalgal biotechnology appears to possess high potential for biodiesel production because a significant increase in lipid content of microalgae is now possible through heterotrophic cultivation and genetic engineering approaches. This paper provides an overview of the technologies in the production of biodiesel from microalgae, including the various modes of cultivation for the production of oil-rich microalgal biomass, as well as the subsequent downstream processing for biodiesel production. The advances and prospects of using microalgal biotechnology for biodiesel production are discussed. (author)

  16. [Importance of reproductive biotechnology in cattle in Europe].

    Science.gov (United States)

    Wrenzycki, C; Stinshoff, H

    2015-01-01

    Reproductive biotechnology has manifold applications and includes a great innovation potential in livestock. Due to the global changes the new findings and techniques can aid to meet the future challenges. The use of biotechnology in animal production can guarantee enough high quality food for the whole population. Genetic resources of animals can be preserved via sperm and embryo banking. Early diagnosis of hereditary defects, generation of offspring with predetermined sex and the avoidance of animal transports for breeding employing shipment of frozen embryos will improve animal welfare. A special application is the use of animal models for human assisted reproductive technologies. Therefore, not only in Germany research related to the methodologies in reproductive biotechnology and their improvement need to be supported.

  17. A review on plant importance, biotechnological aspects, and cultivation challenges of jojoba plant.

    Science.gov (United States)

    Al-Obaidi, Jameel R; Halabi, Mohammed Farouq; AlKhalifah, Nasser S; Asanar, Shanavaskhan; Al-Soqeer, Abdulrahman A; Attia, M F

    2017-08-24

    Jojoba is considered a promising oil crop and is cultivated for diverse purposes in many countries. The jojoba seed produces unique high-quality oil with a wide range of applications such as medical and industrial-related products. The plant also has potential value in combatting desertification and land degradation in dry and semi-dry areas. Although the plant is known for its high-temperature and high-salinity tolerance growth ability, issues such as its male-biased ratio, relatively late flowering and seed production time hamper the cultivation of this plant. The development of efficient biotechnological platforms for better cultivation and an improved production cycle is a necessity for farmers cultivating the plant. In the last 20 years, many efforts have been made for in vitro cultivation of jojoba by applying different molecular biology techniques. However, there is a lot of work to be done in order to reach satisfactory results that help to overcome cultivation problems. This review presents a historical overview, the medical and industrial importance of the jojoba plant, agronomy aspects and nutrient requirements for the plant's cultivation, and the role of recent biotechnology and molecular biology findings in jojoba research.

  18. A review on plant importance, biotechnological aspects, and cultivation challenges of jojoba plant

    Directory of Open Access Journals (Sweden)

    Jameel R. Al-Obaidi

    2017-10-01

    Full Text Available Abstract Jojoba is considered a promising oil crop and is cultivated for diverse purposes in many countries. The jojoba seed produces unique high-quality oil with a wide range of applications such as medical and industrial-related products. The plant also has potential value in combatting desertification and land degradation in dry and semi-dry areas. Although the plant is known for its high-temperature and high-salinity tolerance growth ability, issues such as its male-biased ratio, relatively late flowering and seed production time hamper the cultivation of this plant. The development of efficient biotechnological platforms for better cultivation and an improved production cycle is a necessity for farmers cultivating the plant. In the last 20 years, many efforts have been made for in vitro cultivation of jojoba by applying different molecular biology techniques. However, there is a lot of work to be done in order to reach satisfactory results that help to overcome cultivation problems. This review presents a historical overview, the medical and industrial importance of the jojoba plant, agronomy aspects and nutrient requirements for the plant’s cultivation, and the role of recent biotechnology and molecular biology findings in jojoba research.

  19. Mobilizing technology for developing countries

    Energy Technology Data Exchange (ETDEWEB)

    Weiss, C Jr

    1979-10-01

    Mr. Weiss says that the 15 years since the UN Conference on Science, Technology, and Development in Geneva have taught us that what seem at first to be technological obstacles to development frequently turn out on closer examination to have been policy failures; that introduction of technologies into developing countries must be accompanied by institutional and policy changes if the technologies are to benefit the countries. He points out that choice of alternative technology for a developing country should depend on careful overall assessment of local techno-economic, geographical, ecological, and social factors, as well as the desired balance between growth and equity. Such a technology assessment, a key element in the choice of appropriate (i.e., locally suitable) technology for particular investment projects, should be built into procedures for project preparation and appraisal in governments and development assistance agencies. Turning to technologists, Mr. Weiss says they face a double challenge: (1) to recognize potential for new efforts to harness science and technology for the benefit of the developing countries; and (2) by understanding the social, institutional, and economic framework into which an innovation is to operate, to ease its application and diffusion, and thus speed and increase its practical impact. 25 references.

  20. Sectoral innovation foresight. Biotechnology sector. Final Reeport. Task 2

    NARCIS (Netherlands)

    Valk, T. van der; Gijsbers, G.W.; Meis, M.

    2010-01-01

    Biotechnology has evolved from a single set of technologies in the mid 1970s (e.g. recombinant DNA technology) into the full grown economic activity of today. The set of technologies that constitute the field of biotechnology thus find their applications in different sectors, most notably in

  1. Biotechnology of trees: Chestnut

    Science.gov (United States)

    C.D. Nelson; W.A. Powell; S.A. Merkle; J.E. Carlson; F.V. Hebard; N Islam-Faridi; M.E. Staton; L. Georgi

    2014-01-01

    Biotechnology has been practiced on chestnuts (Castanea spp.) for many decades, including vegetative propagation, controlled crossing followed by testing and selection, genetic and cytogenetic mapping, genetic modifi cation, and gene and genome sequencing. Vegetative propagation methods have ranged from grafting and rooting to somatic embryogenesis, often in...

  2. Past, present, and future industrial biotechnology in China.

    Science.gov (United States)

    Li, Zhenjiang; Ji, Xiaojun; Kan, Suli; Qiao, Hongqun; Jiang, Min; Lu, Dingqiang; Wang, Jun; Huang, He; Jia, Honghua; Ouyuang, Pingkai; Ying, Hanjie

    2010-01-01

    Fossil resources, i.e. concentrated carbon from biomass, have been irrecoverably exhausted through modern industrial civilization in the last two hundred years. Serious consequences including crises in resources, environment and energy, as well as the pressing need for direct and indirect exploitation of solar energy, pose challenges to the science and technology community of today. Bioenergy, bulk chemicals, and biomaterials could be produced from renewable biomass in a biorefinery via biocatalysis. These sustainable industries will match the global mass cycle, creating a new form of civilization with new industries and agriculture driven by solar energy. Industrial biotechnology is the dynamo of a bioeconomy, leading to a new protocol for production of energy, bulk chemicals, and materials. This new mode of innovation will place the industry at center stage supported by universities and research institutes. Creativity in industrial biotechnology will be promoted and China will successfully follow the road to green modernization. China's rapid economic development and its traditional capacity in fermentation will place it in an advantageous position in the industrial biotechnology revolution. The development and current status of industrial biotechnology in China are summarized herein.

  3. Student Content Knowledge Increases after Participation in a Hands-on Biotechnology Intervention

    Science.gov (United States)

    Bigler, Amber M.; Hanegan, Nikki L.

    2011-01-01

    Implementing biotechnology education through hands-on teaching methods should be considered by secondary biology teachers. This study is an experimental research design to examine increased student content knowledge in biotechnology after a hands-on biotechnology intervention. The teachers from both school groups participated in, Project Crawfish,…

  4. Thirty years of European biotechnology programmes: from biomolecular engineering to the bioeconomy.

    Science.gov (United States)

    Aguilar, Alfredo; Magnien, Etienne; Thomas, Daniel

    2013-06-25

    This article traces back thirty years of biotechnology research sponsored by the European Union (EU). It outlines the crucial role played by De Nettancourt, Goffeau and Van Hoeck to promote and prepare the first European programme on biotechnology (1982-1986) run by the European Commission. Following this first biotechnology programme, others followed until the current one, part of the seventh Framework Programme for Research, Technological Development and Demonstration (2007-2013) (FP7). Particular attention is given to the statutory role of the European institutions in the design and orientation of the successive biotechnology programmes, compared to the more informal-yet visionary-role of key individuals upstream to any legislative decision. Examples of success stories and of the role of the biotechnology programmes in addressing societal issues and industrial competitiveness are also presented. Finally, an outline of Horizon 2020, the successor of FP7, is described, together with the role of biotechnology in building the bioeconomy. Copyright © 2012 Elsevier B.V. All rights reserved.

  5. What Ideas Do Students Associate with "Biotechnology" and "Genetic Engineering"?

    Science.gov (United States)

    Hill, Ruaraidh; Stanisstreet, Martin; Boyes, Edward

    2000-01-01

    Explores the ideas that students aged 16-19 associate with the terms 'biotechnology' and 'genetic engineering'. Indicates that some students see biotechnology as risky whereas genetic engineering was described as ethically wrong. (Author/ASK)

  6. Biotechnology Towards Energy Crops.

    Science.gov (United States)

    Margaritopoulou, Theoni; Roka, Loukia; Alexopoulou, Efi; Christou, Myrsini; Rigas, Stamatis; Haralampidis, Kosmas; Milioni, Dimitra

    2016-03-01

    New crops are gradually establishing along with cultivation systems to reduce reliance on depleting fossil fuel reserves and sustain better adaptation to climate change. These biological assets could be efficiently exploited as bioenergy feedstocks. Bioenergy crops are versatile renewable sources with the potential to alternatively contribute on a daily basis towards the coverage of modern society's energy demands. Biotechnology may facilitate the breeding of elite energy crop genotypes, better suited for bio-processing and subsequent use that will improve efficiency, further reduce costs, and enhance the environmental benefits of biofuels. Innovative molecular techniques may improve a broad range of important features including biomass yield, product quality and resistance to biotic factors like pests or microbial diseases or environmental cues such as drought, salinity, freezing injury or heat shock. The current review intends to assess the capacity of biotechnological applications to develop a beneficial bioenergy pipeline extending from feedstock development to sustainable biofuel production and provide examples of the current state of the art on future energy crops.

  7. Too New for Textbooks: The Biotechnology Discoveries & Applications Guidebook

    Science.gov (United States)

    Loftin, Madelene; Lamb, Neil E.

    2013-01-01

    The "Biotechnology Discoveries and Applications" guidebook aims to provide teachers with an overview of the recent advances in genetics and biotechnology, allowing them to share these findings with their students. The annual guidebook introduces a wealth of modern genomic discoveries and provides teachers with tools to integrate exciting…

  8. Agricultural Communications Students' Awareness and Perceptions of Biotechnology Issues.

    Science.gov (United States)

    Wingenbach, Gary J.; Rutherford, Tracy A.; Dunsford, Deborah W.

    2003-01-01

    Agricultural communications students (n=330) from 11 universities were most aware of biotechnology effects on food, less aware of effects on health and the environment. They were somewhat accepting of genetic modifications for plants, not humans. Sources of biotechnology knowledge were science classes, labs, and university professors' beliefs.…

  9. Western Australian High School Students' Attitudes towards Biotechnology Processes

    Science.gov (United States)

    Dawson, Vaille; Schibeci, Renato

    2003-01-01

    This study reports on the attitudes towards biotechnology of 905, 15-16 year-old students from 11 Western Australian schools. Students were asked to read 15 statements about biotechnology processes and to draw a line to separate what they considered "acceptable" statements from those they considered "unacceptable". Overall, the…

  10. Towards sustainable biotechnology innovation in Africa: The roles of stakeholders in local contexts

    OpenAIRE

    Roelofs, Caspar

    2015-01-01

    Aim To contribute to sustainable crop-biotechnology innovation in African contexts by operationalizing guiding concepts from Science, Technology and Society (STS) studies. Objectives To explore the roles of different stakeholders in crop-biotechnology innovation processes in Africa; To explore how local contexts shape crop-biotechnology differently; To explore how crop-biotechnology shapes different contexts differently; To make policy recommendations on stakeholder involvement in decision-ma...

  11. HARNESSING BIG DATA VOLUMES

    Directory of Open Access Journals (Sweden)

    Bogdan DINU

    2014-04-01

    Full Text Available Big Data can revolutionize humanity. Hidden within the huge amounts and variety of the data we are creating we may find information, facts, social insights and benchmarks that were once virtually impossible to find or were simply inexistent. Large volumes of data allow organizations to tap in real time the full potential of all the internal or external information they possess. Big data calls for quick decisions and innovative ways to assist customers and the society as a whole. Big data platforms and product portfolio will help customers harness to the full the value of big data volumes. This paper deals with technical and technological issues related to handling big data volumes in the Big Data environment.

  12. Biotechnology Computing: Information Science for the Era of Molecular Medicine.

    Science.gov (United States)

    Masys, Daniel R.

    1989-01-01

    The evolution from classical genetics to biotechnology, an area of research involving key macromolecules in living cells, is chronicled and the current state of biotechnology is described, noting related advances in computing and clinical medicine. (MSE)

  13. Review of biotechnology applications to nuclear waste treatment

    International Nuclear Information System (INIS)

    Ashley, N.V.; Roach, D.J.W.

    1990-01-01

    This paper gives an overview of the feasibility of the application of biotechnology to nuclear waste treatment. Many living and dead organisms accumulate heavy metals and radionuclides. The controlled use of this phenomenon forms the basis for the application of biotechnology to the removal of radionuclides from nuclear waste streams. An overview of biotechnology areas, namely the use of biopolymers and biosorption using biomass applicable to the removal of radionuclides from industrial nuclear effluents is given. The potential of biomagnetic separation technology, genetic engineering and monoclonal antibody technology is also to be examined. The most appropriate technologies to develop for radionuclide removal in the short term appear to be those based on biosorption of radionuclides by biomass and the use of modified and unmodified biopolymers in the medium term. (author)

  14. Microbial ecology to manage processes in environmental biotechnology.

    Science.gov (United States)

    Rittmann, Bruce E

    2006-06-01

    Microbial ecology and environmental biotechnology are inherently tied to each other. The concepts and tools of microbial ecology are the basis for managing processes in environmental biotechnology; and these processes provide interesting ecosystems to advance the concepts and tools of microbial ecology. Revolutionary advancements in molecular tools to understand the structure and function of microbial communities are bolstering the power of microbial ecology. A push from advances in modern materials along with a pull from a societal need to become more sustainable is enabling environmental biotechnology to create novel processes. How do these two fields work together? Five principles illuminate the way: (i) aim for big benefits; (ii) develop and apply more powerful tools to understand microbial communities; (iii) follow the electrons; (iv) retain slow-growing biomass; and (v) integrate, integrate, integrate.

  15. National Strategy for Modernizing the Regulatory System for Biotechnology Products

    Science.gov (United States)

    This National Strategy for Modernizing the Regulatory System for Biotechnology Products sets forth a vision for ensuring that the federal regulatory system is prepared to efficiently assess the risks, if any, of the future products of biotechnology.

  16. Microbial biotechnology addressing the plastic waste disaster.

    Science.gov (United States)

    Narancic, Tanja; O'Connor, Kevin E

    2017-09-01

    Oceans are a major source of biodiversity, they provide livelihood, and regulate the global ecosystem by absorbing heat and CO 2 . However, they are highly polluted with plastic waste. We are discussing here microbial biotechnology advances with the view to improve the start and the end of life of biodegradable polymers, which could contribute to the sustainable use of marine and coastal ecosystems (UN Sustainability development goal 14). © 2017 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.

  17. African Journal of Biotechnology: Submissions

    African Journals Online (AJOL)

    PROMOTING ACCESS TO AFRICAN RESEARCH ... The African Journal of Biotechnology (AJB) (ISSN 1684-5315) provides rapid publication of .... Authors may still request (in advance) that the editorial board waive some of the handling fee ...

  18. 75 FR 1749 - Syngenta Biotechnology, Inc.; Availability of Petition and Environmental Assessment for...

    Science.gov (United States)

    2010-01-13

    ...] Syngenta Biotechnology, Inc.; Availability of Petition and Environmental Assessment for Determination of... Health Inspection Service has received a petition from Syngenta Biotechnology, Inc., seeking a....gov ). FOR FURTHER INFORMATION CONTACT: Dr. Subray Hegde, Biotechnology Regulatory Services, APHIS...

  19. Workshop proceedings: challenges and opportunities in evaluating protein allergenicity across biotechnology industries.

    Science.gov (United States)

    Stagg, Nicola J; Ghantous, Hanan N; Ladics, Gregory S; House, Robert V; Gendel, Steven M; Hastings, Kenneth L

    2013-01-01

    A workshop entitled "Challenges and Opportunities in Evaluating Protein Allergenicity across Biotechnology Industries" was held at the 51st Annual Meeting of the Society of Toxicology (SOT) in San Francisco, California. The workshop was sponsored by the Biotechnology Specialty Section of SOT and was designed to present the science-based approaches used in biotechnology industries to evaluate and regulate protein allergenicity. A panel of experts from industry and government highlighted the allergenicity testing requirements and research in the agricultural, pharmaceutical/biopharma, and vaccine biotechnology industries and addressed challenges and opportunities for advancing the science of protein allergenicity. The main learning from the workshop was that immunoglobulin E-mediated allergenicity of biotechnology-derived products is difficult to assess without human data. The approaches currently being used to evaluate potential for allergenicity across biotechnology industries are very different and range from bioinformatics, in vitro serology, in vivo animal testing, in vitro and in vivo functional assays, and "biosimilar" assessments (ie, biotherapeutic equivalents to innovator products). The challenge remains with regard to the different or lack of regulatory requirements for allergenicity testing across industries, but the novel approaches being used with bioinformatics and biosimilars may lead to opportunities in the future to collaborate across biotechnology industries.

  20. Nuclear technology and biotechnology for enhancing agricultural production in Malaysia

    International Nuclear Information System (INIS)

    Mohamad Osman

    2005-04-01

    The presentation discussed the following subjects: sustainable development, agriculture in Malaysia, role of biotechnology, role of nuclear technology, improving crops through induced mutations with Malaysian experience in rice and roselle, fusion of nuclear and biotechnology challenges and opportunities

  1. Proteomics meets blue biotechnology: a wealth of novelties and opportunities.

    Science.gov (United States)

    Hartmann, Erica M; Durighello, Emie; Pible, Olivier; Nogales, Balbina; Beltrametti, Fabrizio; Bosch, Rafael; Christie-Oleza, Joseph A; Armengaud, Jean

    2014-10-01

    Blue biotechnology, in which aquatic environments provide the inspiration for various products such as food additives, aquaculture, biosensors, green chemistry, bioenergy, and pharmaceuticals, holds enormous promise. Large-scale efforts to sequence aquatic genomes and metagenomes, as well as campaigns to isolate new organisms and culture-based screenings, are helping to push the boundaries of known organisms. Mass spectrometry-based proteomics can complement 16S gene sequencing in the effort to discover new organisms of potential relevance to blue biotechnology by facilitating the rapid screening of microbial isolates and by providing in depth profiles of the proteomes and metaproteomes of marine organisms, both model cultivable isolates and, more recently, exotic non-cultivable species and communities. Proteomics has already contributed to blue biotechnology by identifying aquatic proteins with potential applications to food fermentation, the textile industry, and biomedical drug development. In this review, we discuss historical developments in blue biotechnology, the current limitations to the known marine biosphere, and the ways in which mass spectrometry can expand that knowledge. We further speculate about directions that research in blue biotechnology will take given current and near-future technological advancements in mass spectrometry. Copyright © 2014 Elsevier B.V. All rights reserved.

  2. Knowledge and Attitudes Towards Biotechnology of Elementary Education Preservice Teachers: The first Spanish experience

    Science.gov (United States)

    Casanoves, Marina; González, Ángel; Salvadó, Zoel; Haro, Juan; Novo, Maite

    2015-11-01

    Due to the important impact that biotechnology has on current Western societies, well-informed critical citizens are needed. People prepared to make conscious decisions about aspects of biotechnology that relate to their own lives. Teachers play a central role in all education systems. Thus, the biotechnological literacy of preservice teachers is an important consideration as they will become an influential collective as future teachers of the next generation of children. The attitudes toward science (and biotechnology) that teachers have affect their behavior and influence the way they implement their daily practice of science teaching in school. This study analyzes the attitudes and knowledge of Spanish preservice teachers toward biotechnology. We designed a new survey instrument that was completed by 407 university students who were taking official degree programs in preschool and primary education. Our results point out that although they are aware of biotechnology applications, topics concerning the structure of DNA, management of genetic information inside the cell, genetically modified organism technology and the use of microorganisms as biotechnological tools were not correctly answered. According to our attitude analysis, Spanish preservice teachers could be defined as opponents of genetically modified product acquisition, supporters of biotechnology for medical purposes and highly interested in increasing their knowledge about biotechnology and other scientific advances. Our results show a positive correlation between better knowledge and more positive attitudes toward biotechnology. A Spanish preservice teacher with positive attitudes toward biotechnology tends to be a student with a strong biology background who scored good marks in our knowledge test.

  3. Review: Biotechnological strategies for conservation of rare and endangered medicinal plants

    Directory of Open Access Journals (Sweden)

    MAHENDRA KUMAR RAI

    2010-07-01

    Full Text Available Rai MK (2010 Review: Biotechnological strategies for conservation of rare and endangered medicinal plants. Biodiversitas 11: 157-166. The use of medicinal plants is as old as human civilization. The biotechnological tools play a crucial role in conservation of rare and endangered medicinal plants. The rapid depletion of plant genetic diversity has made essential to develop new in situ and ex situ conservation methods. Advances in biotechnology offer new methods for conservation of rare and endangered medicinal plants. The present review is focused on biotechnological tools like in vitro culture, micropropagation, mycorrhization, genetic transformation and development of DNA banks. These are imperative and important alternatives for the conservation of rare and endangered medicinal plants.

  4. Comparing the Governance of Novel Products and Processes of Biotechnology

    DEFF Research Database (Denmark)

    Hansen, Janus

    The emergence of novel products and processes of biotechnology in medicine, industry and agriculture has been accompanied by promises of healthier, safer and more productive lives and societies. However, biotechnology has also served as cause and catalyst of social controversy about the physical...... to start to fill this gap and develop a conceptual framework for comparing and analysing new and emerging modes of governance affiliated with biotechnology in the light of more general approaches to governance. We aim for a framework that can facilitate comparative inquiries and learning across different...

  5. Harnessing the private health sector by using prices as a policy instrument: Lessons learned from South Africa.

    Science.gov (United States)

    Barber, Sarah L; Kumar, Ankit; Roubal, Tomas; Colombo, Francesca; Lorenzoni, Luca

    2018-05-01

    Governments frequently draw upon the private health care sector to promote sustainability, optimal use of resources, and increased choice. In doing so, policy-makers face the challenge of harnessing resources while grappling with the market failures and equity concerns associated with private financing of health care. The growth of the private health sector in South Africa has fundamentally changed the structure of health care delivery. A mutually reinforcing ecosystem of private health insurers, private hospitals and specialists has grown to account for almost half of the country's spending on health care, despite only serving 16% of the population with the capacity to pay. Following years of consolidation among private hospital groups and insurance schemes, and after successive failures at establishing credible price benchmarks, South Africa's private hospitals charge prices comparable with countries that are considerably richer. This compromises the affordability of a broad-based expansion in health care for the population. The South African example demonstrates that prices can be part of a structure that perpetuates inequalities in access to health care resources. The lesson for other countries is the importance of norms and institutions that uphold price schedules in high-income countries. Efforts to compromise or liberalize price setting should be undertaken with a healthy degree of caution. Copyright © 2018 Elsevier B.V. All rights reserved.

  6. A systems engineering perspective on process integration in industrial biotechnology

    NARCIS (Netherlands)

    Kiss, Anton A.; Grievink, Johan; Rito-Palomares, Marco

    2015-01-01

    Biotechnology has many applications in health care, agriculture, industry and the environment. By using renewable raw materials, biotechnology contributes to lowering greenhouse gas emissions and moving away from a petro-based towards a circular sustainable economy. However, major developments are

  7. Biotechnological applications of extremophiles, extremozymes and extremolytes

    KAUST Repository

    Raddadi, Noura

    2015-08-14

    In the last decade, attention to extreme environments has increased because of interests to isolate previously unknown extremophilic microorganisms in pure culture and to profile their metabolites. Microorganisms that live in extreme environments produce extremozymes and extremolytes that have the potential to be valuable resources for the development of a bio-based economy through their application to white, red, and grey biotechnologies. Here, we provide an overview of extremophile ecology, and we review the most recent applications of microbial extremophiles and the extremozymes and extremolytes they produce to biotechnology.

  8. Biotechnological processes in the Canadian mining industry

    International Nuclear Information System (INIS)

    McCready, R.G.L.

    1991-01-01

    Since the initiation of the Federal Government's National Strategy on Biotechnology in 1983, CANMET has coordinated the development of numerous biotechnological processes both for economical metal recovery and for the protection of the environment. This presentation will give a brief overview of the development of in-place, underground bacterial leaching of uranium, the development of in-situ bacterial leaching of copper and zinc, bio recovery of metallic selenium from smelter effluents, the degradation of an organic pollutant from a metal smelter and biological treatment of acidic mine drainage. (author)

  9. UK biotechnology companies lead the way for Europe

    Energy Technology Data Exchange (ETDEWEB)

    1984-05-01

    A number of new well-structured biotechnology companies have been launched in Britain over the last few years, e.g. Imperial Biotechnology, IQ(Bio) and Celltech, while Wellcome and Searle (U.K.) are established firms, keeping up with the new technology. Imperial Biotechnology, with its accent on development rather than research and making products not in anyone else's catalogue, has produced a whole range of enzymes, biopolymers, antibiotics, and human proteins under contract. Its long term objective is to develop its own bioproducts. IQ(Bio) is poised to enter the diagnostic big league with its enzyme-linked immunoassay (Aelia) technology and intends to pursue opportunities where there is a strict regulatory climate prohibiting the growth of radioimmunoassays, e.g. France and Japan. It plans to produce kits that a doctor can use simply and give results in less than 30 minutes. Celltech has a culture products division which supplies large quantities of monoclonal antibodies, it has a diagnostics and health care research section, a speciality chemicals area and an industrial microbiology sector. Wellcome Biotechnology has an interferon programme which includes a broad range of chemical trials in the anticancer and antiviral areas. The company could supply the entire world market for interferon using cell culture and produces a very large range of conventional vaccines. Searle uses biotechnology as just another means of producing new drugs as they have a large drug development machine in place. A considerable amount of process development work has focused on Searle's artificial sweetener, aspartame, and they are looking at all the technical approaches to aspartame production.

  10. Biotechnological Production Process and Life Cycle Assessment of Graphene

    Directory of Open Access Journals (Sweden)

    P. Noorunnisa Khanam

    2017-01-01

    Full Text Available The aim of this study is to compare the graphene produced using a biotechnological method (Escherichia coli with the graphene produced by Hummers’ method (a chemical method and to study the effect on the energy consumption and environment. The results indicated that the chemical reduction process has higher energy consumption, approximately 1642 Wh, than the energy consumption of the biotechnological reduction process, which is 5 Wh. The potential of global warming (GWP 100 improved by 71% using the biotechnological route for the production of graphene. Abiotic depletion, the photochemical ozone creation potential, and marine aquatic ecotoxicity potential were improved when the biological route was employed, compared with the chemical route. The eutrophication potential, terrestrial ecotoxicity, and ozone depletion layer changed very little since the main variables involved in the production of graphene oxide and waste management are the same. The biotechnological method can be considered a green technique for the production of graphene, especially given the reduction in the negative effects on global warming, abiotic depletion, the photochemical ozone creation potential, and the marine aquatic ecotoxicity potential.

  11. 75 FR 41798 - Solicitation of Letters of Interest to Participate in Biotechnology Quality Management System...

    Science.gov (United States)

    2010-07-19

    ...] Solicitation of Letters of Interest to Participate in Biotechnology Quality Management System Program AGENCY... participate in the APHIS Biotechnology Quality Management System Program. The Biotechnology Quality Management..., audit-based compliance assistance program known as the Biotechnology Quality Management System Program...

  12. AUTOMATIC RECOGNITION OF FALLS IN GAIT-SLIP: A HARNESS LOAD CELL BASED CRITERION

    OpenAIRE

    Yang, Feng; Pai, Yi-Chung

    2011-01-01

    Over-head-harness systems, equipped with load cell sensors, are essential to the participants’ safety and to the outcome assessment in perturbation training. The purpose of this study was to first develop an automatic outcome recognition criterion among young adults for gait-slip training and then verify such criterion among older adults. Each of 39 young and 71 older subjects, all protected by safety harness, experienced 8 unannounced, repeated slips, while walking on a 7-m walkway. Each tri...

  13. Biotechnology in Argentina: New products, new multilateral challenges

    Directory of Open Access Journals (Sweden)

    Luciano M. Donadio Linares

    2016-06-01

    Full Text Available Since 20 years ago, a public-private alliance has transformed Argentina into a remarkable global actor in developing biotechnological products for food and renewable energies. This strategic alliance resulted in the boosting of scientific knowledge, the extension of the production boundary, the expansion of international trade and the creation of the conditions for an integral development. Furthermore, given the characteristics of biotechnology as a new phenomenon, wto has become the field within where a number of disputes take place, disputes which not only controvert trade issues, but also the State’s limits to design and apply public policies on the matter at issue. As a consequence, the present article seeks to, on the one hand, describe how Argentina built its public policy on Biotechnology and, on the other hand, analyze the challenges that Argentina faces within the multilateral trade system

  14. Automatic recognition of falls in gait-slip training: Harness load cell based criteria.

    Science.gov (United States)

    Yang, Feng; Pai, Yi-Chung

    2011-08-11

    Over-head-harness systems, equipped with load cell sensors, are essential to the participants' safety and to the outcome assessment in perturbation training. The purpose of this study was to first develop an automatic outcome recognition criterion among young adults for gait-slip training and then verify such criterion among older adults. Each of 39 young and 71 older subjects, all protected by safety harness, experienced 8 unannounced, repeated slips, while walking on a 7m walkway. Each trial was monitored with a motion capture system, bilateral ground reaction force (GRF), harness force, and video recording. The fall trials were first unambiguously indentified with careful visual inspection of all video records. The recoveries without balance loss (in which subjects' trailing foot landed anteriorly to the slipping foot) were also first fully recognized from motion and GRF analyses. These analyses then set the gold standard for the outcome recognition with load cell measurements. Logistic regression analyses based on young subjects' data revealed that the peak load cell force was the best predictor of falls (with 100% accuracy) at the threshold of 30% body weight. On the other hand, the peak moving average force of load cell across 1s period, was the best predictor (with 100% accuracy) separating recoveries with backward balance loss (in which the recovery step landed posterior to slipping foot) from harness assistance at the threshold of 4.5% body weight. These threshold values were fully verified using the data from older adults (100% accuracy in recognizing falls). Because of the increasing popularity in the perturbation training coupling with the protective over-head-harness system, this new criterion could have far reaching implications in automatic outcome recognition during the movement therapy. Copyright © 2011 Elsevier Ltd. All rights reserved.

  15. AUTOMATIC RECOGNITION OF FALLS IN GAIT-SLIP: A HARNESS LOAD CELL BASED CRITERION

    Science.gov (United States)

    Yang, Feng; Pai, Yi-Chung

    2012-01-01

    Over-head-harness systems, equipped with load cell sensors, are essential to the participants’ safety and to the outcome assessment in perturbation training. The purpose of this study was to first develop an automatic outcome recognition criterion among young adults for gait-slip training and then verify such criterion among older adults. Each of 39 young and 71 older subjects, all protected by safety harness, experienced 8 unannounced, repeated slips, while walking on a 7-m walkway. Each trial was monitored with a motion capture system, bilateral ground reaction force (GRF), harness force and video recording. The fall trials were first unambiguously indentified with careful visual inspection of all video records. The recoveries without balance loss (in which subjects’ trailing foot landed anteriorly to the slipping foot) were also first fully recognized from motion and GRF analyses. These analyses then set the gold standard for the outcome recognition with load cell measurements. Logistic regression analyses based on young subjects’ data revealed that peak load cell force was the best predictor of falls (with 100% accuracy) at the threshold of 30% body weight. On the other hand, the peak moving average force of load cell across 1-s period, was the best predictor (with 100% accuracy) separating recoveries with backward balance loss (in which the recovery step landed posterior to slipping foot) from harness assistance at the threshold of 4.5% body weight. These threshold values were fully verified using the data from older adults (100% accuracy in recognizing falls). Because of the increasing popularity in the perturbation training coupling with the protective over-head-harness system, this new criterion could have far reaching implications in automatic outcome recognition during the movement therapy. PMID:21696744

  16. Hvorfor skal Adam betale børnepenge, når Eva har bedraget ham?

    DEFF Research Database (Denmark)

    Petersen, Thomas Søbirk

    2016-01-01

    Juridisk abort bør være en mulighed for mænd, der er blevet bedraget, bestjålet eller som har brugt prævention, der ikke virker efter hensigten.......Juridisk abort bør være en mulighed for mænd, der er blevet bedraget, bestjålet eller som har brugt prævention, der ikke virker efter hensigten....

  17. 75 FR 20560 - Syngenta Biotechnology, Inc.; Determination of Nonregulated Status for Corn Genetically...

    Science.gov (United States)

    2010-04-20

    ...] Syngenta Biotechnology, Inc.; Determination of Nonregulated Status for Corn Genetically Engineered for... are advising the public of our determination that a corn line developed by Syngenta Biotechnology, Inc... Biotechnology, Inc., in its petition for a determination of nonregulated status, our analysis of other...

  18. Network harness: bundles of routes in public transport networks

    Science.gov (United States)

    Berche, B.; von Ferber, C.; Holovatch, T.

    2009-12-01

    Public transport routes sharing the same grid of streets and tracks are often found to proceed in parallel along shorter or longer sequences of stations. Similar phenomena are observed in other networks built with space consuming links such as cables, vessels, pipes, neurons, etc. In the case of public transport networks (PTNs) this behavior may be easily worked out on the basis of sequences of stations serviced by each route. To quantify this behavior we use the recently introduced notion of network harness. It is described by the harness distribution P(r, s): the number of sequences of s consecutive stations that are serviced by r parallel routes. For certain PTNs that we have analyzed we observe that the harness distribution may be described by power laws. These power laws indicate a certain level of organization and planning which may be driven by the need to minimize the costs of infrastructure and secondly by the fact that points of interest tend to be clustered in certain locations of a city. This effect may be seen as a result of the strong interdependence of the evolutions of both the city and its PTN. To further investigate the significance of the empirical results we have studied one- and two-dimensional models of randomly placed routes modeled by different types of walks. While in one dimension an analytic treatment was successful, the two dimensional case was studied by simulations showing that the empirical results for real PTNs deviate significantly from those expected for randomly placed routes.

  19. Microbial conversion of agriculture wastes as a source of energy for developing countries: a case study in Nigeria

    International Nuclear Information System (INIS)

    Ejike, C.; Okereke, G.U.

    1991-01-01

    The direct relationship between level of economic development of any nation and its consumption of energy show that there is improve standard of living with increase in the per capita consumption of energy. In Nigeria, the need to offset some of the economic set backs brought about by increasing fuel costs and chronic lack of foreign currency reserves has compelled her to search for alternative sources of energy. The continuous increase in concern over environmental pollution has also resulted in greater negative cost values of wastes and hence has increased their potential as substrates for bio-derived energy. Cellulosic agricultural wastes are available in Nigeria in large amounts, are ordinarily of little economic value and are non toxic. Nigeria produces about 227,500 tons of animal waste per day implying the bio gas production could be a feasible alternative source of energy. Conversion of agricultural waste to usable energy at commercially acceptable rates involves the availability of raw materials and conversion of same to suitable substrates for fermentation to alcohol and then to bio gas. Saccharomyces spp. produced from fermentation of alcoholic beverages in Northern Nigeria have been used in the production of ethanol from corn corp waste and grass straw. Chromolaena odorata a weed that has no economic value which grows luxuriantly in Nigeria has been used in the generation of bio gas. Drying procedure and pH are among other conditions the affect methane yield. The development of the biotechnology of bio-derivable energy from agricultural waste if effectively harnessed will help to aleviate the energy problems of developing countries. The climate for the promotion of this technology is favourable because of low cost of raw material, high cost of fuel energy, and poor foreign exchange earning capacity of developing countries. (author)

  20. Opening remarks SIVB congress 2001: opportunities and challenges in plant biotechnology.

    Science.gov (United States)

    Bond, Christopher

    2003-01-01

    U.S. Senator Christopher Bond joined Dr. Roger Beachy at the podium during the Society for In Vitro Biology's 2001 Congress Plenary Session on Opportunities and Challenges in Plant Biotechnology to Benefit Health and Sustainability, on June 17, 2001, in St. Louis, Missouri. Senator Bond presented an advocate's view regarding the benefits of plant biotechnology development. The strengths of the biotechnology regulatory system were extolled. The opportunities of this new technology to produce more and nutritionally superior food, additional plant-based medicines and vaccines, plant-based renewable sources of energy, and renewable industrial products were outlined. The benefits to the environment by adopting plant biotechnological innovations were discussed. Developing public policy regarding this new technology should be based on facts, science, and reason.

  1. Protein engineering approaches to chemical biotechnology.

    Science.gov (United States)

    Chen, Zhen; Zeng, An-Ping

    2016-12-01

    Protein engineering for the improvement of properties of biocatalysts and for the generation of novel metabolic pathways plays more and more important roles in chemical biotechnology aiming at the production of chemicals from biomass. Although widely used in single-enzyme catalysis process, protein engineering is only being increasingly explored in recent years to achieve more complex in vitro and in vivo biocatalytic processes. This review focuses on major contributions of protein engineering to chemical biotechnology in the field of multi-enzymatic cascade catalysis and metabolic engineering. Especially, we discuss and highlight recent strategies for combining pathway design and protein engineering for the production of novel products. Copyright © 2016. Published by Elsevier Ltd.

  2. Biotechnology Education as Social and Cultural Production/Reproduction of the Biotechnology Community

    Science.gov (United States)

    Andrée, Maria

    2014-01-01

    This paper is a commentary to a paper by Anne Solli, Frank Bach and Björn Åkerman on how students at a technical university learn to argue as biotechnologists. Solli and her colleagues report from an ethnographic study performed during the first semester of a 5-year program in biotechnology at a technical university in Sweden. Their study…

  3. Integration of biotechnology in remediation and pollution prevention activities

    International Nuclear Information System (INIS)

    Strong-Gunderson, J.M.

    1996-01-01

    The North American Free Trade Agreement/North American Agreement on Environmental Cooperation provides a mechanism for an international collaboration between the US, Canada, and Mexico to jointly develop, modify, or refine technologies that remediate or protect the environment. These countries have a vested interest in this type of collaboration because contaminants do not respect the boundaries of a manufacturing site, region, city, state, or country. The Environmental Sciences Division (ESD) at Oak Ridge National Laboratory (ORNL) consists of a diverse group of individuals who address a variety of environmental issues. ESD is involved in basic and applied research on the fate, transport, and remediation of contaminants; environmental assessment; environmental engineering; and demonstrations of advanced remediation technologies. The remediation and protection of the environment includes water, air, and soils for organic, inorganic, and radioactive contaminants. In addition to remediating contaminated sites, research also focuses on life-cycle analyses of industrial processes and the production of green technologies. The author focuses this discussion on subsurface remediation and pollution prevention; however, the research activities encompass water, soil and air and many of the technologies are applicable to all environments. The discussion focuses on the integration of biotechnology with remediation activities and subsequently linking these biological processes to other remediation technologies

  4. Biotechnologies and Human Dignity

    Science.gov (United States)

    Sweet, William; Masciulli, Joseph

    2011-01-01

    In this article, the authors review some contemporary cases where biotechnologies have been employed, where they have had global implications, and where there has been considerable debate. The authors argue that the concept of dignity, which lies at the center of such documents as the 2005 Universal Declaration on Bioethics and Human Rights, the…

  5. Biotechnology for development: Human and animal health perspectives

    International Nuclear Information System (INIS)

    Yilma, Tilahun

    2001-01-01

    In much of the world, resources for human life are meager at best. While the developed parts of the world enjoy a standard of living higher than at any time in history, the benefits of technology and industrialization have not been available to developing countries. The extreme lack of resources leads to very slow progress despite intense interest and hard work; thus the technological gap between developing and developed nations continues to widen, as discoveries and advances accelerate in the more favored countries while technological accomplishments of developing nations are soon outmoded. It is apparent that developing nations will not be able to overcome this disadvantage if the situation is not addressed soon. Developing nations should not be condemned permanently to such status. It is essential for world political and economic stability to develop orderly plans to help struggling nations advance to technological production levels rather than exist as marginal consumers. It is essential that all projects in such countries have distinct, stated goals for conversion of the developing nation to a developed nation, and that such goals be the overriding consideration in the direction of the project. Cognizant of the significance of the recommendations and with a real desire for prompt implementation, we have established an 'International Laboratory of Molecular Biology for Tropical Disease Agents (ILMB)' whose main agenda is the transfer of biotechnology to developing countries. In this spirit, we have entered into partnership with a number of international organizations including the United States Agency for International Development (USAID), a number of United Nations Agencies such as the International Atomic Energy Agency (IAEA), the Organization for African Unity (OAU), and a number of countries from the developing nations in Africa and Asia. We are working with these partners toward: establishment of laboratories of molecular biology in developing countries

  6. International Marine Biotechnology Culture Collection (IMBCC)

    Energy Technology Data Exchange (ETDEWEB)

    Zaborsky, O.R.; Baker, K. [Univ. of Hawaii at Manoa, Honolulu, HI (United States)

    1996-10-01

    The objective of this project is to establish a premier culture collection of tropical marine microorganisms able to generate hydrogen from water or organic substances. Both eukaryotic and prokaryotic microorganisms will serve as the biological reservoir or {open_quotes}library{close_quotes} for other DOE Hydrogen Program contractors, the biohydrogen research community and industry. This project consists of several tasks: (a) transfer of the Mitsui-Miami strains to Hawaii`s International Marine Biotechnology Culture Collection (IMBCC) housed at the Hawaii Natural Energy Institute (HNEI); (b) maintain and distribute Mitsui-Miami strains; (c) characterize key strains by traditional and advanced biotechnological techniques; (d) expand Hawaii`s IMBCC; and (e) establish and operate an information resource (database). The project was initiated only late in the summer of 1995 but progress has been made on all tasks. Of the 161 cyanobacterial strains imported, 147 survived storage and importation and 145 are viable. with most exhibiting growth. Of the 406 strains of other photosynthetic bacteria imported, 392 survived storage and importation and 353 are viable, with many exhibiting growth. This project is linked to cooperative efforts being supported by the Japanese Ministry of International Trade and Industry (MITI) through its Marine Biotechnology Institute (MBI) and Research Institute of Innovative Technology for the Earth (RITE).

  7. Biotechnological applications of bacterial cellulases

    Czech Academy of Sciences Publication Activity Database

    Menéndez, E.; García-Fraile, Paula; Rivas, R.

    2015-01-01

    Roč. 2, č. 3 (2015), s. 163-182 ISSN 2306-5354 R&D Projects: GA MŠk(CZ) EE2.3.30.0003 Institutional support: RVO:61388971 Keywords : Biotechnological applications * Bacterial cellulases * Cellulose degradation Subject RIV: EE - Microbiology, Virology

  8. Progress and Challenges for Implementation of the Common Market for Eastern and Southern Africa Policy on Biotechnology and Biosafety

    Science.gov (United States)

    Waithaka, Michael; Belay, Getachew; Kyotalimye, Miriam; Karembu, Margaret

    2015-01-01

    In 2001, the Meeting of the COMESA Ministers of Agriculture raised concerns that proliferation of genetically modified organisms (GMOs) could impact significantly on trade and food security in the region. This triggered studies on a regional approach to biotechnology and biosafety policy in Eastern and Southern Africa. The studies and stakeholder consultations revealed that farm incomes would increase if they switched from conventional varieties of cotton and maize to genetically modified (GM) counterparts. Commercial risks associated with exports to GM sensitive destinations, e.g., EU were negligible. Intra-regional trade would be affected since exports of GM sensitive commodities, such as maize, cotton, and soya bean, mainly go to other African countries. These findings justified the need to consider a regional approach to biosafety and led to the drafting of a regional policy in 2009. The draft policies were discussed in regional and national workshops between 2010 and 2012 for wider ownership. The workshops involved key stakeholders including ministries of agriculture, trade, environment, national biosafety focal points, biosafety competent authorities, academia, seed traders, millers, the media, food relief agencies, the industry, civil society, competent authorities, and political opinion leaders. The COMESA Council of Ministers in February 2014 adopted the COMESA policy on biotechnology and biosafety that takes into account the sovereign right of each member state. Key provisions of the policy include recognition of the benefits and risks associated with GMOs; establishment of a regional-level biosafety risk-assessment system; national-level final decision, and capacity building assistance to member states. The policies are the first regional effort in Africa to develop a coordinated mechanism for handling biosafety issues related to GMO use. A regional approach to biotechnology and biosafety is expected to foster inter-country cooperation through the

  9. Progress and Challenges for Implementation of the Common Market for Eastern and Southern Africa Policy on Biotechnology and Biosafety.

    Science.gov (United States)

    Waithaka, Michael; Belay, Getachew; Kyotalimye, Miriam; Karembu, Margaret

    2015-01-01

    In 2001, the Meeting of the COMESA Ministers of Agriculture raised concerns that proliferation of genetically modified organisms (GMOs) could impact significantly on trade and food security in the region. This triggered studies on a regional approach to biotechnology and biosafety policy in Eastern and Southern Africa. The studies and stakeholder consultations revealed that farm incomes would increase if they switched from conventional varieties of cotton and maize to genetically modified (GM) counterparts. Commercial risks associated with exports to GM sensitive destinations, e.g., EU were negligible. Intra-regional trade would be affected since exports of GM sensitive commodities, such as maize, cotton, and soya bean, mainly go to other African countries. These findings justified the need to consider a regional approach to biosafety and led to the drafting of a regional policy in 2009. The draft policies were discussed in regional and national workshops between 2010 and 2012 for wider ownership. The workshops involved key stakeholders including ministries of agriculture, trade, environment, national biosafety focal points, biosafety competent authorities, academia, seed traders, millers, the media, food relief agencies, the industry, civil society, competent authorities, and political opinion leaders. The COMESA Council of Ministers in February 2014 adopted the COMESA policy on biotechnology and biosafety that takes into account the sovereign right of each member state. Key provisions of the policy include recognition of the benefits and risks associated with GMOs; establishment of a regional-level biosafety risk-assessment system; national-level final decision, and capacity building assistance to member states. The policies are the first regional effort in Africa to develop a coordinated mechanism for handling biosafety issues related to GMO use. A regional approach to biotechnology and biosafety is expected to foster inter-country cooperation through the

  10. Harnessing Mobile Phones for Prevention of Mother-to-Child HIV ...

    International Development Research Centre (IDRC) Digital Library (Canada)

    Harnessing Mobile Phones for Prevention of Mother-to-Child HIV Transmission. Mobile phone technology, driven by local market forces rather than foreign assistance, ... IDRC invites applications for the IDRC Research Awards 2019. IDRC is ...

  11. Spring 2008 Industry Study: Biotechnology Industry

    National Research Council Canada - National Science Library

    Anttonen, John; Darnauer, Trish; Douglas, Tim; Ferrari, John; Zimdahl, Jennifer; Hall, Ian M; King, William; Klotzsche, Carl; Miller, Doug; Packard, Doug; Renegar, Mike; Rimback, Ed; Rogers, Gordon; Schnedar, Chris; Sekulovski, Zoran

    2008-01-01

    Defined broadly as the manipulation of genetic material in living organisms or the derivatives thereof, biotechnology represents a veritable gold mine of possibilities for improving the human condition...

  12. Bio-Technological Characterization of the Saccharomyces bayanus Yeast Strains in Order to Preserve the Local Specificity

    Directory of Open Access Journals (Sweden)

    Enikő Gaspar

    2011-05-01

    Full Text Available The wine yeasts have multiple and important applications in the industry, aiming to obtain pure cultures and the selection of those strains which, according to the lab investigations, present superior bio-technological properties. In this study we monitored three types of Saccharomyces bayanus yeast strains, isolated from indigenous grapes varieties, Apold Iordana, Italian Blaj Riesling and Royal Feteasca from Jidvei area, which are present in the collection of the Biotechnologies and Microbiology Research Center of SAIAPM University. The yeast strains were subject to alcoholic fermentation in malt must at different temperatures, in the presence of alcohol, sugar and SO2 in various concentrations. The obtained results led to selecting of those strains which had best results regarding the alcoholic tolerance, osmo-tolerance, fermentation speed under stress conditions and resistance to SO2. These results can have practical applications in using the indigenous strains, isolated from grapes which are from inside the country, so that we preserve the local specificity, and reduce imports regarding this area.

  13. Latin-American Co-operation in Biotechnology Programme: Industrial penicillin amidase for 6 amino penicillanic acid production

    Directory of Open Access Journals (Sweden)

    Dolly Montoya C.

    2001-07-01

    Full Text Available This work evaluates technological and economic transference related to the Production of Penicillin Amidase for use in 6 Amine Penicillanic acid (6-APA Production Project, wich is a part of the United Nations1 Regional Biotechnology Programme for Latin America and the Caribbean. This paper analyses the evolution of international cooperation by looking at the project's development. The methodology used includes analysis of: the project's development; participant and budgetary goals; results; copyright; project conditions; and sale of biocatalyst and 6-APA. All technical objectives were achieved; international co-operation, as well as co-operation between Industry and University were successful. Technological transference to the pilot plant was effective; many students involved in the project were simultaneously taking M.Sc. and Ph.D's courses. Nevertheless, neither the technology necessary for the biocatalyst's manufacture nor the biocatalyst itself were used. Analysis of the project has provided some orientation concerning those internal and external problems which arose during the development and sale of biotechnology in our countries and has tried to propose some alternatives for taking advantage of international co-operation.

  14. Utilization of protein-rich residues in biotechnological processes.

    Science.gov (United States)

    Pleissner, Daniel; Venus, Joachim

    2016-03-01

    A drawback of biotechnological processes, where microorganisms convert biomass constituents, such as starch, cellulose, hemicelluloses, lipids, and proteins, into wanted products, is the economic feasibility. Particularly the cost of nitrogen sources in biotechnological processes can make up a large fraction of total process expenses. To further develop the bioeconomy, it is of considerable interest to substitute cost-intensive by inexpensive nitrogen sources. The aim of this mini-review was to provide a comprehensive insight of utilization methods of protein-rich residues, such as fish waste, green biomass, hairs, and food waste. The methods described include (i) production of enzymes, (ii) recovery of bioactive compounds, and/or (iii) usage as nitrogen source for microorganisms in biotechnological processes. In this aspect, the utilization of protein-rich residues, which are conventionally considered as waste, allows the development of value-adding processes for the production of bioactive compounds, biomolecules, chemicals, and materials.

  15. Harnessing supramolecular peptide nanotechnology in biomedical applications

    OpenAIRE

    Chan, Kiat Hwa; Lee, Wei Hao; Zhuo, Shuangmu; Ni, Ming

    2017-01-01

    Kiat Hwa Chan,1 Wei Hao Lee,2 Shuangmu Zhuo,3 Ming Ni3 1Division of Science, Yale-NUS College, Singapore; 2Department of Chemistry, Krieger School of Arts & Sciences, Johns Hopkins University, Baltimore, MD, USA; 3Fujian Provincial Key Laboratory for Photonics Technology, Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education, Fujian Normal University, Fuzhou, People’s Republic of China Abstract: The harnessing of peptides in biomedic...

  16. Overcoming barriers to trust in agricultural biotechnology projects: a case study of Bt cowpea in Nigeria

    Directory of Open Access Journals (Sweden)

    Ezezika Obidimma C

    2012-11-01

    Full Text Available Abstract Background Nigeria, Africa’s most populous country, has been the world’s largest cowpea importer since 2004. The country is currently in the early phases of confined field trials for two genetically modified crops: Bacillus thuringiensis (Bt cowpea and nutritionally enhanced cassava (“BioCassava Plus”. Using the bio-safety guidelines process as a backdrop, we evaluate the role of trust in the operation of the Cowpea Productivity Improvement Project, which is an international agricultural biotechnology public-private partnership (PPP aimed at providing pest-resistant cowpea varieties to Nigerian farmers. Methods We reviewed the published literature and collected data through direct observations and semi-structured, face-to-face interviews. Data were analyzed based on emergent themes to create a comprehensive narrative on how trust is understood and built among the partners and with the community. Results Our findings highlight the importance of respecting mandates and eliminating conflicts of interest; holding community engagement initiatives early on; having on-going internal discussion and planning; and serving a locally-defined need. These four lessons could prove helpful to other agricultural biotechnology initiatives in which partners may face similar trust-related challenges. Conclusions Overcoming challenges to building trust requires concerted effort throughout all stages of project implementation. Currently, plans are being made to backcross the cowpea strain into a local variety in Nigeria. The development and adoption of the Bt cowpea seed hinges on the adoption of a National Biosafety Law in Nigeria. For countries that have decided to adopt biotech crops, the Nigerian cowpea experiment can be used as a model for other West African nations, and is actually applied as such in Ghana and Burkina Faso, interested in developing a Bt cowpea.

  17. Understanding public perceptions of biotechnology through the "Integrative Worldview Framework".

    Science.gov (United States)

    De Witt, Annick; Osseweijer, Patricia; Pierce, Robin

    2015-07-03

    Biotechnological innovations prompt a range of societal responses that demand understanding. Research has shown such responses are shaped by individuals' cultural worldviews. We aim to demonstrate how the Integrative Worldview Framework (IWF) can be used for analyzing perceptions of biotechnology, by reviewing (1) research on public perceptions of biotechnology and (2) analyses of the stakeholder-debate on the bio-based economy, using the Integrative Worldview Framework (IWF) as analytical lens. This framework operationalizes the concept of worldview and distinguishes between traditional, modern, and postmodern worldviews, among others. Applied to these literatures, this framework illuminates how these worldviews underlie major societal responses, thereby providing a unifying understanding of the literature on perceptions of biotechnology. We conclude the IWF has relevance for informing research on perceptions of socio-technical changes, generating insight into the paradigmatic gaps in social science, and facilitating reflexive and inclusive policy-making and debates on these timely issues. © The Author(s) 2015.

  18. Riding Horse Harness (Based on Materials from the Chulkovo Burial Ground

    Directory of Open Access Journals (Sweden)

    Grishakov Valeriy V.

    2013-12-01

    Full Text Available The items of riding horse harness (bits with psalia, stirrups, buckles, decorations of bridles are analyzed in the article on the basis of the materials from the Chulkovo (Murom burial ground site of the 8th-10th centuries, located on right bank of the Oka river. It has been established that the use of horse harness items by the Muroma culture population, which had left the Chulkovo burial ground, is in full correspondence with the general traditions of the Finno-Ugric peoples of the Volga river region characteristic of the 8th-10th centuries. The shapes of the bits correspond to both the steppe (bits with S-shaped and straight psalia and the local traditions (bits with two and three moving rings. A tendency to uniformity is observed in the tradition of stirrups production. The main differences of the Muroma burial grounds from the neighboring Mordovian ones consist in the presence of horse burials (not known among the Mordovians, and, on the other hand, in a practically complete lack of horse harness in the funeral set of human burials. It can be assumed that the importance of cavalry with the Muromа was lower than with the Mordovians who were living next to the steppe world.

  19. Biotechnological sulphide removal with oxygen

    NARCIS (Netherlands)

    Buisman, C.

    1989-01-01

    This thesis deals with the development of a new process for biotechnological sulphide removal from wastewater, in which it is attempted to convert sulphide into elemental sulphur by colourless sulphur bacteria. The toxicity, corrosive properties, unpleasant odor and high oxygen demand of sulphide

  20. High School and University Students' Knowledge and Attitudes regarding Biotechnology: A Turkish Experience

    Science.gov (United States)

    Usak, Muhammet; Erdogan, Mehmet; Prokop, Pavol; Ozel, Murat

    2009-01-01

    Biotechnology has a considerable importance in Turkish biology curriculum. This study was designed to explore or indicate Turkish high school and university students' knowledge and attitudes toward biotechnology. A total number of 352 high school and 276 university students were invited to the study. The Biotechnology Knowledge Questionnaire (BKQ)…

  1. Review of computational fluid dynamics applications in biotechnology processes.

    Science.gov (United States)

    Sharma, C; Malhotra, D; Rathore, A S

    2011-01-01

    Computational fluid dynamics (CFD) is well established as a tool of choice for solving problems that involve one or more of the following phenomena: flow of fluids, heat transfer,mass transfer, and chemical reaction. Unit operations that are commonly utilized in biotechnology processes are often complex and as such would greatly benefit from application of CFD. The thirst for deeper process and product understanding that has arisen out of initiatives such as quality by design provides further impetus toward usefulness of CFD for problems that may otherwise require extensive experimentation. Not surprisingly, there has been increasing interest in applying CFD toward a variety of applications in biotechnology processing in the last decade. In this article, we will review applications in the major unit operations involved with processing of biotechnology products. These include fermentation,centrifugation, chromatography, ultrafiltration, microfiltration, and freeze drying. We feel that the future applications of CFD in biotechnology processing will focus on establishing CFD as a tool of choice for providing process understanding that can be then used to guide more efficient and effective experimentation. This article puts special emphasis on the work done in the last 10 years. © 2011 American Institute of Chemical Engineers

  2. Using New Interactive Media to Enhance the Teaching of Psychology (and Other Disciplines) in Developing Countries.

    Science.gov (United States)

    Myers, David G

    2009-01-01

    My idea for improving psychology responds to the challenge of teaching psychology in lower income, developing countries. With new Web-based e-books on the horizon, I suggest harnessing the Internet to deliver state-of-the-art, interactive, low-cost, locally adapted content to students who cannot afford books. © 2009 Association for Psychological Science.

  3. Harnessing the crowd to accelerate molecular medicine research.

    Science.gov (United States)

    Smith, Robert J; Merchant, Raina M

    2015-07-01

    Crowdsourcing presents a novel approach to solving complex problems within molecular medicine. By leveraging the expertise of fellow scientists across the globe, broadcasting to and engaging the public for idea generation, harnessing a scalable workforce for quick data management, and fundraising for research endeavors, crowdsourcing creates novel opportunities for accelerating scientific progress. Copyright © 2015 Elsevier Ltd. All rights reserved.

  4. Connecting Learners: The Role of Biotechnology Programme in Preparing Students for the Industry

    Science.gov (United States)

    Mohd Saruan, Nadiah; Sagran, Avinash; Fadzil, Kamal Solhaimi; Razali, Zuliana; Ow Phui San, Rebecca; Somasundram, Chandran

    2015-01-01

    The recent growth of biotechnology requires a wide range of expertise within the industry. Education is the primary platform for students to gain information and knowledge on biotechnology. In Malaysia where biotechnology is relatively new, education programs and courses must be tailored to meet the demands of the industry. A combination of…

  5. Using the Mystery of the Cyclopic Lamb to Teach Biotechnology

    Science.gov (United States)

    Jensen, Jamie L.

    2010-01-01

    I present a learning cycle that explores different biotechnologies using the process of in situ hybridization as a platform. Students are presented with a cyclopic lamb and must use biotechnology to discover the mechanism behind the deformity. Through this activity, students learn about signal transduction and discover the processes of polymerase…

  6. Biotechnological Production of Organic Acids from Renewable Resources.

    Science.gov (United States)

    Pleissner, Daniel; Dietz, Donna; van Duuren, Jozef Bernhard Johann Henri; Wittmann, Christoph; Yang, Xiaofeng; Lin, Carol Sze Ki; Venus, Joachim

    2017-03-07

    Biotechnological processes are promising alternatives to petrochemical routes for overcoming the challenges of resource depletion in the future in a sustainable way. The strategies of white biotechnology allow the utilization of inexpensive and renewable resources for the production of a broad range of bio-based compounds. Renewable resources, such as agricultural residues or residues from food production, are produced in large amounts have been shown to be promising carbon and/or nitrogen sources. This chapter focuses on the biotechnological production of lactic acid, acrylic acid, succinic acid, muconic acid, and lactobionic acid from renewable residues, these products being used as monomers for bio-based material and/or as food supplements. These five acids have high economic values and the potential to overcome the "valley of death" between laboratory/pilot scale and commercial/industrial scale. This chapter also provides an overview of the production strategies, including microbial strain development, used to convert renewable resources into value-added products.

  7. 76 FR 27301 - Syngenta Biotechnology, Inc.; Availability of Petition, Plant Pest Risk Assessment, and...

    Science.gov (United States)

    2011-05-11

    ...] Syngenta Biotechnology, Inc.; Availability of Petition, Plant Pest Risk Assessment, and Environmental... Plant Health Inspection Service has received a petition from Syngenta Biotechnology, Inc., seeking a.../brs/aphisdocs/07_10801p _dpra.pdf. FOR FURTHER INFORMATION CONTACT: Mr. Rick Coker, Biotechnology...

  8. 76 FR 60448 - Syngenta Biotechnology, Inc.; Determination of Nonregulated Status for Lepidopteran-Resistant Cotton

    Science.gov (United States)

    2011-09-29

    ...] Syngenta Biotechnology, Inc.; Determination of Nonregulated Status for Lepidopteran-Resistant Cotton AGENCY... our determination that a cotton line developed by Syngenta Biotechnology, Inc., designated as event... submitted by Syngenta Biotechnology, Inc., in its petition for a determination of nonregulated status, our...

  9. Biotechnological and molecular approaches for vanillin production: a review.

    Science.gov (United States)

    Kaur, Baljinder; Chakraborty, Debkumar

    2013-02-01

    Vanillin is one of the most widely used flavoring agents in the world. As the annual world market demand of vanillin could not be met by natural extraction, chemical synthesis, or tissue culture technology, thus biotechnological approaches may be replacement routes to make production of bio-vanillin economically viable. This review's main focus is to highlight significant aspects of biotechnology with emphasis on the production of vanillin from eugenol, isoeugenol, lignin, ferulic acid, sugars, phenolic stilbenes, vanillic acid, aromatic amino acids, and waste residues by applying fungi, bacteria, and plant cells. Production of biovanillin using GRAS lactic acid bacteria and metabolically engineered microorganisms, genetic organization of vanillin biosynthesis operons/gene cassettes and finally the stability of biovanillin generated through various biotechnological procedures are also critically reviewed in the later sections of the review.

  10. The application of biotechnology in medicinal plants breeding research in China.

    Science.gov (United States)

    Huang, He-Ping; Li, Jin-Cai; Huang, Lu-Qi; Wang, Dian-Lei; Huang, Peng; Nie, Jiu-Sheng

    2015-07-01

    Breeding is not only an important area of medicinal plants research but also the foundation for the superior varieties acquirement of medicinal plants. The rise of modern biotechnology provides good opportunities and new means for medicinal plants breeding research in China. Biotechnology shows its technical advantages and new development prospects in breeding of new medicinal plants varieties with high and stable yield, good quality, as well as stress-resistance. In this paper, we describe recent advances, problems, and development prospects about the application of modern biotechnology in medicinal plants breeding research in China.

  11. Taso Mähar : avatud vannitoaga vanalinna korter / Gitte Hint

    Index Scriptorium Estoniae

    Hint, Gitte

    2003-01-01

    Modernne korter (220 m2). Sisearhitekt Taso Mähar, tema kommentaarid. Kogu korteri ulatuses on sisekujundusmaterjalidena kasutatud väärispuitu, metalli, marmorit ja klaasi. T. Mähari projekteeritud on trepp ja piirded, kamin, baarilett ja õhukesed alumiiniumraamidel mattklaasidega uksed. Ill.: I ja II korruse plaan, 8 värv. vaadet

  12. Presentation of a Novel Model for Evaluation of Commercialization of Research and Development: Case Study of the Pharmaceutical Biotechnology Industry.

    Science.gov (United States)

    Emami, Hassan; Radfar, Reza

    2017-01-01

    The current situation in Iran suggests an appropriate basis for developing biotechnology industries, because the patents for the majority of hi-tech medicines registered in developed countries are ending. Biosimilar and technology-oriented companies which do not have patents will have the opportunity to enter the biosimilar market and move toward innovative initiatives. The present research proposed a model by which one can evaluate commercialization of achievements obtained from research with a focus on the pharmaceutical biotechnology industry. This is a descriptive-analytic study where mixed methodology is followed by a heuristic approach. The statistical population was pharmaceutical biotechnology experts at universities and research centers in Iran. Structural equations were employed in this research. The results indicate that there are three effective layers within commercialization in the proposed model. These are a general layer (factors associated with management, human capital, legal infrastructure, communication infrastructure, a technical and executive infrastructures, and financial factors), industrial layer (internal industrial factors and pharmaceutical industry factors), and a third layer that included national and international aspects. These layers comprise 6 domains, 21 indices, 41 dimensions, and 126 components. Compilation of these layers (general layer, industrial layer, and national and international aspects) can serve commercialization of research and development as an effective evaluation package.

  13. 78 FR 13302 - Syngenta Biotechnology, Inc.; Determination of Nonregulated Status of Corn Genetically Engineered...

    Science.gov (United States)

    2013-02-27

    ...] Syngenta Biotechnology, Inc.; Determination of Nonregulated Status of Corn Genetically Engineered for... are advising the public of our determination that a corn line developed by the Syngenta Biotechnology... evaluation of data submitted by Syngenta Biotechnology, Inc., in its petition for a determination of...

  14. SOME TRENDS IN MATHEMATICAL MODELING FOR BIOTECHNOLOGY

    Directory of Open Access Journals (Sweden)

    O. M. Klyuchko

    2018-02-01

    Full Text Available The purpose of present research is to demonstrate some trends of development of modeling methods for biotechnology according to contemporary achievements in science and technique. At the beginning the general approaches are outlined, some types of classifications of modeling methods are observed. The role of mathematic methods modeling for biotechnology in present époque of information computer technologies intensive development is studied and appropriate scheme of interrelation of all these spheres is proposed. Further case studies are suggested: some mathematic models in three different spaces (1D, 2D, 3D models are described for processes in living objects of different levels of hierarchic organization. In course of this the main attention was paid to some processes modeling in neurons as well as in their aggregates of different forms, including glioma cell masses (1D, 2D, 3D brain processes models. Starting from the models that have only theoretical importance for today, we describe at the end a model which application may be important for the practice. The work was done after the analysis of approximately 250 current publications in fields of biotechnology, including the authors’ original works.

  15. Biodiversity, biotechnologies and the philosophy of biology.

    Science.gov (United States)

    Galleni, Lodovico

    2004-01-01

    The thesis of this paper is that in front of the development of biotechnology and of the capacity of techniques of altering the living, there is still a very old philosophy of biology. A rapid historical view is given where the rise and diffusion of the reductionistic paradigm is presented and the connections between this paradigm and biotechnologies are traced. Curiously biotechnologies are still based on the philosophy of F. Bacon. Then the necessity of a new paradigm in biology based on the recent discoveries of complexity is underlined. It is reminded that the main discovery of science of the XX century is that we are living in a small planet of limited resources and frail equilibriums. This discovery asks for a different view of the scientific progress, more linked to the conservation of the Biosphere than to its alteration. Stability is the task for the future interactions of human-kind with nature. For this reason the relationships between stability and diversity are summarised. Finally, as the species is the main step of Biodiversity, a brief discussion of the problems posed by the altering of species barriers is presented.

  16. High performance hybrid magnetic structure for biotechnology applications

    Science.gov (United States)

    Humphries, David E [El Cerrito, CA; Pollard, Martin J [El Cerrito, CA; Elkin, Christopher J [San Ramon, CA

    2009-02-03

    The present disclosure provides a high performance hybrid magnetic structure made from a combination of permanent magnets and ferromagnetic pole materials which are assembled in a predetermined array. The hybrid magnetic structure provides means for separation and other biotechnology applications involving holding, manipulation, or separation of magnetic or magnetizable molecular structures and targets. Also disclosed are further improvements to aspects of the hybrid magnetic structure, including additional elements and for adapting the use of the hybrid magnetic structure for use in biotechnology and high throughput processes.

  17. Applications of biotechnology in olive | Cançado | African Journal of ...

    African Journals Online (AJOL)

    Many scientific and technological fields make use of biotechnology. Among the most important applications of biotechnology in agriculture are large-scale commercial micropropagation, genetic transformation and the development of transgenic varieties, embryo rescue in plant breeding programs, genotyping based on ...

  18. Acinetobacter: environmental and biotechnological applications ...

    African Journals Online (AJOL)

    Among microbial communities involved in different ecosystems such as soil, freshwater, wastewater and solid wastes, several strains belonging to the genus of Acinetobacter have been attracting growing interest from medical, environmental and a biotechnological point of view. Bacteria of this genus are known to be ...

  19. Harnessing light: optical science and engineering for the 21st century

    National Research Council Canada - National Science Library

    Committee on Optical Science and Engineering, National Research Council

    .... Harnessing Light surveys this multitude of applications, as well as the status of the optics industry and of research and education in optics, and identifies actions that could enhance the field's...

  20. Fem sociale medier har »uindskrænket ret« til at misbruge alt dit indhold

    DEFF Research Database (Denmark)

    Nielsen, Jøren Ullits Olai

    2016-01-01

    Ved du, hvor meget kontrol du har over dit indhold på Facebook, YouTube, Snapchat, Instagram og Twitter? Her giver en juraforsker dig det forkromede overblik.......Ved du, hvor meget kontrol du har over dit indhold på Facebook, YouTube, Snapchat, Instagram og Twitter? Her giver en juraforsker dig det forkromede overblik....

  1. Students' Biotechnology Literacy: The Pillars of STEM Education in Malaysia

    Science.gov (United States)

    Bahri, Nurnadiah Mohamed; Suryawati, Evi; Osman, Kamisah

    2014-01-01

    Biotechnology has been widely applied in various products throughout the 21st century. Malaysia selected the biotechnology sector as one of the key strategic technologies that would enable Malaysia to transform into a fully developed nation by the year 2020. However, to date, there has been very little research on the level of biotechnology…

  2. Awareness and knowledge on modern biotechnology

    African Journals Online (AJOL)

    Jane

    2011-09-30

    Sep 30, 2011 ... food; MABIC, Malaysian Biotechnology Information Centre. on public ... in Malaysia and provide linkage to several international website on modern ... scholars and university students) possess at least tertiary level of education ...

  3. Establishing Chlamydomonas reinhardtii as an industrial biotechnology host.

    Science.gov (United States)

    Scaife, Mark A; Nguyen, Ginnie T D T; Rico, Juan; Lambert, Devinn; Helliwell, Katherine E; Smith, Alison G

    2015-05-01

    Microalgae constitute a diverse group of eukaryotic unicellular organisms that are of interest for pure and applied research. Owing to their natural synthesis of value-added natural products microalgae are emerging as a source of sustainable chemical compounds, proteins and metabolites, including but not limited to those that could replace compounds currently made from fossil fuels. For the model microalga, Chlamydomonas reinhardtii, this has prompted a period of rapid development so that this organism is poised for exploitation as an industrial biotechnology platform. The question now is how best to achieve this? Highly advanced industrial biotechnology systems using bacteria and yeasts were established in a classical metabolic engineering manner over several decades. However, the advent of advanced molecular tools and the rise of synthetic biology provide an opportunity to expedite the development of C. reinhardtii as an industrial biotechnology platform, avoiding the process of incremental improvement. In this review we describe the current status of genetic manipulation of C. reinhardtii for metabolic engineering. We then introduce several concepts that underpin synthetic biology, and show how generic parts are identified and used in a standard manner to achieve predictable outputs. Based on this we suggest that the development of C. reinhardtii as an industrial biotechnology platform can be achieved more efficiently through adoption of a synthetic biology approach. © 2015 The Authors The Plant Journal published by Society for Experimental Biology and John Wiley & Sons Ltd.

  4. 77 FR 41366 - Syngenta Biotechnology, Inc.; Availability of Petition, Plant Pest Risk Assessment, and...

    Science.gov (United States)

    2012-07-13

    ...] Syngenta Biotechnology, Inc.; Availability of Petition, Plant Pest Risk Assessment, and Environmental... Biotechnology, Inc., seeking a determination of nonregulated status of corn designated as SYN-05307-1, which has... likely to pose a plant pest risk. We are making available for public comment the Syngenta Biotechnology...

  5. 77 FR 13258 - Biotechnology Regulatory Services; Changes Regarding the Solicitation of Public Comment for...

    Science.gov (United States)

    2012-03-06

    ...] Biotechnology Regulatory Services; Changes Regarding the Solicitation of Public Comment for Petitions for..., Chief of Staff, Biotechnology Regulatory Services, APHIS, 4700 River Road Unit 147, Riverdale, MD 20737... process changes APHIS is making to our petition process, go to http://www.aphis.usda.gov/biotechnology/pet...

  6. Harnessing the Ocean's Power : Energy from Waves and Currents (Part I)

    OpenAIRE

    Yukihisa, Washio; Japan Marine Science and Technology Center

    1985-01-01

    The oceans are a potential source of renewable and pollution-free energy of particular importance to Japan. In this Issue we look at current development work to harness wave energy for power generation.

  7. Research on the Statistical Characteristics of Crosstalk in Naval Ships Wiring Harness Based on Polynomial Chaos Expansion Method

    Directory of Open Access Journals (Sweden)

    Chi Yaodan

    2017-08-01

    Full Text Available Crosstalk in wiring harness has been studied extensively for its importance in the naval ships electromagnetic compatibility field. An effective and high-efficiency method is proposed in this paper for analyzing Statistical Characteristics of crosstalk in wiring harness with random variation of position based on Polynomial Chaos Expansion (PCE. A typical 14-cable wiring harness was simulated as the object of research. Distance among interfering cable, affected cable and GND is synthesized and analyzed in both frequency domain and time domain. The model of naval ships wiring harness distribution parameter was established by utilizing Legendre orthogonal polynomials as basis functions along with prediction model of statistical characters. Detailed mean value, mean square error, probability density function and reasonable varying range of crosstalk in naval ships wiring harness are described in both time domain and frequency domain. Numerical experiment proves that the method proposed in this paper, not only has good consistency with the MC method can be applied in the naval ships EMC research field to provide theoretical support for guaranteeing safety, but also has better time-efficiency than the MC method. Therefore, the Polynomial Chaos Expansion method.

  8. Promotion of Biotechnology amongst Students by University Departments in South Africa

    Science.gov (United States)

    Boshoff, N.; Treptow, R. F.

    2011-01-01

    University departments (including schools and centres) with a direct or indirect link to biotechnology were identified. Representatives at these entities were surveyed to establish what measures South African universities are undertaking to promote biotechnology amongst students. Of the 168 departments identified, 55 submitted usable…

  9. Seventeenth symposium on biotechnology for fuels and chemicals. Program and abstracts

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-05-01

    This volume contains the abstracts of oral and poster presentations made at the Seventeenth Symposium on Biotechnology for Fuels and Chemicals. Session titles include Thermal, Chemical, and Biological Processing; Applied Biological Research; Bioprocessing Research; Special Topics Discussion Groups; Process Economics and Commercialization; and Environmental Biotechnology.

  10. Infusing Authentic Inquiry into Biotechnology

    Science.gov (United States)

    Hanegan, Nikki L.; Bigler, Amber

    2009-10-01

    Societal benefit depends on the general public's understandings of biotechnology (Betsch in World J Microbiol Biotechnol 12:439-443, 1996; Dawson and Cowan in Int J Sci Educ 25(1):57-69, 2003; Schiller in Business Review: Federal Reserve Bank of Philadelphia (Fourth Quarter), 2002; Smith and Emmeluth in Am Biol Teach 64(2):93-99, 2002). A National Science Foundation funded survey of high school biology teachers reported that hands-on biotechnology education exists in advanced high school biology in the United States, but is non-existent in mainstream biology coursework (Micklos et al. in Biotechnology labs in American high schools, 1998). The majority of pre-service teacher content preparation courses do not teach students appropriate content knowledge through the process of inquiry. A broad continuum exists when discussing inquiry-oriented student investigations (Hanegan et al. in School Sci Math J 109(2):110-134, 2009). Depending on the amount of structure in teacher lessons, inquiries can often be categorized as guided or open. The lesson can be further categorized as simple or authentic (Chinn and Malhotra in Sci Educ 86(2):175-218, 2002). Although authentic inquiries provide the best opportunities for cognitive development and scientific reasoning, guided and simple inquiries are more often employed in the classroom (Crawford in J Res Sci Teach 37(9):916-937, 2000; NRC in Inquiry and the national science education standards: a guide for teaching and learning, 2000). For the purposes of this study we defined inquiry as "authentic" if original research problems were resolved (Hanegan et al. in School Sci Math J 109(2):110-134, 2009; Chinn and Malhotra in Sci Educ 86(2):175-218, 2002; Roth in Authentic school science: knowing and learning in open-inquiry science laboratories, 1995). The research question to guide this study through naturalistic inquiry research methods was: How will participants express whether or not an authentic inquiry experience enhanced

  11. Vaccine manufacturing and technology: from biotechnological platforms to syntethic epitopes, current viepoint.

    Science.gov (United States)

    Ignateva, G A

    2016-01-01

    The Purposes: the review take into account short history of vaccination practice and development of vaccine technology. In the review we include data from several monographs about manufacturing of vaccines published by authors from such companies as Merck & Co; Sanofi Pasteur; Dynavax Europe/Rhein Biotech GmbH; Latham Biopharm Group; Aridis Pharmaceuticals LLC; Genentech; Amgen; Shamir Biologics LLC; Biopharm Services US; Novartis Pharma AG, аnd several research centers: Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research; Purdue University, West Lafayette, IN, US; Department of Pharmaceutical Chemistry, Univ. Of Kansas; Max Planck Institute for dynamics of Complex Technical Systems; Fraunhofer USA Center for Molecular Biotechnology; US Dep. of Agriculture Animal and Plant Health Inspection Service, etc. In historic literature there are data about inoculation practices in antique China, Persia, India, Byzantium, native Americans, some African population. In modern immunology since the end of XIX century the vaccines were produced at the in vivo platforms - in animals (rabbits, mice, cows). Since 1931 due to E. Goodpasture' elaboration most virus vaccines were and are produced at the in ovo platform. In 1949 J.F. Enders elaborated large-scale polio virus production in the primary culture of monkey kidney cells in vitro. Up to day primary culture of chiken embrio fibroblasts are used to large-scale production of vaccine viruses of measles, mumps, rabies. Since 2000-th in Western countries most part of virus vaccines were began to produced via a cultivation in continuous tumor cell lines. The last technology is the most low cost for large-scale production of vaccines. We review several new biotechnological platforms for the production of the recombinant protein or virus-like particles as subunit vaccines: plant system, algae, mushrooms, insect cells, etc. Beside of good purpose of vaccination - prophylactic of several infectious

  12. Knowledge and Attitudes towards Biotechnology of Elementary Education Preservice Teachers: The First Spanish Experience

    Science.gov (United States)

    Casanoves, Marina; González, Ángel; Salvadó, Zoel; Haro, Juan; Novo, Maite

    2015-01-01

    Due to the important impact that biotechnology has on current Western societies, well-informed critical citizens are needed. People prepared to make conscious decisions about aspects of biotechnology that relate to their own lives. Teachers play a central role in all education systems. Thus, the biotechnological literacy of preservice teachers is…

  13. Harnessing sorghum and millet biotechnology for food and health

    CSIR Research Space (South Africa)

    O'Kennedy, MM

    2006-11-01

    Full Text Available , the causal agent of rust disease, and the oomycete S. graminicola, causal agent of downy mildew, resulted in a significant reduction of disease symptoms in comparison to wild type control plants. The disease resistance of pearl millet was increased by up... of a wound-inducible promoter from a maize protease inhibitor gene (mpi) were produced via particle bombardment of shoot apices (Girijashankar et al., 2005). Although reductions in leaf damage (60%), larval mortality (40%) and larval weight (36...

  14. The translations and the organizing of scientific practices in R&D biotechnology

    Directory of Open Access Journals (Sweden)

    Lorena Bezerra de Souza Matos

    Full Text Available Abstract Considering the scientific practices related to Research & Development in biotechnology and, based on the assumptions of Actor Network Theory (ANT, this study aimed to describe the main translations that influenced the composition of an actor-networks, reflecting on the organizing practices in a scientific laboratory Research & Development of Northeast Biotechnology Network (Brazil. The methodological procedures were based on the historical approach of biotechnology under study from an ethnographic posture. The composition of the corpus was organized in the form of reports, observing the historical passages. The history of biotechnology has been reported between the plots of design, patenting and commercialization practices, highlighting the creation of heterogeneous actors’ networks. Finally, he emphasized the influence of laboratory scientist's leadership in the way of organizing of scientific practices.

  15. Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.

    Science.gov (United States)

    Schneider, P J

    1998-07-01

    Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.

  16. Metabolomics for functional genomics, systems biology, and biotechnology.

    Science.gov (United States)

    Saito, Kazuki; Matsuda, Fumio

    2010-01-01

    Metabolomics now plays a significant role in fundamental plant biology and applied biotechnology. Plants collectively produce a huge array of chemicals, far more than are produced by most other organisms; hence, metabolomics is of great importance in plant biology. Although substantial improvements have been made in the field of metabolomics, the uniform annotation of metabolite signals in databases and informatics through international standardization efforts remains a challenge, as does the development of new fields such as fluxome analysis and single cell analysis. The principle of transcript and metabolite cooccurrence, particularly transcriptome coexpression network analysis, is a powerful tool for decoding the function of genes in Arabidopsis thaliana. This strategy can now be used for the identification of genes involved in specific pathways in crops and medicinal plants. Metabolomics has gained importance in biotechnology applications, as exemplified by quantitative loci analysis, prediction of food quality, and evaluation of genetically modified crops. Systems biology driven by metabolome data will aid in deciphering the secrets of plant cell systems and their application to biotechnology.

  17. Overview on the biotechnological production of L-DOPA.

    Science.gov (United States)

    Min, Kyoungseon; Park, Kyungmoon; Park, Don-Hee; Yoo, Young Je

    2015-01-01

    L-DOPA (3,4-dihydroxyphenyl-L-alanine) has been widely used as a drug for Parkinson's disease caused by deficiency of the neurotransmitter dopamine. Since Monsanto developed the commercial process for L-DOPA synthesis for the first time, most of currently supplied L-DOPA has been produced by the asymmetric method, especially asymmetric hydrogenation. However, the asymmetric synthesis shows critical limitations such as a poor conversion rate and a low enantioselectivity. Accordingly, alternative biotechnological approaches have been researched for overcoming the shortcomings: microbial fermentation using microorganisms with tyrosinase, tyrosine phenol-lyase, or p-hydroxyphenylacetate 3-hydroxylase activity and enzymatic conversion by immobilized tyrosinase. Actually, Ajinomoto Co. Ltd commercialized Erwinia herbicola fermentation to produce L-DOPA from catechol. In addition, the electroenzymatic conversion system was recently introduced as a newly emerging scheme. In this review, we aim to not only overview the biotechnological L-DOPA production methods, but also to briefly compare and analyze their advantages and drawbacks. Furthermore, we suggest the future potential of biotechnological L-DOPA production as an industrial process.

  18. Dansk Taxi Råd har brug for et sprogkursus

    DEFF Research Database (Denmark)

    Riis, Helle Bach

    2011-01-01

    16.10. afviser formanden for Dansk Taxi Råd, John Lindbom, at det nyindførte pointsystem har til hensigt at holde indvandrere fra at blive vognmænd. I stedet siger han, at det handler om at højne fagets status og serviceniveau. Dansk Taxi Råd kan komme langt ved at forbedre sin interkulturelle...

  19. Biotechnology software in the digital age: are you winning?

    Science.gov (United States)

    Scheitz, Cornelia Johanna Franziska; Peck, Lawrence J; Groban, Eli S

    2018-01-16

    There is a digital revolution taking place and biotechnology companies are slow to adapt. Many pharmaceutical, biotechnology, and industrial bio-production companies believe that software must be developed and maintained in-house and that data are more secure on internal servers than on the cloud. In fact, most companies in this space continue to employ large IT and software teams and acquire computational infrastructure in the form of in-house servers. This is due to a fear of the cloud not sufficiently protecting in-house resources and the belief that their software is valuable IP. Over the next decade, the ability to quickly adapt to changing market conditions, with agile software teams, will quickly become a compelling competitive advantage. Biotechnology companies that do not adopt the new regime may lose on key business metrics such as return on invested capital, revenue, profitability, and eventually market share.

  20. 78 FR 27977 - Office of Biotechnology Activities; Recombinant DNA Research: Proposed Actions Under the NIH...

    Science.gov (United States)

    2013-05-13

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology... Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) SUMMARY: The NIH Office of Biotechnology... of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda...

  1. The evolution of biotechnology and its impact on health care.

    Science.gov (United States)

    Evens, Ronald; Kaitin, Kenneth

    2015-02-01

    For more than three decades the field of biotechnology has had an extraordinary impact on science, health care, law, the regulatory environment, and business. During this time more than 260 novel biotechnology products were approved for over 230 indications. Global sales of these products exceeded $175 billion in 2013 and have helped sustain a vibrant life sciences sector that includes more than 4,600 biotech companies worldwide. In this article we examine the evolution of biotechnology during the past three decades and the profound impact that it has had on health care through four interrelated and interdependent tracks: innovations in science, government activity, business development, and patient care. The future impact of biotechnology is promising, as long as the public and private sectors continue to foster policies and provide funds that lead to scientific breakthroughs; governments continue to offer incentives for private-sector biotech innovation; industry develops business models for cost-effective research and development; and all stakeholders establish policies to ensure that the therapeutic advances that mitigate or cure medical conditions that currently have inadequate or no available therapies are accessible to the public at a reasonable cost. Project HOPE—The People-to-People Health Foundation, Inc.

  2. Recent Major Advances of Biotechnology and Sustainable Aquaculture in China

    Science.gov (United States)

    Xiang, Jianhai

    2015-01-01

    Background: Global aquaculture production has increased continuously over the last five decades, and particularly in China. Its aquaculture has become the fastest growing and most efficient agri-sector, with production accounting for more than 70% of the world’s aquaculture output. In the new century, with serious challenges regarding population, resources and the environment, China has been working to develop high-quality, effective, healthy, and sustainable blue agriculture through the application of modern biotechnology. Sound knowledge related to the biology and ecology of aquatic organisms has laid a solid foundation and provided the innovation and technology for rapid development of the aquaculture industry. Marine biotechnology, which is enabling solutions for ocean productivity and sustainability, has been promoted since the last decades of the 20th Century in China. Objective: In this article, priority areas of research, mainly genetic breeding, omics studies, novel production systems, biosecurity, bioprocesses and biorefinery, as well as the major progress of marine biotechnology R&D in China are reviewed. Conclusion: Current innovative achievements in China are not enough and the level and frequency of academic advancements must be improved. International cooperation and assistance remain crucial for the success of marine biotechnology. PMID:28553577

  3. Progress on research of materials science and biotechnology by ion beam application

    Energy Technology Data Exchange (ETDEWEB)

    Ishigaki, Isao [Japan Atomic Energy Research Inst., Takasaki, Gunma (Japan). Takasaki Radiation Chemistry Research Establishment

    1997-03-01

    Research of materials science and biotechnology by ion beam application in Takasaki Establishment was reviewed. Especially, the recent progresses of research on semiconductors in space, creation of new functional materials and topics in biotechnology were reported. (author)

  4. To harness, transport and store the CO2

    International Nuclear Information System (INIS)

    Anon.

    2009-01-01

    This article about the CO 2 sequestration is divided in eight parts. The first part concerns the question of why it is important to harness the carbon dioxide. The second part reviews the different technologies to harness it. In part three, the conditioning and transport of CO 2 are studied. Then, the question of geological storage is tackled. The economical aspect of the CO 2 sequestration makes the following part. The acceptability of a underground storage is evoked because of the risk relative to the CO 2 storage. Some examples and projects (Usa, Canada, France) are presented. The conclusion ends this article with the assurance that the CO 2 sequestration is possible, but expansive on the energy level and financing (double investment cost and increasing at least 30% for the production costs for the energy coming from coal). It should be realized on a big scale only if significant tax are imposed to the atmospheric releases in CO 2 as it is the case in the Norwegian example (Sleipner field). The storage potentials are important by calling for aquifer layers. The questions of law and acceptability by the public are uncertain but not insurmountable if we think to the aquifers under the seas. (N.C.)

  5. Essential Features of Responsible Governance of Agricultural Biotechnology.

    Science.gov (United States)

    Hartley, Sarah; Gillund, Frøydis; van Hove, Lilian; Wickson, Fern

    2016-05-01

    Agricultural biotechnology continues to generate considerable controversy. We argue that to address this controversy, serious changes to governance are needed. The new wave of genomic tools and products (e.g., CRISPR, gene drives, RNAi, synthetic biology, and genetically modified [GM] insects and fish), provide a particularly useful opportunity to reflect on and revise agricultural biotechnology governance. In response, we present five essential features to advance more socially responsible forms of governance. In presenting these, we hope to stimulate further debate and action towards improved forms of governance, particularly as these new genomic tools and products continue to emerge.

  6. Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent.

    Science.gov (United States)

    Jiang, Li

    2018-03-12

    Some fundamental biotechnologies hold unprecedented potential to eradicate many incurable diseases. However, in absence of regulations, the power of patent makes the future use of some important biotechnology in few institution's hands. The excessive patents restrict researcher access to the fundamental technologies. It generates concerns and complaints of deteriorating the public health and social welfare. Furthermore, intellectual curiosities, funding, respect among colleagues etc., rather than patents, are the real motivations driving a major ground-breaking discoveries in biotechnology. These phenomena reveal that some biotechnology patents are alienated from the purpose of patent system. Therefore, it is necessary to take some approaches to stop over-patenting these fundamental biotechnology inventions. This article proposes a model regulatory framework for controlling biotechnology patent alienating from the purpose of patent system.

  7. Mathematical Modelling of Continuous Biotechnological Processes

    Science.gov (United States)

    Pencheva, T.; Hristozov, I.; Shannon, A. G.

    2003-01-01

    Biotechnological processes (BTP) are characterized by a complicated structure of organization and interdependent characteristics. Partial differential equations or systems of partial differential equations are used for their behavioural description as objects with distributed parameters. Modelling of substrate without regard to dispersion…

  8. Gas, oil, and environmental biotechnology IV

    Energy Technology Data Exchange (ETDEWEB)

    Akin, C; Markuszewski, R; Smith, J [eds.; Institute of Gas Technology, Chicago, IL (United States)

    1992-01-01

    Contains 32 papers presented at the 4th international IGT symposium on gas, oil and environmental biotechnology. Topics covered were: hydrocarbon bioremediation; groundwater, soil and explosives bioremediation; gas and oil reservoir souring; and biodesulfurization. 2 papers have been abstracted separately.

  9. Application of biotechnology in genetics and breeding of tall fescue

    International Nuclear Information System (INIS)

    Huang Xin; Ye Hongxia; Shu Xiaoli; Wu Dianxing

    2008-01-01

    Tall fescue (Festuca arundinacea Schred.) is an important lawn and pasture grass in agriculture, animal husbandy and lawn industry. The historical and present situations of tall fescue breeding were briefly introduced, and advances in the researches of molecular biology and germplasm enhancement by biotechnology in tall fescue were reviewed in the paper, which would provide the references for tall fescue breeding by biotechnology. (authors)

  10. Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition.

    Science.gov (United States)

    Evens, Ronald P

    2016-01-01

    The biotechnology segment of the overall biopharma industry has existed for only about 40–45 years, as a driver of new product development. This driving force was initiated with the FDA approval of recombinant human insulin in 1982, originating from the Genentech company. The pharma industry in the early years of 1970s and 1980s engaged with biotechnology companies only to a small extent with their in-licensing of a few recombinant molecules, led by Roche, Eli Lilly, and Johnson and Johnson. However, subsequently and dramatically over the last 25 years, biotechnology has become a primary driver of product and technology innovation and has become a cornerstone in new product development by all biopharma companies. This review demonstrates these evolutionary changes regarding approved products, product pipelines, novelty of the products, FDA approval rates, product sales, financial R&D investments in biotechnology, partnerships, mergers and acquisitions, and patent issues. We now have about 300 biotechnology products approved in USA covering 16 medical disciplines and about 250 indications, with the engagement of 25 pharma companies, along with their biotechnology company innovators and partners. The biotechnology pipeline involves over 1000 molecules in clinical trials, including over 300 molecules associated with the top 10 pharma companies. Product approval rates by the FDA for biotechnology products are over double the rate for drugs. Yes, the R&D paradigm has changed with biotechnology now as one of the major focuses for new product development with novel molecules by the whole biopharma industry.

  11. 75 FR 21008 - Office of Biotechnology Activities; Recombinant DNA Research: Proposed Actions Under the NIH...

    Science.gov (United States)

    2010-04-22

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology... Biotechnology Activities (OBA) published a proposal to revise the NIH Guidelines for Research with Recombinant... by fax to 301-496-9839 or mail to the Office of Biotechnology Activities, National Institutes of...

  12. Failed Pavlik harness treatment for DDH as a risk factor for avascular necrosis.

    Science.gov (United States)

    Tiruveedhula, Madhu; Reading, Isabel C; Clarke, Nicholas M P

    2015-03-01

    Avascular necrosis (AVN) of the femoral head is an irreversible complication seen in the treatment of developmental dysplasia of hip (DDH) with the Pavlik harness. Its incidence is reported to be low after successful reduction of the hip but high if the hip is not concentrically relocated. We aim to investigate its incidence after failed Pavlik harness treatment. We prospectively followed up a group of children who failed Pavlik harness treatment for DDH treated at our institution by the senior author between 1988 and 2001 and compared their rates of AVN with a group of children who presented late and hence were treated surgically. AVN was graded as described by Kalamchi and MacEwen and only grade 2 to 4 AVN was considered significant and included in the analysis. Thirty-seven hips were included in the failed Pavlik group (group 1) and 86 hips in the no Pavlik group (group 2). Ten hips in group 1 developed AVN (27%), whereas only 7 hips in group 2 (8%) developed AVN; the odds of developing AVN after failed Pavlik treatment was 4.7 (95% confidence interval, 1.3-14.1) (P=0.009) with a relative risk of 3.32 (range, 1.37 to 8.05). There was no statistically significant association observed with duration of splintage and severity of AVN (Spearman's correlation, -0.46; P=0.18). However, there was a positive correlation noted with age at presentation and severity of AVN. Therefore, we advise close monitoring of hips in the Pavlik harness and discontinue its use if the hips are not reduced within 3 weeks. Level III.

  13. Potential applications of biotechnology in the energy and the environment sectors

    Energy Technology Data Exchange (ETDEWEB)

    Chakrabarty, A.M.

    1988-06-01

    Biotechnological approaches to solving some of the problems of environmental pollution or developing better or alternate sources of energy are considered realistic and technically feasible within the near future. Some of the potential applications of biotechnology of interest to chemists in the energy and the environment sectors are considered briefly in this article.

  14. Bioanalysis-related highlights from the 2011 AAPS National Biotechnology Conference.

    Science.gov (United States)

    Crisino, Rebecca M; Dulanto, Beatriz

    2011-08-01

    The American Association of Pharmaceutical Scientists is a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to drug development. The annual National Biotechnology Conference, conducted and organized by the American Association of Pharmaceutical Scientists, is a forum dedicated to advancements in science and technology related to discovery, development and manufacture of medical biotechnology products. The 2011 National Biotechnology Conference meeting convened in San Francisco, CA, USA on 16-18 May. Over 300 abstracts were submitted and approximately 50 sessions examined topics pertaining to advances in drug development, emerging analytical technologies, bioanalysis-related issues, biosimilar therapies, updates on global regulatory documents and expectations, and other topics. The focus of this article is to highlight key developments relevant to immunogenicity and pharmacokinetic drug concentration bioanalysis.

  15. Agricultural biotechnology research and development in Ethiopia

    African Journals Online (AJOL)

    PRECIOUS

    2009-12-29

    Dec 29, 2009 ... Review. Agricultural biotechnology research and development in Ethiopia ... seed micropropagation, virus-cleaning ongoing, good progress. Garlic meristem ... large quantities of disease-free planting materials in short time.

  16. Are Students Prepared to Communicate? A Case Study of an Australian Degree Course in Biotechnology

    Science.gov (United States)

    Edmondston, Joanne; Dawson, Vaille; Schibeci, Renato

    2010-01-01

    Public concerns about biotechnology have resulted in greater attention being paid to the mechanisms by which biotechnology is communicated with non-scientists, including the provision of science communication training. As undergraduate and postgraduate courses form the foundation of the biotechnology sector by providing a pipeline of university…

  17. 78 FR 12074 - Office of Biotechnology Activities; Recombinant DNA Research: Actions Under the NIH Guidelines...

    Science.gov (United States)

    2013-02-21

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology... recommendations of the RAC, the NIH Office of Biotechnology Activities (OBA) concluded that more specific guidance... address or by fax at 301-496-9839 or by mail to the Office of Biotechnology Activities, National...

  18. 75 FR 28811 - Office of Biotechnology Activities; Recombinant DNA Research: Proposed Actions Under the NIH...

    Science.gov (United States)

    2010-05-24

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology... Yersinia pestis has been submitted to the NIH Office of Biotechnology Activities (OBA) by the Institutional... Biotechnology Activities, National Institutes of Health. [FR Doc. 2010-12453 Filed 5-21-10; 8:45 am] BILLING...

  19. Biotechnological production of limonene in microorganisms

    NARCIS (Netherlands)

    Jongedijk, Esmer; Cankar, Katarina; Buchhaupt, Markus; Schrader, Jens; Bouwmeester, Harro; Beekwilder, Jules

    2016-01-01

    This mini review describes novel, biotechnology-based, ways of producing the monoterpene limonene. Limonene is applied in relatively highly priced products, such as fragrances, and also has applications with lower value but large production volume, such as biomaterials. Limonene is currently

  20. Realizing the promises of marine biotechnology

    NARCIS (Netherlands)

    Luiten, EEM; Akkerman, [No Value; Koulman, A; Kamermans, P; Reith, H; Barbosa, MJ; Sipkema, D; Wijffels, RH

    High-quality research in the field of marine biotechnology is one of the key-factors for successful innovation in exploiting the vast diversity of marine life. However, fascinating scientific research with promising results and claims on promising potential applications (e.g. for pharmaceuticals,

  1. Realizing the promises of marine biotechnology

    NARCIS (Netherlands)

    Luiten, E.E.M.; Akkerman, I.; Koulman, A.; Kamermans, P.; Reith, H.; Barbosa, M.J.; Sipkema, D.; Wijffels, R.H.

    2003-01-01

    High-quality research in the field of marine biotechnology is one of the key-factors for successful innovation in exploiting the vast diversity of marine life. However, fascinating scientific research with promising results and claims on promising potential applications (e.g. for pharmaceuticals,

  2. The use of different type of electron beam radiation equipment for biotechnological materials

    International Nuclear Information System (INIS)

    Ferdes, O.; Minea, R.; Oproiu, C.; Ferdes, M.

    1998-01-01

    The potential of using electron beam radiation and bremsstrahlung for some biotechnological materials treatment is presented based on the results of the R and D programme established in 1993 at the Institute of Lasers, Plasma and Radiation Physics Bucharest, Electron Accelerator Laboratory. The main parameters of different electron accelerator types used to process biotechnological materials are presented as these machines were designed, developed and improved. In order to fulfil the radiation processing requirements for biotechnology and environmental protection, betatron, linear and microtron-type electron accelerators are considered and there is an interest to develop a dedicated one as well. The results of irradiation of different biotechnological items as cell cultures, microbial strains, enzymes and biopreparates and cellulose-based wastes are presented

  3. Foundations for a Colombian Biotechnology policy

    Directory of Open Access Journals (Sweden)

    Óscar Castellanos

    2001-07-01

    Full Text Available Globalisation has created challenges for industry related to the constant need for improving national and international productivity and competitivity. Biological knowledge today has growing industrial application as it proposes innovative production methods. This type of biotechnology is becoming more relevant in Colombia's economic and social development all the time. The Colombian Ministry of Development, Colciencias and the National University of Colombia have therefore been jointly developing an integral set of guidelines. These are framed within Colombia's biotechnology policy to create concrete goals, objectives, strategies and direct action from the State, academic institutions and the business world. They encompass six fundamental approaches: markets and management; normativity and legislation; research and development (R&D; economic resources; human resources; and integration training. They al so explicitly raise the question of who shall be responsible for follow-up and the way that the policy's execution and achievements will be evaluated.

  4. Symposium on chemistry and biotechnology for national development. Proceedings

    International Nuclear Information System (INIS)

    Garba, A.; Ogunmola, G.B.

    1998-01-01

    This document is the full proceedings of the symposium on chemistry and biotechnology for national development held at SHESTCO in 1995. It contains the full texts of a forward, opening and special remarks, welcome and keynote addresses and abstracts and texts of 21 technical papers. The subjects covered included information technology,chemistry and biotechnology in agriculture, health care and industrial development. Additionally, the abstracts in respect of 19 other papers are included. We wish to thank the Coordinator of SHESTCO for making available this proceedings

  5. Symposium on chemistry and biotechnology for national development. Proceedings

    Energy Technology Data Exchange (ETDEWEB)

    Garba, A; Ogunmola, G B [eds.

    1998-12-01

    This document is the full proceedings of the symposium on chemistry and biotechnology for national development held at SHESTCO in 1995. It contains the full texts of a forward, opening and special remarks, welcome and keynote addresses and abstracts and texts of 21 technical papers. The subjects covered included information technology,chemistry and biotechnology in agriculture, health care and industrial development. Additionally, the abstracts in respect of 19 other papers are included. We wish to thank the Coordinator of SHESTCO for making available this proceedings.

  6. Possible application of brewer’s spent grain in biotechnology

    OpenAIRE

    Pejin Jelena D.; Radosavljević Miloš S.; Grujić Olgica S.; Mojović Ljiljana V.; Kocić-Tanackov Sunčica D.; Nikolić Svetlana B.; Đukić-Vuković Aleksandra J.

    2013-01-01

    Brewer’s spent grain is the major by-product in beer production. It is produced in large quantities (20 kg per 100 liters of produced beer) throughout the year at a low cost or no cost, and due to its high protein and carbohydrates content it can be used as a raw material in biotechnology. Biotechnological processes based on renewable agro-industrial by-products have ecological (zero CO2 emission, eco-friendly by-products) and economical (cheap raw materials and reduction of storage cos...

  7. Assisted reproductive techniques for cattle breeding in developing countries: a critical appraisal of their value and limitations.

    Science.gov (United States)

    Rodriguez-Martinez, H

    2012-01-01

    Commercialization of animal biotechnologies, including those related to reproduction [also known as assisted reproductive techniques (ARTS)], is an increasing reality in developing countries, following the enormous flow of information around us and the increasing global commercial interests in areas where cattle production has its major assets. The present review discusses the achievements of various biotechnological tools for reproduction in cattle including semen handling for artificial insemination (AI), superovulation and embryo transfer (MOET), in vitro handling of oocytes and production of embryos, reproductive cloning and emerging technologies (sex selection, gene targeting and nuclear transfer for livestock transgenesis, genomics for marker-assisted selection, etc.). The application of these technologies for cattle breeding is critically discussed in relation to their impact in the improvement of the efficiency of dairy and beef production in developed and - particularly - in developing countries, which ultimately rule the possibilities of a competitive and sound production of food for human consumption. Despite the remarkable progress made and the punctual importance of some of the above-mentioned technologies, AI remains the most important assisted reproductive technology (ART) in developing countries. Any attempt to gain widespread of any other ART under the predominant economical conditions in developing countries ought to match the simplicity and the success of AI as a breeding tool. © 2012 Blackwell Verlag GmbH.

  8. Plant biotechnology patents: applications in agriculture and medicine.

    Science.gov (United States)

    Hefferon, Kathleen

    2010-06-01

    Recent advances in agricultural biotechnology have enabled the field of plant biology to move forward in great leaps and bounds. In particular, recent breakthroughs in molecular biology, plant genomics and crop science have brought about a paradigm shift of thought regarding the manner by which plants can be utilized both in agriculture and in medicine. Besides the more well known improvements in agronomic traits of crops such as disease resistance and drought tolerance, plants can now be associated with topics as diverse as biofuel production, phytoremediation, the improvement of nutritional qualities in edible plants, the identification of compounds for medicinal purposes in plants and the use of plants as therapeutic protein production platforms. This diversification of plant science has been accompanied by the great abundance of new patents issued in these fields and, as many of these inventions approach commercial realization, the subsequent increase in agriculturally-based industries. While this review chapter is written primarily for plant scientists who have great interest in the new directions being taken with respect to applications in agricultural biotechnology, those in other disciplines, such as medical researchers, environmental scientists and engineers, may find significant value in reading this article as well. The review attempts to provide an overview of the most recent patents issued for plant biotechnology with respect to both agriculture and medicine. The chapter concludes with the proposal that the combined driving forces of climate change, as well as the ever increasing needs for clean energy and food security will play a pivotal role in leading the direction for applied plant biotechnology research in the future.

  9. Importance of lactobacilli in food and feed biotechnology.

    Science.gov (United States)

    Giraffa, Giorgio; Chanishvili, Nina; Widyastuti, Yantyati

    2010-01-01

    The genus Lactobacillus is a heterogeneous group of lactic acid bacteria (LAB) with important implications in food fermentation. The ability to colonize a variety of habitats is a direct consequence of the wide metabolic versatility of this group of LAB. Consequently, lactobacilli have been used for decades in food preservation, as starters for dairy products, fermented vegetables, fish and sausages as well as silage inoculants. Lactobacilli have also been proposed as probiotics and microbial cell factories for the production of nutraceuticals. However, a wide range of applications of lactobacilli in food biotechnology remains potential, whereas a number of important strains still need to be discovered and characterized. This article provides an overview of the taxonomy of lactobacilli and describes four of the most significant case studies on the application of this group of LAB in food and feed biotechnology, including their use as probiotics, dairy starters, silage inoculants, and microbial cell factories. The importance of access to and exchange of biological material within and between different strain collections as a crucial step in expanding the range of different biotechnological applications of lactobacilli is also emphasized. (c) 2010 Elsevier Masson SAS. All rights reserved.

  10. Nigerian Journal of Biotechnology: Editorial Policies

    African Journals Online (AJOL)

    Nigerian Journal of Biotechnology publishes original research papers, shot ... State Univ., Mubi, Nigeria. yada525@adsu.edu.ng, Molecular biology and bioremediation ... Dr. Kelechi C. Njoku, Dept. of Cell Biology & Genetics, University of Lagos, Lagos, kecynjoku@gmail.com, Environmental Biology ... HOW TO USE AJOL.

  11. Wearing a safety harness during treadmill walking influences lower extremity kinematics mainly through changes in ankle regularity and local stability

    Directory of Open Access Journals (Sweden)

    Decker Leslie M

    2012-02-01

    Full Text Available Abstract Background Wearing a harness during treadmill walking ensures the subject's safety and is common practice in biomedical engineering research. However, the extent to which such practice influences gait is unknown. This study investigated harness-related changes in gait patterns, as evaluated from lower extremity kinematics during treadmill walking. Findings Healthy subjects (n = 10 walked on a treadmill at their preferred speed for 3 minutes with and without wearing a harness (LiteGait®, Mobility Research, Inc.. In the former condition, no weight support was provided to the subjects. Lower extremity kinematics was assessed in the sagittal plane from the mean (meanRoM, standard deviation (SDRoM and coefficient of variation (CoVRoM of the hip, knee, and ankle ranges of motion (RoM, as well as from the sample entropy (SampEn and the largest Lyapunov exponent (LyE of the joints' angles. Wearing the harness increased the meanRoM of the hip, the SDRoM and the CoVRoM of the knee, and the SampEn and the LyE of the ankle. In particular, the harness effect sizes for both the SampEn and the LyE of the ankle were large, likely reflecting a meaningful decline in the neuromuscular stabilizing control of this joint. Conclusions Wearing a harness during treadmill walking marginally influences lower extremity kinematics, resulting in more or less subtle changes in certain kinematic variables. However, in cases where differences in gait patterns would be expressed through modifications in these variables, having subjects walk with a harness may mask or reinforce such differences.

  12. Improved molecular tools for sugar cane biotechnology.

    Science.gov (United States)

    Kinkema, Mark; Geijskes, Jason; Delucca, Paulo; Palupe, Anthony; Shand, Kylie; Coleman, Heather D; Brinin, Anthony; Williams, Brett; Sainz, Manuel; Dale, James L

    2014-03-01

    Sugar cane is a major source of food and fuel worldwide. Biotechnology has the potential to improve economically-important traits in sugar cane as well as diversify sugar cane beyond traditional applications such as sucrose production. High levels of transgene expression are key to the success of improving crops through biotechnology. Here we describe new molecular tools that both expand and improve gene expression capabilities in sugar cane. We have identified promoters that can be used to drive high levels of gene expression in the leaf and stem of transgenic sugar cane. One of these promoters, derived from the Cestrum yellow leaf curling virus, drives levels of constitutive transgene expression that are significantly higher than those achieved by the historical benchmark maize polyubiquitin-1 (Zm-Ubi1) promoter. A second promoter, the maize phosphonenolpyruvate carboxylate promoter, was found to be a strong, leaf-preferred promoter that enables levels of expression comparable to Zm-Ubi1 in this organ. Transgene expression was increased approximately 50-fold by gene modification, which included optimising the codon usage of the coding sequence to better suit sugar cane. We also describe a novel dual transcriptional enhancer that increased gene expression from different promoters, boosting expression from Zm-Ubi1 over eightfold. These molecular tools will be extremely valuable for the improvement of sugar cane through biotechnology.

  13. Dynamic Externalities, Universities and Social Capital Formation in the EU Biotechnology Industry

    Directory of Open Access Journals (Sweden)

    Malgorzata RUNIEWICZ-WARDYN

    2017-03-01

    Full Text Available The paper investigates the role of dynamic externalities, university-industry linkages and role of social networking in the biotechnology industry in the European Union (EU. Universities act as platforms for local knowledge spillovers and university-industry cluster development in the biotechnology field. The R&D activities at universities contribute to successful business innovations. However, the relationship between the universities and the local innovation capabilities is much more complex and therefore requires more in-depth analysis. The following study derives from the knowledge of the new economic geography, endogenous growth theory, biotechnology, as well as theories of social capital and social networks. The quantitative research elaborates contemporary literature and databases to find channels of interdependence between local university-based knowledge flows, social capital, and biotechnology cluster performance. The results of the study show that the biotechnology industry relies very much on university-business R&D partnerships and research mobility (e.g. pharmaceutical firms that performed basic research in close cooperation with academia produced more patents. In addition, social networking and informal contacts seem to be a more important for the diffusion of knowledge, especially at the beginning of R&D process, as they allow for building credibility between potential partners.

  14. Use of isotopic tools to delimit areas of harnessing for drinking water supply - Final report

    International Nuclear Information System (INIS)

    Gourcy, L.; Petelet-Giraud, E.

    2011-03-01

    Within the frame of an action of the ONEMA-BRGM convention (Methodological approaches and tools for the protection of drinking water harnessing against diffuse pollutions), this study aims at developing a synthesis of isotopic geochemical tools to obtain the information required for the delimitation of harnessing supply areas. The report first describes the conventional tools: water molecule steady isotopes, radioactive isotopes, water dating tools, tools developed for another use, and artificial tracers. It presents the possible uses of natural and artificial tracers to determine parameters like flow directions, water residence duration, exchanges between aquifers and water sheet-river interactions. It gives an overview of knowledge on the use of isotopic methods to determine the origin of contaminants. It proposes a brief overview of a previous study of water sheets-rivers relationships. It finally discusses the use of geochemical and isotopic tools when delimiting supply areas for harnessing aimed at drinking water supply

  15. BIOTECHNOLOGY AND MOLECULAR-BASED METHODS FOR GENETIC IMPROVEMENT OF TULIPS

    Directory of Open Access Journals (Sweden)

    Aurel Popescu

    2012-04-01

    Full Text Available Although the conventional methods of improvement have changed significantly throughout the last fifty years, additional tools and novel approaches are needed in order to fasten the process of creation new and highly valuable tulip varieties. The genetic base of tulip production can be preserved and widen by an integration of biotechnology tools in conventional breeding. Micropropagation in vitro may produce very fast large numbers of vigorous plants with high quality and free of endogenous pathogens. The in vitro rescue of embryos resulted from interspecific crosses between more or less distant species, chromosome doubling, somaclonal variation, transformation, and marker-aided selection and breeding are just a few of the examples of the applications of biotechnology in tulip improvement. This review provides an overview of the opportunities presented by the integration of plant biotechnology into the tulip improvement efforts.

  16. 75 FR 69687 - Office of Biotechnology Activities Recombinant DNA Research: Proposed Actions Under the NIH...

    Science.gov (United States)

    2010-11-15

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of Biotechnology... to the NIH Office of Biotechnology Activities (OBA). The data to be considered for certifying a new... same e-mail address or by fax at 301-496-9839 or sent by U.S. mail to the Office of Biotechnology...

  17. Hello World: Harnessing social media for the Rosetta mission

    Science.gov (United States)

    Baldwin, E.; Mignone, C.; O'Flaherty, K. S.; Homfeld, A.-M.; Bauer, M.; McCaughrean, M. J.

    2015-10-01

    The European Space Agency's (ESA) comet-chasing Rosetta mission was launched in 2004, before social media became a popular tool for mainstream communication. By harnessing a range of platforms for communicating the key messages of this unprecedented space adventure as the spacecraft reached its destination ten years later, a wide range of new audiences were reached and could follow this once-in-a-lifetime mission.

  18. Success Factors of Biotechnology Industry Based on Triangular Fuzzy Number

    OpenAIRE

    Lei, Lei

    2013-01-01

    Based on the theory of competitive advantage and value chain, this paper establishes the indicator system, and develop the strategic framework using the fuzzy Delphi method. Then the triangular fuzzy number model is established using Fuzzy Analytic Hierarchy Process, and the key factors influencing biotechnology industry are extracted. The results show that in terms of weight, the key factors influencing the success of biotechnology industry are sequenced as follows: “open innovation capaci...

  19. Biopolicies and biotechnologies: reflections on surrogate maternity in India

    Directory of Open Access Journals (Sweden)

    Mónica Amador

    2010-07-01

    Full Text Available This article explores the impact of biotechnology, particularly on assisted reproductive technologies such as surrogate motherhood. The study is based on interviews and field work conducted in the city of Hyderabad in India within the frame of the seminar on “Research Methodology” given by Dr. Rohan D´Souza at the Centre for Studies in Science Policy at the Jawaharlal Nehru University in India. The theoretical framework of this analysis focuses on exploring concepts such as cyborg (Haraway,1991 and subaltern subject (Spivak, 1998 in the context of biotechnological production in India

  20. [Education on biosafety and bioethics: necessary articulation in biotechnology].

    Science.gov (United States)

    Bonis, Marcos De; Costa, Marco Antonio Ferreira da

    2009-01-01

    Science education has been discussed in some segments of the society and, international organizations have encouraged nations to invest in this strategic area. In this context, education in bioethics and biosafety explores a rich content on prevention, standards and ethical principles which serve to guide the paths track by biotechnology. The recovery of bioethics and biosafety, as part of an educational policy scientific, effective and consistent, can stimulate the formation of individuals with a scientific and citizen awareness, in a position to participate on ethical and technological issues produced by biotechnology.